# EDGAR Filing Document

**Accession Number:** 0000759944
**File Stem:** 0000759944-25-000153
**Filing Date:** 2025-11
**Character Count:** 398219
**Document Hash:** a2afe5a58b87a91620587e3feac4339b
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000759944-25-000153.hdr.sgml**: 20251103

**ACCESSION NUMBER**: 0000759944-25-000153

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 112

**CONFORMED PERIOD OF REPORT**: 20250930

**FILED AS OF DATE**: 20251103

**DATE AS OF CHANGE**: 20251103

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** CITIZENS FINANCIAL GROUP INC/RI
- **CENTRAL INDEX KEY:** 0000759944
- **STANDARD INDUSTRIAL CLASSIFICATION:** STATE COMMERCIAL BANKS [6022]
- **ORGANIZATION NAME:** 02 Finance
- **EIN:** 050412693
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-36636
- **FILM NUMBER:** 251443966

**BUSINESS ADDRESS:**
- **STREET 1:** 1 CITIZENS PLAZA
- **CITY:** PROVIDENCE
- **STATE:** RI
- **ZIP:** 02903
- **BUSINESS PHONE:** 2039006715

**MAIL ADDRESS:**
- **STREET 1:** 1 CITIZENS PLAZA
- **CITY:** PROVIDENCE
- **STATE:** RI
- **ZIP:** 02903

?xml version='1.0' encoding='ASCII'? cfg-20250930

    

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 10-Q**

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

**For the quarterly period ended September 30, 2025**

**or**

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

**For the transition period from _____ to _____**

Commission File Number 001-36636

![image1-logoa03.jpg](cfg-20250930_g1.jpg)

**(Exact name of registrant as specified in its charter)**

---

| | |
|:---|:---|
| **Delaware** | **05-0412693** |
| **(State or other jurisdiction of**<br>**incorporation or organization)** | **(I.R.S. Employer<br>Identification Number)** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**One Citizens Plaza, Providence, RI 02903** 

**(Address of principal executive offices, including zip code)**

**(203) 900-6715** 

**(Registrant's telephone number, including area code)**

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**<u>Title of each class</u>** | **<u>Trading Symbol(s)</u>** | **<u>Name of each exchange on which registered</u>** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Common stock, $0.01 par value per share | CFG | New York Stock Exchange |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depositary Shares, each representing a 1/40th interest in a share of 5.000% Fixed-Rate Non-Cumulative Perpetual Preferred Stock, Series E | CFG PrE | New York Stock Exchange |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depositary Shares, each representing a 1/40th interest in a share of 7.375% Fixed-Rate Non-Cumulative Perpetual Preferred Stock, Series H | CFG PrH | New York Stock Exchange |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depositary Shares, each representing a 1/40th interest in a share of 6.500% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock, Series I | CFG PrI | New York Stock Exchange |

---

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. ☑ Yes ☐ No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☑ Yes ☐ No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act:

---

| | | | |
|:---|:---|:---|:---|
| &nbsp;&nbsp;Large accelerated filer | ☑ | Accelerated filer | ☐ |
| &nbsp;&nbsp;Non-accelerated filer  | ☐ | Smaller reporting company | ☐ |
| | | Emerging growth company | ☐ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐ Yes ☑ No

There were 429,486,191 shares of the registrant's common stock ($0.01 par value) outstanding on October 24, 2025.

------

---

| | | |
|:---|:---|:---|
| | **Table of Contents** | |
| **<u>[Glossary of Acronyms and Terms](#i8c5674cd6d39421d826c711b06a6c8c1_10)</u>** | **<u>[Glossary of Acronyms and Terms](#i8c5674cd6d39421d826c711b06a6c8c1_10)</u>** | <u>[3](#i8c5674cd6d39421d826c711b06a6c8c1_10)</u> |
| **<u>[Part I. Financial Information](#i8c5674cd6d39421d826c711b06a6c8c1_13)</u>** | **<u>[Part I. Financial Information](#i8c5674cd6d39421d826c711b06a6c8c1_13)</u>** | <u>[5](#i8c5674cd6d39421d826c711b06a6c8c1_13)</u> |
| &nbsp;&nbsp;**<u>[Item 1. Financial Statements (unaudited)](#i8c5674cd6d39421d826c711b06a6c8c1_103)</u>** | &nbsp;&nbsp;**<u>[Item 1. Financial Statements (unaudited)](#i8c5674cd6d39421d826c711b06a6c8c1_103)</u>** | <u>[37](#i8c5674cd6d39421d826c711b06a6c8c1_103)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**<u>[Consolidated Balance Sheets](#i8c5674cd6d39421d826c711b06a6c8c1_106)</u>** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**<u>[Consolidated Balance Sheets](#i8c5674cd6d39421d826c711b06a6c8c1_106)</u>** | <u>[38](#i8c5674cd6d39421d826c711b06a6c8c1_106)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**<u>[Consolidated Statements of Operations](#i8c5674cd6d39421d826c711b06a6c8c1_109)</u>** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**<u>[Consolidated Statements of Operations](#i8c5674cd6d39421d826c711b06a6c8c1_109)</u>** | <u>[39](#i8c5674cd6d39421d826c711b06a6c8c1_109)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**<u>[Consolidated Statements of Comprehensive Income](#i8c5674cd6d39421d826c711b06a6c8c1_112)</u>** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**<u>[Consolidated Statements of Comprehensive Income](#i8c5674cd6d39421d826c711b06a6c8c1_112)</u>** | <u>[40](#i8c5674cd6d39421d826c711b06a6c8c1_112)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**<u>[Consolidated Statements of Changes in Stockholders' Equity](#i8c5674cd6d39421d826c711b06a6c8c1_115)</u>** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**<u>[Consolidated Statements of Changes in Stockholders' Equity](#i8c5674cd6d39421d826c711b06a6c8c1_115)</u>** | <u>[41](#i8c5674cd6d39421d826c711b06a6c8c1_115)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**<u>[Consolidated Statements of Cash Flows](#i8c5674cd6d39421d826c711b06a6c8c1_118)</u>** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**<u>[Consolidated Statements of Cash Flows](#i8c5674cd6d39421d826c711b06a6c8c1_118)</u>** | <u>[43](#i8c5674cd6d39421d826c711b06a6c8c1_118)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**<u>[Notes to Consolidated Financial Statements](#i8c5674cd6d39421d826c711b06a6c8c1_121)</u>** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**<u>[Notes to Consolidated Financial Statements](#i8c5674cd6d39421d826c711b06a6c8c1_121)</u>** | <u>[44](#i8c5674cd6d39421d826c711b06a6c8c1_121)</u> |
| &nbsp;&nbsp;**<u>[Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations](#i8c5674cd6d39421d826c711b06a6c8c1_16)</u>** | &nbsp;&nbsp;**<u>[Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations](#i8c5674cd6d39421d826c711b06a6c8c1_16)</u>** | <u>[5](#i8c5674cd6d39421d826c711b06a6c8c1_16)</u> |
| &nbsp;&nbsp;**<u>[Item 3. Quantitative and Qualitative Disclosures about Market Risk](#i8c5674cd6d39421d826c711b06a6c8c1_184)</u>** | &nbsp;&nbsp;**<u>[Item 3. Quantitative and Qualitative Disclosures about Market Risk](#i8c5674cd6d39421d826c711b06a6c8c1_184)</u>** | <u>[80](#i8c5674cd6d39421d826c711b06a6c8c1_184)</u> |
| &nbsp;&nbsp;**<u>[Item 4. Controls and Procedures](#i8c5674cd6d39421d826c711b06a6c8c1_187)</u>** | &nbsp;&nbsp;**<u>[Item 4. Controls and Procedures](#i8c5674cd6d39421d826c711b06a6c8c1_187)</u>** | <u>[81](#i8c5674cd6d39421d826c711b06a6c8c1_187)</u> |
| **<u>[Part II. Other Information](#i8c5674cd6d39421d826c711b06a6c8c1_190)</u>** | **<u>[Part II. Other Information](#i8c5674cd6d39421d826c711b06a6c8c1_190)</u>** | <u>[81](#i8c5674cd6d39421d826c711b06a6c8c1_190)</u> |
| &nbsp;&nbsp;**<u>[Item 1. Legal Proceedings](#i8c5674cd6d39421d826c711b06a6c8c1_193)</u>** | &nbsp;&nbsp;**<u>[Item 1. Legal Proceedings](#i8c5674cd6d39421d826c711b06a6c8c1_193)</u>** | <u>[81](#i8c5674cd6d39421d826c711b06a6c8c1_193)</u> |
| &nbsp;&nbsp;**<u>[Item 1A. Risk Factors](#i8c5674cd6d39421d826c711b06a6c8c1_196)</u>** | &nbsp;&nbsp;**<u>[Item 1A. Risk Factors](#i8c5674cd6d39421d826c711b06a6c8c1_196)</u>** | <u>[81](#i8c5674cd6d39421d826c711b06a6c8c1_196)</u> |
| &nbsp;&nbsp;**<u>[Item 2. Unregistered Sales of Equity Securities and Use of Proceeds](#i8c5674cd6d39421d826c711b06a6c8c1_199)</u>** | &nbsp;&nbsp;**<u>[Item 2. Unregistered Sales of Equity Securities and Use of Proceeds](#i8c5674cd6d39421d826c711b06a6c8c1_199)</u>** | <u>[81](#i8c5674cd6d39421d826c711b06a6c8c1_199)</u> |
| &nbsp;&nbsp;**<u>[Item 3. Defaults Upon Senior Securities](#i8c5674cd6d39421d826c711b06a6c8c1_202)</u>** | &nbsp;&nbsp;**<u>[Item 3. Defaults Upon Senior Securities](#i8c5674cd6d39421d826c711b06a6c8c1_202)</u>** | <u>[81](#i8c5674cd6d39421d826c711b06a6c8c1_202)</u> |
| &nbsp;&nbsp;**<u>[Item 4. Mine Safety Disclosures](#i8c5674cd6d39421d826c711b06a6c8c1_205)</u>** | &nbsp;&nbsp;**<u>[Item 4. Mine Safety Disclosures](#i8c5674cd6d39421d826c711b06a6c8c1_205)</u>** | <u>[81](#i8c5674cd6d39421d826c711b06a6c8c1_205)</u> |
| &nbsp;&nbsp;**<u>[Item 5. Other Information](#i8c5674cd6d39421d826c711b06a6c8c1_208)</u>** | &nbsp;&nbsp;**<u>[Item 5. Other Information](#i8c5674cd6d39421d826c711b06a6c8c1_208)</u>** | <u>[82](#i8c5674cd6d39421d826c711b06a6c8c1_208)</u> |
| &nbsp;&nbsp;**<u>[Item 6. Exhibits](#i8c5674cd6d39421d826c711b06a6c8c1_211)</u>** | &nbsp;&nbsp;**<u>[Item 6. Exhibits](#i8c5674cd6d39421d826c711b06a6c8c1_211)</u>** | <u>[82](#i8c5674cd6d39421d826c711b06a6c8c1_211)</u> |
| **<u>[Signature](#i8c5674cd6d39421d826c711b06a6c8c1_214)</u>** | **<u>[Signature](#i8c5674cd6d39421d826c711b06a6c8c1_214)</u>** | <u>[83](#i8c5674cd6d39421d826c711b06a6c8c1_214)</u> |

---

Citizens Financial Group, Inc. \| 2

------

**GLOSSARY OF ACRONYMS AND TERMS**

&nbsp;&nbsp;&nbsp;&nbsp;The following is a list of common acronyms and terms used regularly in our financial reporting:

---

| | |
|:---|:---|
| **2024 Form 10-K** | Annual Report on Form 10-K for the year ended December 31, 2024 |
| **AACL** | Adjusted Allowance for Credit Losses |
| **ACL** | Allowance for Credit Losses: Allowance for Loan and Lease Losses plus Allowance for Unfunded Lending Commitments |
| **AFS** | Available for Sale |
| **ALM** | Asset and Liability Management |
| **AOCI** | Accumulated Other Comprehensive Income (Loss) |
| **ASU** | Accounting Standards Update |
| **ATM** | Automated Teller Machine |
| **Board or Board of Directors** | The Board of Directors of Citizens Financial Group, Inc. |
| **bps** | Basis Points |
| **CBNA** | Citizens Bank, National Association |
| **CCB** | Capital Conservation Buffer |
| **CECL** | Current Expected Credit Losses  |
| **CET1** | Common Equity Tier 1 |
| **CET1 capital ratio** | Common Equity Tier 1 capital divided by total risk-weighted assets as defined under the U.S. Basel III Standardized approach |
| **Citizens, CFG, the Company, we, us, or our** | Citizens Financial Group, Inc. and its Consolidated Subsidiaries  |
| **CLTV** | Combined Loan-to-Value |
| **CODM** | Chief Operating Decision Maker |
| **CRE** | Commercial Real Estate |
| **Efficiency Ratio** | Noninterest expense divided by total revenue, inclusive of net interest income and noninterest income |
| **EPS** | Earnings Per Share |
| **EVE** | Economic Value of Equity |
| **Exchange Act** | The Securities Exchange Act of 1934, as amended |
| **Fannie Mae (FNMA)** | Federal National Mortgage Association |
| **FDIC** | Federal Deposit Insurance Corporation |
| **FDM** | Financially Distressed Modification |
| **FHA** | Federal Housing Administration |
| **FHLB** | Federal Home Loan Bank |
| **FICO** | Fair Isaac Corporation (credit rating) |
| **FRB or Federal Reserve** | Board of Governors of the Federal Reserve System and, as applicable, Federal Reserve Bank(s) |
| **Freddie Mac (FHLMC)** | Federal Home Loan Mortgage Corporation |
| **FTE** | Fully Taxable Equivalent |
| **GAAP** | Accounting Principles Generally Accepted in the United States of America |
| **GDP** | Gross Domestic Product |
| **Ginnie Mae (GNMA)** | Government National Mortgage Association |
| **GSE** | Government Sponsored Entity |
| **HTM** | Held To Maturity |
| **LHFS** | Loans Held for Sale |
| **LIHTC** | Low Income Housing Tax Credit |
| **M&A** | Merger and Acquisition |
| **MD&A** | Management's Discussion and Analysis of Financial Condition and Results of Operations |

---

Citizens Financial Group, Inc. \| 3

------

---

| | |
|:---|:---|
| **Modified AACL transition** | The Day-1 CECL adoption entry booked to ACL plus 25% of subsequent CECL ACL reserve build |
| **Modified CECL transition** | The Day-1 CECL adoption entry booked to retained earnings plus 25% of subsequent CECL ACL reserve build |
| **MSR** | Mortgage Servicing Right |
| **NM** | Not meaningful |
| **NMTC** | New Markets Tax Credit |
| **OCC** | Office of the Comptroller of the Currency |
| **OCI** | Other Comprehensive Income (Loss) |
| **Parent Company** | Citizens Financial Group, Inc. (the Parent Company of Citizens Bank, National Association and other subsidiaries) |
| **PCD** | Purchased Credit Deteriorated |
| **ROTCE** | Return on Average Tangible Common Equity |
| **RPA** | Risk Participation Agreement |
| **RWA** | Risk-Weighted Assets |
| **SBA** | United States Small Business Administration |
| **SCB** | Stress Capital Buffer |
| **SEC** | United States Securities and Exchange Commission |
| **SOFR** | Secured Overnight Financing Rate |
| **SPE** | Special Purpose Entity |
| **TBA** | To-Be-Announced Mortgage Security |
| **Tier 1 capital ratio** | Tier 1 capital, which includes Common Equity Tier 1 capital plus non-cumulative perpetual preferred equity that qualifies as additional Tier 1 capital, divided by total risk-weighted assets as defined under the U.S. Basel III Standardized approach |
| **Tier 1 leverage ratio** | Tier 1 capital, which includes Common Equity Tier 1 capital plus non-cumulative perpetual preferred equity that qualifies as additional Tier 1 capital, divided by quarterly adjusted average assets as defined under the U.S. Basel III Standardized approach |
| **Total capital ratio** | Total capital, which includes Common Equity Tier 1 capital, Tier 1 capital, and allowance for credit losses and qualifying subordinated debt that qualifies as Tier 2 capital, divided by total risk-weighted assets as defined under the U.S. Basel III Standardized approach |
| **USDA** | United States Department of Agriculture |
| **VA** | United States Department of Veterans Affairs |
| **VaR** | Value at Risk |
| **VIE** | Variable Interest Entity |

---

Citizens Financial Group, Inc. \| 4

------

**PART I. FINANCIAL INFORMATION**

**ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS**

---

| | |
|:---|:---|
| | <u>Page</u> |
| **<u>[Forward-Looking Statements](#i8c5674cd6d39421d826c711b06a6c8c1_19)</u>** | <u>[6](#i8c5674cd6d39421d826c711b06a6c8c1_19)</u> |
| **<u>[Introduction](#i8c5674cd6d39421d826c711b06a6c8c1_22)</u>** | <u>[7](#i8c5674cd6d39421d826c711b06a6c8c1_22)</u> |
| **<u>[Executive Summary](#i8c5674cd6d39421d826c711b06a6c8c1_25)</u>** | <u>[7](#i8c5674cd6d39421d826c711b06a6c8c1_25)</u> |
| **<u>[Results of Operations](#i8c5674cd6d39421d826c711b06a6c8c1_28)</u>** | <u>[9](#i8c5674cd6d39421d826c711b06a6c8c1_28)</u> |
| **<u>[Analysis of Financial Condition](#i8c5674cd6d39421d826c711b06a6c8c1_46)</u>** | <u>[14](#i8c5674cd6d39421d826c711b06a6c8c1_46)</u> |
| **<u>[Business Segments](#i8c5674cd6d39421d826c711b06a6c8c1_64)</u>** | <u>[20](#i8c5674cd6d39421d826c711b06a6c8c1_64)</u> |
| **<u>[Risk Management](#i8c5674cd6d39421d826c711b06a6c8c1_67)</u>** | <u>[21](#i8c5674cd6d39421d826c711b06a6c8c1_67)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;**<u>[Credit Risk](#i8c5674cd6d39421d826c711b06a6c8c1_70)</u>** | <u>[22](#i8c5674cd6d39421d826c711b06a6c8c1_70)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;**<u>[Market Risk](#i8c5674cd6d39421d826c711b06a6c8c1_73)</u>** | <u>[22](#i8c5674cd6d39421d826c711b06a6c8c1_73)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;**<u>[Liquidity Risk](#i8c5674cd6d39421d826c711b06a6c8c1_79)</u>** | <u>[25](#i8c5674cd6d39421d826c711b06a6c8c1_79)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;**<u>[Operational Risk](#i8c5674cd6d39421d826c711b06a6c8c1_82)</u>** | <u>[28](#i8c5674cd6d39421d826c711b06a6c8c1_82)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;**<u>[Compliance Risk](#i8c5674cd6d39421d826c711b06a6c8c1_85)</u>** | <u>[29](#i8c5674cd6d39421d826c711b06a6c8c1_85)</u> |
| **<u>[Capital](#i8c5674cd6d39421d826c711b06a6c8c1_88)</u>** | <u>[29](#i8c5674cd6d39421d826c711b06a6c8c1_88)</u> |
| **<u>[Critical Accounting Estimates](#i8c5674cd6d39421d826c711b06a6c8c1_91)</u>** | <u>[32](#i8c5674cd6d39421d826c711b06a6c8c1_91)</u> |
| **<u>[Accounting and Reporting Developments](#i8c5674cd6d39421d826c711b06a6c8c1_94)</u>** | <u>[34](#i8c5674cd6d39421d826c711b06a6c8c1_94)</u> |
| **<u>[Non-GAAP Financial Measures](#i8c5674cd6d39421d826c711b06a6c8c1_97)</u>** | <u>[35](#i8c5674cd6d39421d826c711b06a6c8c1_97)</u> |

---

Citizens Financial Group, Inc. \| 5

------

**FORWARD-LOOKING STATEMENTS**

This document contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statement that does not describe historical or current facts is a forward-looking statement. These statements often include the words "believes," "expects," "anticipates," "estimates," "intends," "plans," "goals," "targets," "initiatives," "potentially," "probably," "projects," "outlook," "guidance" or similar expressions or future conditional verbs such as "may," "will," "likely," "should," "would," and "could."

Forward-looking statements are based upon the current beliefs and expectations of management, and on information currently available to management. Our statements speak as of the date hereof, and we do not assume any obligation to update these statements or to update the reasons why actual results could differ from those contained in such statements in light of new information or future events. We caution you, therefore, against relying on any of these forward-looking statements. They are neither statements of historical fact nor guarantees or assurances of future performance. While there is no assurance that any list of risks and uncertainties or risk factors is complete, important factors that could cause actual results to differ materially from those in the forward-looking statements include the following, without limitation:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Negative economic, business, and political conditions, including as a result of the interest rate environment, supply chain disruptions, tariffs, inflationary pressures, and labor shortages that adversely affect the general economy, housing prices, the job market, consumer confidence, and spending habits;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The general state of the economy and employment, as well as general business and economic conditions, and changes in the competitive environment;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our capital and liquidity requirements under regulatory standards and our ability to generate capital and liquidity on favorable terms;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The effect of changes in our credit ratings on our cost of funding, access to capital markets, ability to market our securities, and overall liquidity position;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The effect of changes in the level of commercial and consumer deposits on our funding costs and net interest margin;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our ability to execute on our strategic business initiatives and achieve our financial performance goals across our Consumer and Commercial businesses, including our Private Bank;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The effects of geopolitical instability, including the wars in Ukraine and the Middle East, on economic and market conditions, inflationary pressures and the interest rate environment, commodity price and foreign exchange rate volatility, and heightened cybersecurity risks;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our ability to comply with heightened supervisory requirements and expectations as well as new or amended regulations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Liabilities and business restrictions resulting from litigation and regulatory investigations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The effect of changes in interest rates on our net interest income, net interest margin, mortgage originations, mortgage servicing rights, and mortgages held for sale;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Changes in interest rates and market liquidity, as well as the magnitude of such changes, which may reduce interest margins, impact funding sources, and affect the ability to originate and distribute financial products in the primary and secondary markets;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Financial services reform and other current, pending, or future legislation or regulation that could have a negative effect on our revenue and businesses;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Environmental risks, such as physical or transition risks associated with climate change, and social and governance risks that could adversely affect our reputation, operations, business, and customers;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• A failure in, or breach of, our compliance with laws, as well as operational or security systems or infrastructure, or those of our third-party vendors or other service providers, including as a result of cyberattacks; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Management's ability to identify and manage these and other risks.

Citizens Financial Group, Inc. \| 6

------

In addition to the above factors, we also caution that the actual amounts and timing of any future common stock dividends or share repurchases will be subject to various factors, including our capital position, financial performance, balance sheet growth, market conditions, and regulatory considerations, as well as any other factors that our Board of Directors deems relevant in making such a determination. Therefore, there can be no assurance that we will repurchase shares from, or pay any dividends to, holders of our common stock, or as to the amount of any such repurchases or dividends.

More information about factors that could cause actual results to differ materially from those described in the forward-looking statements can be found in the "Risk Factors" section in Part I, Item 1A of our 2024 Form 10-K.

**INTRODUCTION**

Citizens Financial Group, Inc. is one of the nation's oldest and largest financial institutions, with $222.7 billion in assets as of September 30, 2025. Headquartered in Providence, Rhode Island, we offer a broad range of retail and commercial banking products and services to individuals, small businesses, middle-market companies, large corporations, and institutions. We help our customers reach their potential by listening to them and by understanding their needs in order to offer tailored advice, ideas, and solutions. In Consumer Banking, we provide an integrated experience that includes mobile and online banking, a full-service customer contact center, and the convenience of approximately 3,100 ATMs and approximately 1,000 branches in 14 states and the District of Columbia. Consumer Banking products and services include a full range of banking, lending, savings, wealth management, and small business offerings. In Commercial Banking, we offer a broad complement of financial products and solutions, including lending and leasing, deposit and treasury management services, foreign exchange, interest rate and commodity risk management solutions, as well as loan syndication, corporate finance, merger and acquisition, and debt and equity capital markets capabilities.

The following MD&A is intended to assist readers in their analysis of the accompanying unaudited interim Consolidated Financial Statements and supplemental financial information. It should be read in conjunction with the unaudited interim Consolidated Financial Statements and Notes to Consolidated Financial Statements in Part I, Item 1, as well as other information contained in this document and our 2024 Form 10-K.

**EXECUTIVE SUMMARY**

This summary highlights select financial information of the Company as well as information regarding certain significant events and transactions occurring during the nine months ended September 30, 2025. This summary should be read in conjunction with this entire document for a more complete understanding of trends, events, commitments, uncertainties, liquidity, capital resources, and critical accounting policies and estimates. Each of these items, taken individually or collectively, could have an impact on the Company's financial condition, results of operations, and cash flows. For additional information regarding our financial performance and condition, see "Results of Operations" and "Analysis of Financial Condition."

*Key Financial Highlights*

***•*** Net income of $494 million and $1.3 billion for the three and nine months ended September 30, 2025, respectively, increased $112 million and $195 million, with earnings per diluted common share up $0.28 to $1.05 and up $0.54 to $2.74, compared to the same periods in 2024.

• Net interest income of $1.5 billion and $4.3 billion for the three and nine months ended September 30, 2025, respectively, increased $119 million and $95 million compared to the same periods in 2024, driven by higher net interest margin reflecting lower funding costs, the time-based benefits of the Non-Core portfolio runoff, terminated swap impacts, and fixed-rate asset repricing benefits.

• Net interest margin on an FTE basis of 3.00% and 2.95% for the three and nine months ended September 30, 2025, respectively, increased 23 basis points and 10 basis points compared to the same periods in 2024, driven by lower funding costs, the time-based benefits of the Non-Core portfolio runoff, terminated swap impacts, and fixed-rate asset repricing benefits.

• Noninterest income of $630 million and $1.8 billion for the three and nine months ended September 30, 2025, respectively, increased $98 million and $172 million compared to the same periods in 2024, primarily driven by higher wealth, mortgage banking, capital markets, and service charge fees.

Citizens Financial Group, Inc. \| 7

------

• Noninterest expense of $1.3 billion and $4.0 billion for the three and nine months ended September 30, 2025, respectively, increased $76 million and $50 million compared to the same periods in 2024, driven by salaries and employee benefits reflecting hiring related to the Private Bank and Private Wealth build-out, strong capital markets fee performance, and increased medical benefit costs. The increase during the nine-month period was partially offset by a decline in other operating expense primarily driven by lower FDIC deposit insurance costs.

• Provision expense of $154 million and $471 million for the three and nine months ended September 30, 2025, respectively, decreased $18 million and $54 million compared to the same periods in 2024, reflecting runoff of the Non-Core portfolio and improving loan mix.

• The efficiency ratio of 63.03% and 65.16% for the three and nine months ended September 30, 2025, respectively, compared to 66.23% and 67.28% for the same periods in 2024.

• ROTCE of 11.75% and 10.84% for the three and nine months ended September 30, 2025, respectively, compared to 9.45% and 9.63% for the same periods in 2024.

• Tangible book value per common share of $36.73 increased 14% from December 31, 2024, driven by a decrease in common shares outstanding of nine million and a net increase in tangible common equity of $1.6 billion. The increase in tangible common equity is primarily attributable to increases in AOCI of $1.3 billion and retained earnings of $644 million, including net income of $1.3 billion for the nine months ended September 30, 2025.

See "Non-GAAP Financial Measures" for more information regarding the ROTCE and tangible book value per common share non-GAAP financial measures presented herein.

*Sale of Education Loans*

During the first quarter of 2025, we entered into an agreement to sell $1.9 billion of Non-Core education loans and subsequently reclassified these loans to LHFS. Upon reclassification to LHFS, a charge-off of $25 million was recognized, which was covered by existing reserves. This transaction will settle ratably each quarter throughout 2025, of which approximately $1.4 billion has settled to date, with the remaining $500 million scheduled to settle during the fourth quarter of 2025.

*Share Repurchases*

On June 13, 2025, we announced that our Board of Directors increased the capacity of our common share repurchase program to $1.5 billion, an increase of $1.2 billion above the $300 million of capacity remaining under the prior June 2024 authorization. During the three and nine months ended September 30, 2025, the Parent Company repurchased $75 million and $475 million, respectively, of its outstanding common stock. See Note 10 and Item 2 for additional information on share repurchase activity.

*Preferred Stock* 

On July 31, 2025, we issued $400 million, or 400,000 shares, of 6.500% fixed-rate reset non-cumulative perpetual Series I Preferred Stock, par value of $25 per share with a liquidation preference of $1,000 per share. Holders of Series I Preferred Stock will be entitled to receive dividend payments only when, as, and if declared by our Board of Directors. Any such dividends will be payable quarterly in arrears on January 6, April 6, July 6, and October 6 of each year, beginning on January 6, 2026 (long first dividend period).

The net proceeds from the issuance of the Series I Preferred Stock were used to redeem all of the outstanding shares of our 5.650% fixed-rate reset non-cumulative perpetual Series F Preferred Stock on the dividend payment and earliest available redemption date of October 6, 2025.

For more information regarding our Series I Preferred Stock issuance and Series F Preferred Stock redemption, see Note 10.

*Common Stock Dividend*

On October 15, 2025, we announced that our Board of Directors declared a quarterly common stock dividend of $0.46 per share, a $0.04, or 9.5%, increase compared to the prior quarter. The dividend is payable on November 12, 2025 to shareholders of record at the close of business on October 29, 2025.

Citizens Financial Group, Inc. \| 8

------

*Other Developments*

On March 27, 2025, the SEC voted to end its defense of several court challenges of its climate disclosure rule. The rule requires companies to disclose certain climate-related matters, including risks, activities to mitigate or adapt to such risks, governance, financial effects of severe weather events, and audited measurements of certain greenhouse gas emissions. The SEC paused implementation of the rule last year while federal courts considered various legal challenges brought by states, businesses, and business groups, which were consolidated in the U.S. Court of Appeals for the Eighth Circuit. With the SEC withdrawing from the lawsuit, litigation is expected to continue with the court ultimately deciding whether the rule will remain in effect as adopted. The rule remains stayed until the litigation is resolved. For additional information regarding the SEC's climate-related rule and other climate-related laws and regulations that we may be subject to, see "Regulation and Supervision" in our 2024 Form 10-K.

On July 4, 2025, H.R. 1, entitled the *One Big Beautiful Bill Act,* was signed into law*.* This bill includes a broad range of tax reform provisions affecting individuals and businesses, including extending and modifying certain key Tax Cuts & Jobs Act provisions, extending certain Inflation Reduction Act energy incentives while accelerating the phase-out of others, and implementing various other tax cuts and spending measures. We have completed our initial evaluation of the bill and do not expect it to have a material impact on our Consolidated Financial Statements.

On July 16, 2025, the FDIC, FRB, and OCC issued a joint notice of proposed rulemaking ("NPR") to rescind the Community Reinvestment Act ("CRA") final rule issued in October 2023 and replace it with the prior CRA regulations adopted by the agencies in 1995, with certain technical amendments. The NPR is intended to restore certainty in the CRA regulatory framework for stakeholders and limit regulatory burden on financial institutions. For additional information regarding the CRA, see "Regulation and Supervision" in our 2024 Form 10-K.

We will continue to monitor these regulatory and legislative developments and evaluate their associated impact on us.

**RESULTS OF OPERATIONS**

**Net Interest Income**

Net interest income is our largest source of revenue and is the difference between the interest earned on interest-earning assets (generally loans and investment securities) and the interest expense incurred in connection with interest-bearing liabilities (generally deposits and borrowed funds). The level of net interest income is primarily a function of the difference between the effective yield on our average interest-earning assets and the effective cost of our interest-bearing liabilities. Factors that influence our net interest income include, but are not limited to, the pricing and mix of interest-earning assets and interest-bearing liabilities which, in turn, are impacted by external factors such as economic conditions, competition for loans and deposits, the monetary policy of the FRB, and market interest rates. For further discussion, refer to the "Market Risk" and "Risk Governance" sections of our 2024 Form 10-K.

Citizens Financial Group, Inc. \| 9

------

The following tables present the major components of our net interest income. Average balance represents amortized cost, excluding the unamortized basis adjustments related to the transfer of certain HTM securities from AFS. The yield/rate is based on annualized interest income or expense for the periods presented and includes the impact of hedging activities associated with the respective asset and liability categories.

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| ***Table 1: Major Components of Net Interest Income*** | ***Table 1: Major Components of Net Interest Income*** | ***Table 1: Major Components of Net Interest Income*** | ***Table 1: Major Components of Net Interest Income*** | ***Table 1: Major Components of Net Interest Income*** | | | | | |
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Three Months Ended September 30,** | | | |
|  | **2025** | **2025** | **2025** | **2024** | **2024** | **2024** | **Change** | **Change** | **Change** |
| (dollars in millions) | **Average<br>Balance** | **Income/<br>Expense** | **Yield/<br>Rate** | **Average<br>Balance** | **Income/<br>Expense** | **Yield/<br>Rate** | **Average<br>Balance** | **Yield/<br>Rate (bps)** | **Yield/<br>Rate (bps)** |
| **Assets** |  |  |  |  |  |  |  |  |  |
| Interest-bearing cash and due from banks and deposits in banks | $9015 | $97 | 4.24% | $8896 | $121 | 5.30% | $119 | (106) bps | (106) bps |
| Taxable investment securities | 46452 | 433 | 3.71 | 45083 | 423 | 3.75 | 1369 | (4) |  |
| Non-taxable investment securities | 1 |  | 2.60 | 1 |  | 2.60 |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total investment securities | 46453 | 433 | 3.71 | 45084 | 423 | 3.75 | 1369 | (4) |  |
| Commercial and industrial | 46351 | 581 | 4.91 | 44071 | 556 | 4.95 | 2280 | (4) |  |
| Commercial real estate | 25799 | 380 | 5.76 | 28209 | 452 | 6.26 | (2410) | (50) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total commercial | 72150 | 961 | 5.21 | 72280 | 1008 | 5.46 | (130) | (25) |  |
| Residential mortgages | 34134 | 339 | 3.98 | 32117 | 301 | 3.75 | 2017 | 23 |  |
| Home equity | 18027 | 322 | 7.07 | 15733 | 317 | 8.02 | 2294 | (95) |  |
| Automobile | 3096 | 35 | 4.44 | 5942 | 64 | 4.28 | (2846) | 16 |  |
| Education | 8513 | 129 | 5.98 | 11155 | 153 | 5.45 | (2642) | 53 |  |
| Other retail | 4091 | 111 | 10.92 | 4776 | 133 | 11.04 | (685) | (12) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total retail | 67861 | 936 | 5.49 | 69723 | 968 | 5.53 | (1862) | (4) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total loans and leases | 140011 | 1897 | 5.35 | 142003 | 1976 | 5.50 | (1992) | (15) |  |
| Loans held for sale | 2119 | 31 | 5.73 | 1181 | 19 | 6.26 | 938 | (53) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest-earning assets | 197598 | 2458 | 4.92 | 197164 | 2539 | 5.09 | 434 | (17) |  |
| Noninterest-earning assets | 21519 |  |  | 21414 |  |  | 105 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total assets | $219117 |  |  | $218578 |  |  | $539 |  |  |
| **Liabilities and Stockholders' Equity** |  |  |  |  |  |  |  |  |  |
| Checking with interest | $34748 | $134 | 1.54% | $33090 | $131 | 1.58% | $1658 | (4) |  |
| Savings | 25001 | 86 | 1.36 | 26868 | 128 | 1.89 | (1867) | (53) |  |
| Money market | 57783 | 411 | 2.82 | 53152 | 444 | 3.32 | 4631 | (50) |  |
| Time | 20355 | 185 | 3.61 | 24705 | 287 | 4.65 | (4350) | (104) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total interest-bearing deposits | 137887 | 816 | 2.35 | 137815 | 990 | 2.86 | 72 | (51) |  |
| Short-term borrowed funds | 589 | 5 | 2.91 | 150 | 3 | 6.06 | 439 | (315) |  |
| Long-term borrowed funds | 11643 | 149 | 5.11 | 13690 | 177 | 5.20 | (2047) | (9) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total borrowed funds | 12232 | 154 | 5.01 | 13840 | 180 | 5.21 | (1608) | (20) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total interest-bearing liabilities | 150119 | 970 | 2.56 | 151655 | 1170 | 3.07 | (1536) | (51) |  |
| Noninterest-bearing demand deposits | 38070 |  |  | 36236 |  |  | 1834 |  |  |
| Other noninterest-bearing liabilities | 5387 |  |  | 6194 |  |  | (807) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | 193576 |  |  | 194085 |  |  | (509) |  |  |
| Stockholders' equity | 25541 |  |  | 24493 |  |  | 1048 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total liabilities and stockholders' equity | $219117 |  |  | $218578 |  |  | $539 |  |  |
| Interest rate spread |  |  | 2.36% |  |  | 2.02% |  | 34 |  |
| Net interest income and net interest margin |  | $1488 | 2.99% |  | $1369 | 2.76% |  | 23 |  |
| Net interest income and net interest margin, FTE<sup>(1)</sup> |  | $1492 | 3.00% |  | $1373 | 2.77% |  | 23 |  |
| Memo: Total deposits (interest-bearing and noninterest-bearing demand) | $175957 | $816 | 1.84% | $174051 | $990 | 2.26% | $1906 | (42) | bps |

---

Citizens Financial Group, Inc. \| 10

------

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** | | | |
| | **2025** | **2025** | **2025** | **2024** | **2024** | **2024** | **Change** | **Change** | **Change** |
| (dollars in millions) | **Average<br>Balance** | **Income/<br>Expense** | **Yield/<br>Rate** | **Average<br>Balance** | **Income/<br>Expense** | **Yield/<br>Rate** | **Average<br>Balance** | **Yield/<br>Rate (bps)** | **Yield/<br>Rate (bps)** |
| **Assets:** |  |  |  |  |  |  |  |  |  |
| Interest-bearing cash and due from banks and deposits in banks | $8445 | $278 | 4.35% | $9602 | $391 | 5.35% | ($1157) | (100) bps | (100) bps |
| Taxable investment securities | 46354 | 1279 | 3.68 | 44561 | 1239 | 3.71 | 1793 | (3) |  |
| Non-taxable investment securities | 1 |  | 2.60 | 1 |  | 2.60 |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total investment securities | 46355 | 1279 | 3.68 | 44562 | 1239 | 3.71 | 1793 | (3) |  |
| Commercial and industrial | 44972 | 1645 | 4.83 | 44342 | 1795 | 5.32 | 630 | (49) |  |
| Commercial real estate | 26429 | 1151 | 5.74 | 28681 | 1376 | 6.30 | (2252) | (56) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total commercial | 71401 | 2796 | 5.16 | 73023 | 3171 | 5.71 | (1622) | (55) |  |
| Residential mortgages | 33480 | 984 | 3.92 | 31713 | 874 | 3.68 | 1767 | 24 |  |
| Home equity | 17338 | 923 | 7.11 | 15387 | 920 | 7.99 | 1951 | (88) |  |
| Automobile | 3727 | 123 | 4.41 | 6832 | 218 | 4.27 | (3105) | 14 |  |
| Education | 9280 | 405 | 5.83 | 11472 | 463 | 5.39 | (2192) | 44 |  |
| Other retail | 4285 | 346 | 10.83 | 4866 | 392 | 10.76 | (581) | 7 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total retail | 68110 | 2781 | 5.45 | 70270 | 2867 | 5.45 | (2160) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total loans and leases | 139511 | 5577 | 5.31 | 143293 | 6038 | 5.58 | (3782) | (27) |  |
| Loans held for sale | 2023 | 83 | 5.45 | 1104 | 56 | 6.71 | 919 | (126) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest-earning assets | 196334 | 7217 | 4.88 | 198561 | 7724 | 5.15 | (2227) | (27) |  |
| Noninterest-earning assets | 21372 |  |  | 20959 |  |  | 413 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total assets | $217706 |  |  | $219520 |  |  | ($1814) |  |  |
| **Liabilities and Stockholders' Equity:** |  |  |  |  |  |  |  |  |  |
| Checking with interest | $33770 | $367 | 1.45% | $33017 | $368 | 1.49% | $753 | (4) |  |
| Savings | 25430 | 260 | 1.36 | 27389 | 369 | 1.80 | (1959) | (44) |  |
| Money market | 55656 | 1144 | 2.75 | 52552 | 1320 | 3.35 | 3104 | (60) |  |
| Time | 22093 | 642 | 3.89 | 25274 | 885 | 4.68 | (3181) | (79) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total interest-bearing deposits | 136949 | 2413 | 2.36 | 138232 | 2942 | 2.84 | (1283) | (48) |  |
| Short-term borrowed funds | 729 | 22 | 3.85 | 324 | 14 | 5.64 | 405 | (179) |  |
| Long-term borrowed funds | 12263 | 466 | 5.07 | 14147 | 547 | 5.15 | (1884) | (8) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total borrowed funds | 12992 | 488 | 5.00 | 14471 | 561 | 5.16 | (1479) | (16) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total interest-bearing liabilities | 149941 | 2901 | 2.58 | 152703 | 3503 | 3.06 | (2762) | (48) |  |
| Noninterest-bearing demand deposits | 37326 |  |  | 36374 |  |  | 952 |  |  |
| Other noninterest-bearing liabilities | 5618 |  |  | 6544 |  |  | (926) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | 192885 |  |  | 195621 |  |  | (2736) |  |  |
| Stockholders' equity | 24821 |  |  | 23899 |  |  | 922 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total liabilities and stockholders' equity | $217706 |  |  | $219520 |  |  | ($1814) |  |  |
| Interest rate spread |  |  | 2.30% |  |  | 2.09% |  | 21 |  |
| Net interest income and net interest margin |  | $4316 | 2.94% |  | $4221 | 2.84% |  | 10 |  |
| Net interest income and net interest margin, FTE<sup>(1)</sup> |  | $4328 | 2.95% |  | $4234 | 2.85% |  | 10 |  |
| Memo: Total deposits (interest-bearing and noninterest-bearing demand) | $174275 | $2413 | 1.85% | $174606 | $2942 | 2.25% | ($331) | (40) | bps |

---

<sup>(1)</sup> Net interest income and net interest margin on an FTE basis are non-GAAP financial measures. See "Non-GAAP Financial Measures" for more information.

Net interest income increased $119 million, or 9%, and increased $95 million, or 2%, for the three and nine months ended September 30, 2025, respectively, compared to the same periods in 2024, driven by higher net interest margin reflecting lower funding costs, the time-based benefits of the Non-Core portfolio runoff, terminated swap impacts, and fixed-rate asset repricing benefits.

Net interest margin on an FTE basis increased 23 basis points and 10 basis points for the three and nine months ended September 30, 2025, respectively, compared to the same periods in 2024, driven by lower funding costs, the time-based benefits of the Non-Core portfolio runoff, terminated swap impacts, and fixed-rate asset repricing benefits.

Average interest-earning assets increased $434 million for the three months ended September 30, 2025, compared to the same period in 2024, driven by an increase in investment securities and loans held for sale, partially offset by a decline in total loans and leases. For the nine months ended September 30, 2025, average interest-earnings assets decreased $2.2 billion compared to the same period in 2024, driven by a decline in total loans and leases and cash held in interest-bearing deposits, partially offset by an increase in investment securities and loans held for sale.

Citizens Financial Group, Inc. \| 11

------

Average deposits increased $1.9 billion for the three months ended September 30, 2025 and were stable for the nine months ended September 30, 2025, compared to the same periods in 2024. The increase during the three-month period was driven by growth in the Private Bank, partially offset by a reduction in higher-cost brokered deposits.

Average total borrowed funds decreased $1.6 billion and $1.5 billion for the three and nine months ended September 30, 2025, respectively, compared to the same periods in 2024, driven primarily by a decline in auto collateralized borrowings given runoff of the Non-Core portfolio. A decline in FHLB advances is also a driver during the nine-month period.

**Noninterest Income**

The following table presents the components of noninterest income:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| ***Table 2: Noninterest Income*** | | | | | | | | |
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | | | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** | | |
|<br>(dollars in millions) | **2025** | **2024** |<br>**Change** |<br>**Percent** | **2025** | **2024** |<br>**Change** |<br>**Percent** |
| Service charges and fees | $112 | $109 | $3 | 3% | $332 | $311 | $21 | 7% |
| Capital markets fees | 166 | 94 | 72 | 77 | 371 | 346 | 25 | 7 |
| Card fees | 87 | 93 | (6) | (6) | 260 | 271 | (11) | (4) |
| Wealth fees | 93 | 76 | 17 | 22 | 262 | 219 | 43 | 20 |
| Mortgage banking fees | 49 | 46 | 3 | 7 | 181 | 149 | 32 | 21 |
| Foreign exchange and derivative products | 42 | 36 | 6 | 17 | 122 | 111 | 11 | 10 |
| Letter of credit and loan fees | 48 | 45 | 3 | 7 | 137 | 130 | 7 | 5 |
| Securities gains, net | 2 | 9 | (7) | (78) | 14 | 14 |  |  |
| Other income<sup>(1)</sup> | 31 | 24 | 7 | 29 | 95 | 51 | 44 | 86 |
| Noninterest income | $630 | $532 | $98 | 18% | $1774 | $1602 | $172 | 11% |

---

<sup>(1)</sup> Includes bank-owned life insurance income and other income for all periods presented.

The primary drivers for the change in noninterest income for the three and nine months ended September 30, 2025, compared to the same periods in 2024, are described below:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;***•*** Wealth fees increased reflecting growth in assets under management, primarily from the Private Bank;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Mortgage banking fees increased driven by higher MSR valuation, net of hedging;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Capital markets fees increased driven by higher M&A, loan syndication, and equity underwriting fees during the three-month period, and by higher loan syndication and equity underwriting fees during the nine-month period; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Service charges and fees increased driven primarily by higher overdraft and cash management fees.

Citizens Financial Group, Inc. \| 12

------

**Noninterest Expense**

The following table presents the components of noninterest expense:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| ***Table 3: Noninterest Expense*** | | | | | | | | |
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | | | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** | | |
|<br>(dollars in millions) | **2025** | **2024** |<br>**Change** |<br>**Percent** | **2025** | **2024** |<br>**Change** |<br>**Percent** |
| Salaries and employee benefits | $705 | $647 | $58 | 9% | $2082 | $1983 | $99 | 5% |
| Equipment and software | 197 | 194 | 3 | 2 | 584 | 576 | 8 | 1 |
| Outside services | 161 | 146 | 15 | 10 | 485 | 469 | 16 | 3 |
| Occupancy | 106 | 108 | (2) | (2) | 326 | 335 | (9) | (3) |
| Other operating expense | 166 | 164 | 2 | 1 | 491 | 555 | (64) | (12) |
| Noninterest expense | $1335 | $1259 | $76 | 6% | $3968 | $3918 | $50 | 1% |

---

The primary drivers for the change in noninterest expense for the three and nine months ended September 30, 2025, compared to the same periods in 2024, are described below:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Salaries and employee benefits increased reflecting hiring related to the Private Bank and Private Wealth build-out, strong Capital Markets fee performance, and increased medical benefit costs; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The decline in Other operating expense during the nine-month period was driven primarily by lower FDIC deposit insurance, reflecting CBNA's special assessment of $40 million recognized in 2024, and lower fraud losses, partially offset by higher travel and marketing-related costs.

For more information regarding CBNA's special assessment, see "Regulation and Supervision - Deposit Insurance" in our 2024 Form 10-K.

**Provision for Credit Losses**

The provision for credit losses is the result of a detailed analysis performed to estimate our ACL. The total provision for credit losses includes the provision for loan and lease losses and the provision for unfunded commitments. Refer to "Analysis of Financial Condition — Credit Quality" for more information.

Provision expense of $154 million and $471 million for the three and nine months ended September 30, 2025, respectively, compared with a provision of $172 million and $525 million for the same periods in 2024, reflecting runoff of the Non-Core portfolio and improving loan mix.

**Income Tax Expense**

Income tax expense of $135 million and $348 million increased $47 million and $76 million for the three and nine months ended September 30, 2025, respectively, compared to the same periods in 2024. The effective income tax rate of 21.4% and 21.1% for the three and nine months ended September 30, 2025, respectively, increased from 18.6% and 19.7% compared to the same periods in 2024. These increases are primarily driven by higher pre-tax income and a reduced benefit from tax-advantaged investments. Provision for income taxes is calculated by applying the estimated annual effective tax rate to year-to-date pre-tax income, adjusting for discrete items that occurred during the period.

Citizens Financial Group, Inc. \| 13

------

**ANALYSIS OF FINANCIAL CONDITION**

**Securities**

The following table presents the major components of securities at amortized cost and fair value:

---

| | | | | |
|:---|:---|:---|:---|:---|
| ***Table 4: Amortized Cost and Fair Value of Securities*** | ***Table 4: Amortized Cost and Fair Value of Securities*** | | | |
| | **September 30, 2025** | **September 30, 2025** | **December 31, 2024** | **December 31, 2024** |
|<br>(dollars in millions) | **Amortized** <br>**Cost**<sup>(1)</sup> | **Fair Value** | **Amortized** <br>**Cost**<sup>(1)</sup> | **Fair Value** |
| U.S. Treasury and other | $4563 | $4514 | $3631 | $3525 |
| State and political subdivisions | 1 | 1 | 1 | 1 |
| Mortgage-backed securities: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Federal agencies and U.S. government sponsored entities | 31865 | 30551 | 30897 | 28795 |
| &nbsp;&nbsp;&nbsp;Other/non-agency | 268 | 263 | 273 | 260 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total mortgage-backed securities | 32133 | 30814 | 31170 | 29055 |
| Collateralized loan obligations | 90 | 90 | 184 | 184 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total debt securities available for sale | $36787 | $35419 | $34986 | $32765 |
| Mortgage-backed securities: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Federal agencies and U.S. government sponsored entities | $7767 | $6938 | $8187 | $7136 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total mortgage-backed securities | 7767 | 6938 | 8187 | 7136 |
| Asset-backed securities | 357 | 357 | 412 | 404 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total debt securities held to maturity | $8124 | $7295 | $8599 | $7540 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total debt securities available for sale and held to maturity | $44911 | $42714 | $43585 | $40305 |
| Equity securities, at cost<sup>(2)</sup> | $710 | $710 | $710 | $710 |
| Equity securities, at fair value<sup>(2)</sup> | 286 | 286 | 220 | 220 |

---

<sup>(1)</sup> Excludes portfolio level basis adjustments of $37 million and $(75) million, respectively, for securities designated in active fair value hedge relationships under the portfolio layer method at September 30, 2025 and December 31, 2024.

<sup>(2)</sup> Included in Other assets in the Consolidated Balance Sheets.

The primary objective of our securities portfolio is to provide a readily available source of liquidity. The portfolio primarily includes high-quality and highly liquid investments that reflect our ongoing commitment to maintain strong contingent liquidity levels and pledging capacity.

As of September 30, 2025, U.S. Treasuries and mortgage-backed securities issued by GNMA and GSEs represented 98% of the fair value of our debt securities portfolio, with approximately $38.8 billion of unencumbered high-quality liquid securities serving as potential collateral for borrowings from the FHLB, FRB discount window, and the Fixed Income Clearing Corporation bilateral repurchase agreement market.

For further discussion of the use of our securities as liquidity collateral see the "Liquidity Risk" section in this report. For further discussion of liquidity requirements, see "Regulation and Supervision — Liquidity Requirements" in our 2024 Form 10-K.

We manage our securities portfolio duration and convexity risk through asset selection and securities structure, and maintain duration levels within our risk appetite in the context of our broader interest rate risk framework and limits. As of September 30, 2025, the portfolio's average effective duration, including hedging actions to reduce duration, was 3.6 years compared with 3.7 years as of December 31, 2024.

Citizens Financial Group, Inc. \| 14

------

**Loans and Leases**

The following table presents loans and leases, excluding LHFS:&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | |
|:---|:---|:---|:---|:---|
| ***Table 5: Composition of Loans and Leases, Excluding LHFS*** | ***Table 5: Composition of Loans and Leases, Excluding LHFS*** | | | |
| (dollars in millions) | **September 30, 2025** |<br>**December 31, 2024** |<br>**Change** |<br> **Percent** |
| Commercial and industrial | $46953 | $42551 | $4402 | 10% |
| Commercial real estate | 25540 | 27225 | (1685) | (6) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total commercial | 72493 | 69776 | 2717 | 4 |
| Residential mortgages | 34477 | 32726 | 1751 | 5 |
| Home equity | 18415 | 16495 | 1920 | 12 |
| Automobile | 2816 | 4744 | (1928) | (41) |
| Education | 8556 | 10812 | (2256) | (21) |
| Other retail | 4113 | 4650 | (537) | (12) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total retail | 68377 | 69427 | (1050) | (2) |
| Total loans and leases | $140870 | $139203 | $1667 | 1% |

---

The increase in total loans and leases as of September 30, 2025 compared to December 31, 2024 reflects a $2.7 billion increase in commercial driven by higher line of credit utilization, partially offset by CRE paydowns. Retail reflects a $1.1 billion decrease driven by an agreement entered into during the first quarter to sell $1.9 billion of Non-Core education loans. The decrease in retail is also attributable to runoff of the Non-Core portfolio, partially offset by growth in home equity and mortgage, including the Private Bank.

**Credit Quality**

The ACL is maintained at a level the Company believes to be appropriate to absorb expected lifetime credit losses over the contractual life of a loan or lease and on unfunded lending commitments, inclusive of recoveries. For additional information regarding the ACL, see "Critical Accounting Estimates — Allowance for Credit Losses" and Note 4 in this report, and "Credit Quality" and Note 6 in our 2024 Form 10-K.

The following table presents the ACL and associated coverage ratio for our loan and lease portfolios:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| ***Table 6: ACL and Related Coverage Ratios by Portfolio*** | ***Table 6: ACL and Related Coverage Ratios by Portfolio*** | | | | | |
| | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
|<br>(dollars in millions) | **Loans and Leases** | **Allowance** | **Coverage Ratio** | **Loans and Leases** | **Allowance** | **Coverage Ratio** |
| <u>Allowance for Loan and Lease Losses</u> |  |  |  |  |  |  |
| &nbsp;&nbsp;Commercial and industrial | $46953 | $486 | 1.04% | $42551 | $480 | 1.13% |
| &nbsp;&nbsp;Commercial real estate | 25540 | 597 | 2.34 | 27225 | 660 | 2.42 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total commercial | 72493 | 1083 | 1.49 | 69776 | 1140 | 1.63 |
| &nbsp;&nbsp;Residential mortgages | 34477 | 211 | 0.61 | 32726 | 194 | 0.59 |
| &nbsp;&nbsp;Home equity | 18415 | 121 | 0.66 | 16495 | 112 | 0.68 |
| &nbsp;&nbsp;Automobile | 2816 | 13 | 0.45 | 4744 | 24 | 0.51 |
| &nbsp;&nbsp;Education | 8556 | 268 | 3.13 | 10812 | 292 | 2.70 |
| &nbsp;&nbsp;Other retail | 4113 | 276 | 6.72 | 4650 | 299 | 6.44 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total retail | 68377 | 889 | 1.30 | 69427 | 921 | 1.33 |
| Total loans and leases | $140870 | $1972 | 1.40% | $139203 | $2061 | 1.48% |
| <u>Allowance for Unfunded Lending Commitments</u> |  |  |  |  |  |  |
| &nbsp;&nbsp;Commercial<sup>(1)</sup> |  | $182 | 1.74% |  | $155 | 1.86% |
| &nbsp;&nbsp;Retail<sup>(2)</sup> |  | 47 | 1.37 |  | 43 | 1.39 |
| &nbsp;&nbsp;&nbsp;&nbsp; Total allowance for unfunded lending commitments |  | 229 |  |  | 198 |  |
| Allowance for credit losses | $140870 | $2201 | 1.56% | $139203 | $2259 | 1.62% |

---

<sup>(1)</sup> Coverage ratio includes total commercial allowance for unfunded lending commitments and total commercial allowance for loan and lease losses in the numerator and total commercial loans and leases in the denominator.

<sup>(2)</sup> Coverage ratio includes total retail allowance for unfunded lending commitments and total retail allowance for loan losses in the numerator and total retail loans in the denominator.

The ACL as of September 30, 2025 compared to December 31, 2024 decreased $58 million, driven by a $28 million decrease in retail, given the benefit of runoff of the Non-Core portfolio and improving loan mix, and a $30 million decrease in commercial.

Citizens Financial Group, Inc. \| 15

------

The following table presents nonaccrual loans and leases:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| ***Table 7: Nonaccrual Loans and Leases*** | | | | | |
| (dollars in millions) |<br>**September 30, 2025** |<br>**December 31, 2024** | **Change** | **Change** |<br>**Percent** |
| Commercial and industrial | $230 | $241 | ($11) |  | (5%) |
| Commercial real estate | 703 | 776 | (73) |  | (9) |
| Total commercial | 933 | 1017 | (84) |  | (8) |
| Residential mortgages | 188 | 192 | (4) |  | (2) |
| Home equity | 297 | 283 | 14 |  | 5 |
| Automobile | 31 | 48 | (17) |  | (35) |
| Education | 20 | 56 | (36) |  | (64) |
| Other retail | 49 | 68 | (19) |  | (28) |
| Total retail | 585 | 647 | (62) |  | (10) |
| Nonaccrual loans and leases | $1518 | $1664 | ($146) |  | (9%) |
| Nonaccrual loans and leases to total loans and leases | 1.08% | 1.20% | (12 | bps) |  |
| Allowance for loan and lease losses to nonaccrual loans and leases | 130 | 124 | 6 | % |  |
| Allowance for credit losses to nonaccrual loans and leases | 145 | 136 | 9 | % |  |

---

The decline in nonaccrual loans and leases as of September 30, 2025 compared to December 31, 2024 reflects a decrease in commercial primarily driven by the general office segment of CRE, and a decrease in retail driven by the sale of Non-Core education loans and continued runoff of the auto portfolio. See "Executive Summary" for more information regarding the sale of education loans.

The following tables present the net charge-off ratio for our loan and lease portfolios:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| ***Table 8: Ratio of Net Charge-Offs to Average Loans and Leases*** | ***Table 8: Ratio of Net Charge-Offs to Average Loans and Leases*** | ***Table 8: Ratio of Net Charge-Offs to Average Loans and Leases*** | ***Table 8: Ratio of Net Charge-Offs to Average Loans and Leases*** | ***Table 8: Ratio of Net Charge-Offs to Average Loans and Leases*** | ***Table 8: Ratio of Net Charge-Offs to Average Loans and Leases*** | ***Table 8: Ratio of Net Charge-Offs to Average Loans and Leases*** |
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Three Months Ended September 30,** |
|  | **2025** | **2025** | **2025** | **2024** | **2024** | **2024** |
| (dollars in millions) | **Net Charge-Offs** | **Average Balance** | **Ratio** | **Net Charge-Offs** | **Average Balance** | **Ratio** |
| Commercial and industrial | $30 | $46351 | 0.26% | $54 | $44071 | 0.49% |
| Commercial real estate | 55 | 25799 | 0.85 | 44 | 28209 | 0.62 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total commercial | 85 | 72150 | 0.47 | 98 | 72280 | 0.54 |
| Residential mortgages |  | 34134 |  |  | 32117 |  |
| Home equity | (3) | 18027 | (0.06) | (1) | 15733 | (0.03) |
| Automobile | 4 | 3096 | 0.43 | 13 | 5942 | 0.81 |
| Education | 20 | 8513 | 0.92 | 24 | 11155 | 0.85 |
| Other retail | 56 | 4091 | 5.45 | 58 | 4776 | 4.93 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total retail | 77 | 67861 | 0.45 | 94 | 69723 | 0.54 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total loans and leases | $162 | $140011 | 0.46% | $192 | $142003 | 0.54% |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| | **2025** | **2025** | **2025** | **2024** | **2024** | **2024** |
|<br>(dollars in millions) | **Net Charge-Offs** | **Average Balance** | **Ratio** | **Net Charge-Offs** | **Average Balance** | **Ratio** |
| Commercial and industrial | $99 | $44972 | 0.30% | $61 | $44342 | 0.18% |
| Commercial real estate | 159 | 26429 | 0.81 | 218 | 28681 | 1.02 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total commercial | 258 | 71401 | 0.48 | 279 | 73023 | 0.51 |
| Residential mortgages |  | 33480 |  | 1 | 31713 |  |
| Home equity | (5) | 17338 | (0.04) | (6) | 15387 | (0.05) |
| Automobile | 15 | 3727 | 0.52 | 31 | 6832 | 0.60 |
| Education | 89 | 9280 | 1.28 | 77 | 11472 | 0.90 |
| Other retail | 172 | 4285 | 5.38 | 175 | 4866 | 4.82 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total retail | 271 | 68110 | 0.53 | 278 | 70270 | 0.53 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total loans and leases | $529 | $139511 | 0.51% | $557 | $143293 | 0.52% |

---

Citizens Financial Group, Inc. \| 16

------

For the three and nine months ended September 30, 2025, net charge-offs decreased $30 million and decreased $28 million, respectively, compared to the same periods in 2024. The net charge-off ratio decreased 8 basis points and decreased 1 basis point, respectively, compared to the same periods in 2024. The nine-month period ended September 30, 2025 includes a $25 million charge-off resulting from the sale of Non-Core education loans. See "Executive Summary" for more information regarding the sale of education loans.

*Commercial Loan Asset Quality*

Our commercial portfolio consists of traditional commercial and industrial loans, commercial leases, and commercial real estate loans. As discussed in our 2024 Form 10-K, we utilize internal risk ratings to monitor credit quality for commercial loans and leases.

Total commercial criticized balances of $6.6 billion at September 30, 2025 decreased $523 million compared to December 31, 2024.

Commercial and industrial criticized balances of $2.6 billion at September 30, 2025 remained stable compared to December 31, 2024.

Commercial real estate criticized balances of $4.0 billion at September 30, 2025 decreased from $4.5 billion at December 31, 2024, attributable to office, multifamily, and industrial loan upgrades driven by improved leasing and operating performance, credit-enhanced extensions, pending sales, and refinancing activity, along with net charge-offs in the general office portfolio. Approximately 97% of commercial real estate loans remain current on payments as of September 30, 2025.

For more information on the distribution of commercial loans by vintage date and regulatory classification rating, see Note 4.

The following table presents our commercial and industrial loan portfolio by industry sector:

---

| | | | | |
|:---|:---|:---|:---|:---|
| ***Table 9: Commercial and Industrial Loans by Industry Sector*** | ***Table 9: Commercial and Industrial Loans by Industry Sector*** | ***Table 9: Commercial and Industrial Loans by Industry Sector*** | | |
| | **September 30, 2025** | **September 30, 2025** | **December 31, 2024** | **December 31, 2024** |
|<br>(dollars in millions) | **Balance** | **% of** <br>**Total Loans and Leases** | **Balance** | **% of** <br>**Total Loans and Leases** |
| **Industry sector** |  |  |  |  |
| &nbsp;&nbsp;Finance and insurance |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Capital call facilities | $8349 | 6% | $6070 | 4% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Secured private credit finance | 3310 | 2 | 2908 | 2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other finance and insurance | 4139 | 3 | 3538 | 3 |
| &nbsp;&nbsp;Other manufacturing | 3676 | 3 | 3491 | 3 |
| &nbsp;&nbsp;Technology | 2868 | 2 | 2818 | 2 |
| &nbsp;&nbsp;Accommodation and food services | 2070 | 1 | 2599 | 2 |
| &nbsp;&nbsp;Health, pharma, and social assistance | 2334 | 2 | 2322 | 2 |
| &nbsp;&nbsp;Professional, scientific, and technical services | 2628 | 2 | 2313 | 2 |
| &nbsp;&nbsp;Energy and related | 1934 | 1 | 2085 | 1 |
| &nbsp;&nbsp;Other services | 2280 | 1 | 2061 | 1 |
| &nbsp;&nbsp;Wholesale trade | 2393 | 2 | 2010 | 1 |
| &nbsp;&nbsp;Retail trade | 1959 | 1 | 2000 | 1 |
| &nbsp;&nbsp;Arts, entertainment, and recreation | 1660 | 1 | 1509 | 1 |
| &nbsp;&nbsp;Administrative and waste management | 1217 | 1 | 1352 | 1 |
| &nbsp;&nbsp;Automotive | 1180 | 1 | 1026 | 1 |
| &nbsp;&nbsp;Rental and leasing | 1181 | 1 | 923 | 1 |
| &nbsp;&nbsp;Consumer products manufacturing | 783 | 1 | 710 | 1 |
| &nbsp;&nbsp;Other | 2992 | 2 | 2816 | 2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total commercial and industrial | $46953 | 33% | $42551 | 31% |

---

Citizens Financial Group, Inc. \| 17

------

The following table presents our commercial real estate loan portfolio by property type and state:

---

| | | | | |
|:---|:---|:---|:---|:---|
| ***Table 10: Commercial Real Estate by Property Type and State*** | ***Table 10: Commercial Real Estate by Property Type and State*** | ***Table 10: Commercial Real Estate by Property Type and State*** | | |
| | **September 30, 2025** | **September 30, 2025** | **December 31, 2024** | **December 31, 2024** |
|<br>(dollars in millions) | **Balance** | **% of** <br>**Total Loans and Leases** | **Balance** | **% of** <br>**Total Loans and Leases** |
| **Property type** |  |  |  |  |
| &nbsp;&nbsp;Multifamily | $9592 | 7% | $9791 | 7% |
| &nbsp;&nbsp;Office |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Credit tenant lease and life sciences<sup>(1)</sup> | 2095 | 1 | 2135 | 2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other general office | 2522 | 2 | 2930 | 2 |
| &nbsp;&nbsp;Industrial | 2596 | 2 | 3575 | 3 |
| &nbsp;&nbsp;Retail | 2875 | 2 | 2940 | 2 |
| &nbsp;&nbsp;Co-op | 1791 | 1 | 1802 | 1 |
| &nbsp;&nbsp;Data center | 875 | 1 | 1024 | 1 |
| &nbsp;&nbsp;Hospitality | 368 |  | 418 |  |
| &nbsp;&nbsp;Other | 2826 | 2 | 2610 | 2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total commercial real estate | $25540 | 18% | $27225 | 20% |
| **State** |  |  |  |  |
| &nbsp;&nbsp;New York | $6437 | 4% | $6643 | 5% |
| &nbsp;&nbsp;New Jersey | 3001 | 2 | 3370 | 2 |
| &nbsp;&nbsp;Pennsylvania | 2266 | 2 | 2594 | 2 |
| &nbsp;&nbsp;California | 2588 | 2 | 2398 | 2 |
| &nbsp;&nbsp;Massachusetts | 1601 | 1 | 1682 | 1 |
| &nbsp;&nbsp;Texas | 1512 | 1 | 1571 | 1 |
| &nbsp;&nbsp;Florida | 1030 | 1 | 1123 | 1 |
| &nbsp;&nbsp;Other Southeast<sup>(2)</sup> | 2533 | 2 | 2789 | 2 |
| &nbsp;&nbsp;Other | 4572 | 3 | 5055 | 4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total commercial real estate | $25540 | 18% | $27225 | 20% |

---

<sup>(1)</sup> Credit tenant lease includes loans to nationally recognized tenants with high credit ratings and life sciences includes loans to provide lab and office space for tenants involved in the study and development of scientific discoveries.

<sup>(2)</sup> Includes Georgia, Maryland, North Carolina, South Carolina, and Virginia.

*Retail Loan Asset Quality* 

We utilize credit scores provided by FICO, which are generally refreshed on a quarterly basis, and payment and delinquency status, among other data points, to monitor credit quality for retail loans. FICO credit scores represent current and historical national industry-wide consumer level credit performance data, which management believes are the strongest indicator of potential credit losses over the contractual life of the loan and a good predictor of a borrower's future payment performance.

The following table presents an aging analysis of accruing and nonaccrual loans for our retail loan portfolio:

---

| | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| ***Table 11: Retail Loan Portfolio Analysis*** | ***Table 11: Retail Loan Portfolio Analysis*** | ***Table 11: Retail Loan Portfolio Analysis*** | ***Table 11: Retail Loan Portfolio Analysis*** | ***Table 11: Retail Loan Portfolio Analysis*** | | | | | | |
| | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
| | | **Days Past Due and Accruing** | **Days Past Due and Accruing** | **Days Past Due and Accruing** | | | **Days Past Due and Accruing** | **Days Past Due and Accruing** | **Days Past Due and Accruing** | |
| |<br>**Current** | **30-59** | **60-89** | **90+** |<br>**Nonaccrual** |<br>**Current** | **30-59** | **60-89** | **90+** |<br>**Nonaccrual** |
| Residential mortgages | 98.77% | 0.23% | 0.12% | 0.33% | 0.55% | 97.81% | 0.77% | 0.28% | 0.55% | 0.59% |
| Home equity | 97.79 | 0.45 | 0.15 |  | 1.61 | 97.59 | 0.53 | 0.16 |  | 1.72 |
| Automobile | 95.95 | 2.20 | 0.75 |  | 1.10 | 96.18 | 2.11 | 0.70 |  | 1.01 |
| Education | 99.14 | 0.40 | 0.21 | 0.02 | 0.23 | 98.83 | 0.42 | 0.21 | 0.02 | 0.52 |
| Other retail | 97.50 | 0.78 | 0.53 |  | 1.19 | 96.86 | 0.99 | 0.67 | 0.02 | 1.46 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total retail | 98.35% | 0.43% | 0.19% | 0.17% | 0.86% | 97.75% | 0.76% | 0.30% | 0.26% | 0.93% |

---

Citizens Financial Group, Inc. \| 18

------

The following table presents certain asset quality metrics for our retail loan portfolio:

---

| | | |
|:---|:---|:---|
| ***Table 12: Retail Asset Quality Metrics*** | | |
| |<br>**September 30, 2025** |<br>**December 31, 2024** |
| Average refreshed FICO for total portfolio | 776 | 775 |
| CLTV ratio for secured real estate<sup>(1)</sup> | 49% | 50% |

---

<sup>(1)</sup> The real estate secured portfolio CLTV is calculated as the mortgage and second lien loan balance divided by the most recently available value of the property.

For more information on the aging of accruing and nonaccrual retail loans and the distribution of retail loans by vintage date and FICO score, see Note 4.

**Deposits**

The following table presents the composition of deposits:

---

| | | | | |
|:---|:---|:---|:---|:---|
| ***Table 13: Composition of Deposits*** | | | | |
| (dollars in millions) |<br>**September 30, 2025** |<br>**% of Total Deposits** |<br>**December 31, 2024** |<br>**% of Total Deposits** |
| Noninterest-bearing demand | $39472 | 22% | $36920 | 21% |
| Checking with interest | 35219 | 19 | 33246 | 19 |
| Savings | 24759 | 14 | 25976 | 15 |
| Money market | 59709 | 33 | 55321 | 32 |
| Time | 20852 | 12 | 23313 | 13 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total deposits | $180011 | 100% | $174776 | 100% |

---

Total deposits as of September 30, 2025 increased compared to December 31, 2024, reflecting growth in the Private Bank, partially offset by a decline in time deposits given elevated retail maturities and continued reduction in higher-cost Treasury brokered deposits.

The following table presents an analysis of estimated insured/secured deposits as a percentage of total deposits:

---

| | | |
|:---|:---|:---|
| ***Table 14: Uninsured and Insured/Secured Deposits*** | | |
| (dollars in millions) |<br>**September 30, 2025** |<br>**December 31, 2024** |
| Total deposits | $180011 | $174776 |
| Estimated uninsured deposits<sup>(1)</sup> | 82202 | 76764 |
| Less: Uninsured affiliate deposits eliminated in consolidation | 11288 | 12705 |
| Less: Preferred deposits<sup>(1)(2)</sup> | 6445 | 6902 |
| CFG adjusted estimated uninsured deposits, excluding preferred deposits | 64469 | 57157 |
| Total estimated insured/secured deposits | $115542 | $117619 |
| Insured/secured deposits to total deposits | 64% | 67% |

---

<sup>(1)</sup> As reported on CBNA's Call Report.

<sup>(2)</sup> Represents uninsured deposits of states and political subdivisions that are secured or collateralized as required under state law.

**Borrowed Funds**

Total borrowed funds of $10.7 billion as of September 30, 2025 decreased $1.7 billion compared to December 31, 2024, driven by a decline in secured borrowings collateralized by loans and senior debt. For more information regarding our borrowed funds, see "Liquidity Risk" and Note 7.

Citizens Financial Group, Inc. \| 19

------

**BUSINESS SEGMENTS** 

We have three reportable business segments: Consumer Banking, Commercial Banking, and Non-Core. The business segments are determined based on the products and services provided, or the type of customer served. Each business segment has a segment head that reports directly to the Chief Executive Officer, who has final authority over resource allocation decisions and performance assessment. The business segments reflect this management structure and the manner in which financial information is currently evaluated by the Chief Executive Officer. See Note 16 for more information regarding our business segments.

The following tables present certain financial data of our reportable business segments. Total business segment financial results differ from total consolidated financial results. These differences are reflected in Other non-segment operations, consisting primarily of treasury and community development, and include assets, liabilities, capital, revenues, provision (benefit) for credit losses, expenses, and income tax expense (benefit) not attributed to the Company's reportable business segments.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| ***Table 15: Selected Financial Data for Business Segments*** | ***Table 15: Selected Financial Data for Business Segments*** | ***Table 15: Selected Financial Data for Business Segments*** | ***Table 15: Selected Financial Data for Business Segments*** | | | |
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Three Months Ended September 30,** |
| | **Consumer Banking** | **Consumer Banking** | **Commercial Banking** | **Commercial Banking** | **Non-Core** | **Non-Core** |
|<br>(dollars in millions) | **2025** | **2024** | **2025** | **2024** | **2025** | **2024** |
| Net interest income | $1262 | $1156 | $448 | $478 | ($7) | ($28) |
| Noninterest income | 311 | 285 | 286 | 207 | 4 |  |
| Total revenue | 1573 | 1441 | 734 | 685 | (3) | (28) |
| Noninterest expense | 979 | 916 | 333 | 300 | 12 | 23 |
| Profit (loss) before credit losses | 594 | 525 | 401 | 385 | (15) | (51) |
| Net charge-offs | 81 | 84 | 78 | 91 | 4 | 17 |
| Income (loss) before income tax expense (benefit) | 513 | 441 | 323 | 294 | (19) | (68) |
| Income tax expense (benefit) | 130 | 114 | 75 | 63 | (5) | (17) |
| Net income (loss) | $383 | $327 | $248 | $231 | ($14) | ($51) |
| **Average Balances:** |  |  |  |  |  |  |
| Total assets | $80729 | $75392 | $66134 | $68092 | $4000 | $8389 |
| Total loans and leases<sup>(1)</sup> | 74274 | 69021 | 62905 | 64974 | 3976 | 8352 |
| Deposits | 128547 | 121899 | 44482 | 44190 |  |  |
| Interest-earning assets | 74870 | 69608 | 63719 | 65550 | 3976 | 8352 |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| | **Consumer Banking** | **Consumer Banking** | **Commercial Banking** | **Commercial Banking** | **Non-Core** | **Non-Core** |
|<br>(dollars in millions) | **2025** | **2024** | **2025** | **2024** | **2025** | **2024** |
| Net interest income | $3673 | $3369 | $1328 | $1486 | ($27) | ($96) |
| Noninterest income | 937 | 820 | 733 | 676 | 7 |  |
| Total revenue | 4610 | 4189 | 2061 | 2162 | (20) | (96) |
| Noninterest expense | 2896 | 2734 | 977 | 928 | 43 | 74 |
| Profit (loss) before credit losses | 1714 | 1455 | 1084 | 1234 | (63) | (170) |
| Net charge-offs | 248 | 249 | 239 | 262 | 43 | 46 |
| Income (loss) before income tax expense (benefit) | 1466 | 1206 | 845 | 972 | (106) | (216) |
| Income tax expense (benefit) | 371 | 311 | 195 | 223 | (27) | (55) |
| Net income (loss) | $1095 | $895 | $650 | $749 | ($79) | ($161) |
| **Average Balances:** |  |  |  |  |  |  |
| Total assets | $79040 | $74510 | $65931 | $69046 | $5241 | $9450 |
| Total loans and leases<sup>(1)</sup> | 72588 | 68146 | 62801 | 66048 | 5217 | 9408 |
| Deposits | 127193 | 120803 | 43056 | 44766 |  |  |
| Interest-earning assets | 73176 | 68740 | 63485 | 66507 | 5217 | 9408 |

---

<sup>(1)</sup> Includes LHFS.

*Consumer Banking* 

Net interest income increased $106 million and $304 million for the three and nine months ended September 30, 2025, respectively, compared to the same periods in 2024, driven by higher net interest margin and growth in average interest-earning assets.

Citizens Financial Group, Inc. \| 20

------

Noninterest income increased $26 million and $117 million for the three and nine months ended September 30, 2025, respectively, compared to the same periods in 2024, driven by wealth fees, mortgage banking fees, and service charges and fees, reflecting growth in assets under management, primarily from the Private Bank, higher MSR valuation, net of hedging, and higher overdraft and cash management fees.

Noninterest expense increased $63 million and $162 million for the three and nine months ended September 30, 2025, respectively, compared to the same periods in 2024, driven primarily by salaries and benefits reflecting hiring related to the Private Bank and Private Wealth build-out, as well as an increase in medical benefit costs, and outside services given investments across the enterprise.

Net charge-offs were stable for the three and nine months ended September 30, 2025 compared to the same periods in 2024.

*Commercial Banking* 

Net interest income decreased $30 million and $158 million for the three and nine months ended September 30, 2025, respectively, compared to the same periods in 2024, driven by lower net interest margin and a decline in average interest-earning assets.

Noninterest income increased $79 million and $57 million for the three and nine months ended September 30, 2025, respectively, compared to the same periods in 2024, driven by capital markets fees reflecting higher M&A, loan syndication, and equity underwriting fees during the three-month period, and by higher loan syndication and equity underwriting fees during the nine-month period.

Noninterest expense increased $33 million and $49 million for the three and nine months ended September 30, 2025, respectively, compared to the same periods in 2024, driven primarily by salaries and benefits given strong Capital Markets fee performance and increased medical benefit costs, and outside services given investments across the enterprise.

Net charge-offs decreased $23 million for the nine months ended September 30, 2025 compared to the same period in 2024, driven by CRE, partially offset by an increase in commercial and industrial.

*Non-Core*

Net interest income increased $69 million for the nine months ended September 30, 2025, compared to the same period in 2024, driven by a decline in funding costs relative to the highest-cost marginal funding sources during 2025, including secured borrowings collateralized by auto loans and FHLB advances.

Net charge-offs were stable for the nine months ended September 30, 2025 compared to the same period in 2024.

Average loans and leases decreased $4.4 billion and $4.2 billion for the three and nine months ended September 30, 2025, respectively, compared to the same periods in 2024, driven by expected runoff of the Non-Core portfolio.

**RISK MANAGEMENT** 

We are committed to maintaining a strong, integrated, and proactive approach to the management of all risks to which we are exposed in pursuit of our business objectives. A key aspect of our Board's responsibility as the main decision-making body is setting our risk appetite to ensure that the level of risk that we are willing to accept in the attainment of our strategic business and financial objectives is clearly understood.

To enable our Board to carry out its objectives, it has delegated authority for risk management activities, as well as governance and oversight of those activities, to a number of Board and executive management level risk committees. The Executive Risk Committee, chaired by the Chief Risk Officer, is responsible for oversight of risk across the enterprise and actively considers our inherent material risks, analyzes our overall risk profile, and seeks confirmation that the risks are being appropriately identified, assessed, and mitigated. Reporting to the Executive Risk Committee are the following committees covering specific areas of risk: Compliance and Operational Risk, Model Risk, Credit Policy, Asset Liability, Business Initiatives Review, and Conduct and Ethics.

There have been no significant changes in our risk management practices, risk framework, risk appetite, or credit risk management as described in "Risk Governance" in our 2024 Form 10-K.

Citizens Financial Group, Inc. \| 21

------

**Credit Risk**

Credit risk represents the potential for loss arising from the failure of a customer, counterparty, or issuer to perform in accordance with the contractual terms of an obligation. While the majority of our credit risk is associated with lending activities, we do engage with other financial counterparties for a variety of purposes including investing, asset and liability management, and trading activities. Given the financial impact of credit risk on our earnings and balance sheet, the assessment, approval, and management of credit risk represents a significant part of our overall risk-management responsibility.

Our independent Credit Risk Function is responsible for reviewing and approving the credit risk appetite across all lines of business and credit products, approving larger and higher-risk credit transactions, monitoring portfolio performance, identifying problem credit exposures, and ensuring remedial management. Credit Risk actively monitors and manages concentrations of loan limits, loan types, industries, and geographies to ensure that our risk appetite is well balanced to achieve our goals.

We employ a comprehensive and integrated risk control program to proactively identify, measure, monitor, and mitigate existing and emerging credit risks across the credit life cycle including origination, account/portfolio management, and loss mitigation and recovery. For more information regarding our credit risk management practices, see "Credit Risk Management" in our 2024 Form 10-K.

For more information regarding credit quality, see "Credit Quality" in Item 2.

**Market Risk**

Market risk refers to potential losses arising from changes in interest rates, foreign exchange rates, equity prices, commodity prices, and/or other relevant market rates or prices. Modest market risk arises from trading activities that serve customer needs, including the hedging of interest rate and foreign exchange risks. As described below, the market risk arising from our non-trading banking activities, such as the origination of loans and deposit gathering, is more significant. We have established enterprise-wide policies and methodologies to identify, measure, monitor, and report market risk. We actively manage market risk for both non-trading and trading activities.

*Non-Trading Risk* 

Our non-trading banking activities expose us to market risk. This market risk is composed of interest rate risk, as we have no commodity risk and de minimis direct currency and equity risk. We also have market risk related to capital markets loan originations, as well as the valuation of our MSRs. There have been no significant changes in our sources of interest rate risk, interest rate risk practices, risk framework, metrics, or assumptions as described in "Market Risk — Non-Trading Risk" in our 2024 Form 10-K.

Citizens Financial Group, Inc. \| 22

------

The table below presents the sensitivity of net interest income to various parallel yield curve shifts from the market implied forward yield curve. Our policies involve measuring exposures as a percentage change in net interest income over the next year due to either instantaneous or gradual parallel changes in rates relative to the market implied forward yield curve. As the following table illustrates, our balance sheet is slightly asset sensitive; net interest income would benefit from an increase in interest rates, while exposure to a decline in interest rates is within limits established and monitored by senior management. While an instantaneous and severe shift in interest rates is included in this analysis, we believe that any actual shift in interest rates would be more gradual and, therefore, have a more modest impact.

---

| | | |
|:---|:---|:---|
| ***Table 16: Sensitivity of Net Interest Income*** | | |
| | **Estimated % Change in Net Interest Income over 12 Months** | **Estimated % Change in Net Interest Income over 12 Months** |
|<br>**Basis points** | **September 30, 2025** | **December 31, 2024** |
| **Gradual Change in Interest Rates** | | |
| +200 | 2.4% | 2.2% |
| +100 | 1.2 | 1.0 |
| -100 | (1.2) | (0.9) |
| -200 | (2.5) | (1.8) |
| **Instantaneous Change in Interest Rates** |  |  |
| +200 | 2.3% | 1.8% |
| +100 | 1.5 | 1.1 |
| -100 | (1.9) | (1.3) |
| -200 | (4.6) | (3.3) |

---

We continue to manage asset sensitivity within the scope of our policy, changing market conditions, and changes in our balance sheet. The Company's base case net interest income assumes the forward-rate path implied by the period-end yield curve is realized. The rate risk exposure is then measured based on assumed changes from that base case rate path.

Our risk position is slightly asset sensitive to a gradual change in rates as of September 30, 2025, consistent with our position as of December 31, 2024. Our interest rate sensitivity incorporates the impact of changes in our balance sheet mix, including securities, loans, deposits, borrowed funds, and hedge activity. Receive-fixed swaps that offset our naturally asset-sensitive balance sheet represent the primary hedging tool utilized to manage overall asset sensitivity. Pay-fixed swaps against our securities portfolio are also utilized to protect capital by reducing AOCI volatility.

We use a valuation measure of exposure to structural interest rate risk, EVE, as a supplement to net interest income simulations. EVE complements net interest income simulation analysis as it estimates risk exposure over a long-term horizon. EVE measures the extent to which the economic value of assets, liabilities, and off-balance sheet instruments may change in response to fluctuations in interest rates. This analysis is highly dependent upon assumptions applied to assets and liabilities with non-contractual maturities. We employ sophisticated models for prepayments and deposit pricing and attrition, which provide a granular view of cash flows based on the unique characteristics of the underlying products and customer segments. The change in value is expressed as a percentage of regulatory capital.

We use interest rate derivative contracts as part of our ALM strategy to manage exposure to the variability in the interest cash flows on our floating-rate assets and wholesale funding, the variability in the fair value of AFS securities, and to hedge market risk on fixed-rate capital markets debt issuances.

Citizens Financial Group, Inc. \| 23

------

The following table presents interest rate derivative contracts that we have entered into as of September 30, 2025 and December 31, 2024:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| ***Table 17: Interest Rate Hedges Used to Manage Non-Trading Interest Rate Exposure*** | ***Table 17: Interest Rate Hedges Used to Manage Non-Trading Interest Rate Exposure*** | ***Table 17: Interest Rate Hedges Used to Manage Non-Trading Interest Rate Exposure*** | ***Table 17: Interest Rate Hedges Used to Manage Non-Trading Interest Rate Exposure*** | ***Table 17: Interest Rate Hedges Used to Manage Non-Trading Interest Rate Exposure*** | ***Table 17: Interest Rate Hedges Used to Manage Non-Trading Interest Rate Exposure*** | ***Table 17: Interest Rate Hedges Used to Manage Non-Trading Interest Rate Exposure*** | ***Table 17: Interest Rate Hedges Used to Manage Non-Trading Interest Rate Exposure*** | |
| | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
| | | **Weighted Average** | **Weighted Average** | **Weighted Average** | | **Weighted Average** | **Weighted Average** | **Weighted Average** |
|<br>(dollars in millions) |<br>**Notional Amount** | **Maturity (Years)** | **Fixed Rate** | **Reset Rate** |<br>**Notional Amount** | **Maturity (Years)** | **Fixed Rate** | **Reset Rate** |
| **Fair value hedges:** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Asset conversion swaps: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;AFS securities: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pay fixed/receive SOFR | $8253 | 4.1 | 3.8% | 4.2% | $7827 | 4.7 | 3.8% | 4.5% |
| &nbsp;&nbsp;Liability conversion swaps: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Long-term borrowed funds: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Receive fixed/pay SOFR | 500 | 0.1 | 2.6 | 4.5 | 500 | 0.9 | 2.6 | 4.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total fair value hedges | 8753 |  |  |  | 8327 |  |  |  |
| **Cash flow hedges:** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Asset conversion swaps: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Loans: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Swaps |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Receive fixed/pay SOFR | 30750 | 1.1 | 3.3 | 4.2 | 26250 | 1.7 | 3.1 | 4.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Receive fixed/pay SOFR - forward-starting | 18500 | 3.4 | 3.7 | 3.4 | 20000 | 3.5 | 3.7 | 4.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pay fixed/receive SOFR - forward-starting | 434 | 3.1 | 3.7 | 3.9 |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Basis swaps |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Receive SOFR/pay 1-month term SOFR | 13000 | 1.0 |  | 4.2/4.1 | 11500 | 1.6 |  | 4.5/4.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Receive SOFR/pay 1-month term SOFR - forward-starting | 1000 | 1.3 |  | 3.8/3.7 | 3000 | 2.4 |  | 4.0/4.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total cash flow hedges | 63684 |  |  |  | 60750 |  |  |  |
| Total hedges | $72437 |  |  |  | $69077 |  |  |  |

---

Included in AOCI is a net loss from terminated swaps of $376 million that will reduce net interest income by $103 million in the fourth quarter of 2025. The remaining $273 million will reduce net interest income by $230 million in 2026 and $43 million after 2026.

*Capital Markets*

A key component of our capital markets activities is the underwriting and distribution of corporate credit facilities to finance M&A transactions for our clients. We have a rigorous risk management process around these activities, including a limit structure capping our underwriting risk, potential loss, and sub-limits for specific asset classes. Further, the ability to approve underwriting exposure is delegated only to senior level individuals in the credit risk management and capital markets organizations with each transaction reviewed by the Loan Underwriting Approval Committee.

*Mortgage Servicing Rights*&nbsp;&nbsp;&nbsp;&nbsp;

We have market risk associated with the value of residential MSRs, which are impacted by various types of inherent risks, including duration, basis, convexity, volatility, and yield curve.

As part of our overall risk management strategy we enter into various freestanding derivatives, such as interest rate swaps, interest rate swaptions, interest rate futures, and forward contracts to purchase mortgage-backed securities to economically hedge the changes in fair value of our MSRs. For more information regarding the fair value of our MSRs and associated derivatives see Note 5 and Note 8.

As with our traded market risk-based activities, earnings at risk excludes the impact of MSRs. MSRs are captured under our single price risk management framework that is used for calculating a management VaR consistent with the definition used by banking regulators.

Citizens Financial Group, Inc. \| 24

------

*Trading Risk* 

We are exposed to market risk primarily through client facilitation activities from certain derivative and foreign exchange products as well as underwriting and market making activities. Market risk exposure arises from fluctuations in interest rates, basis spreads, volatility, foreign exchange rates, equity prices, and credit spreads across various financial instruments. Securities underwriting and trading activities are conducted through CBNA and Citizens JMP Securities, LLC. There have been no significant changes in our market risk governance, market risk measurement, or market risk practices including VaR, stressed VaR, sensitivity analysis, stress testing, VaR model review and validation, or VaR backtesting as described in "Market Risk — Trading Risk" in our 2024 Form 10-K.

*Market Risk Regulatory Capital* 

The U.S. banking regulators' "Market Risk Rule" covers the calculation of market risk capital. Under this rule, all of our client facing trades and associated hedges maintain a low net risk and qualify as "covered positions." The internal management VaR measure is calculated based on the same population of trades that is utilized for regulatory VaR.

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| ***Table 18: Results of Modeled and Non-Modeled Measures for Regulatory Capital Calculations*** | ***Table 18: Results of Modeled and Non-Modeled Measures for Regulatory Capital Calculations*** | ***Table 18: Results of Modeled and Non-Modeled Measures for Regulatory Capital Calculations*** | ***Table 18: Results of Modeled and Non-Modeled Measures for Regulatory Capital Calculations*** | ***Table 18: Results of Modeled and Non-Modeled Measures for Regulatory Capital Calculations*** | ***Table 18: Results of Modeled and Non-Modeled Measures for Regulatory Capital Calculations*** | ***Table 18: Results of Modeled and Non-Modeled Measures for Regulatory Capital Calculations*** | ***Table 18: Results of Modeled and Non-Modeled Measures for Regulatory Capital Calculations*** | ***Table 18: Results of Modeled and Non-Modeled Measures for Regulatory Capital Calculations*** |
| (dollars in millions) | **For the Three Months Ended September 30, 2025** | **For the Three Months Ended September 30, 2025** | **For the Three Months Ended September 30, 2025** | **For the Three Months Ended September 30, 2025** | **For the Three Months Ended September 30, 2024** | **For the Three Months Ended September 30, 2024** | **For the Three Months Ended September 30, 2024** | **For the Three Months Ended September 30, 2024** |
| **Market Risk Category**  | **Period End** | **Average** | **High** | **Low** | **Period End** | **Average** | **High** | **Low** |
| Interest Rate | $1 | $1 | $2 | $1 | $2 | $2 | $4 | $1 |
| Foreign Exchange Currency Rate |  |  | 21 |  |  |  |  |  |
| Credit Spread | 1 | 1 | 2 |  | 1 | 2 | 3 |  |
| Commodity |  |  |  |  |  |  |  |  |
| General VaR | 2 | 2 | 2 | 2 | 2 | 3 | 4 | 1 |
| Specific Risk VaR |  |  |  |  |  |  |  |  |
| Total VaR | $2 | $2 | $2 | $2 | $2 | $3 | $4 | $1 |
| Stressed General VaR | $9 | $7 | $12 | $5 | $6 | $7 | $14 | $2 |
| Stressed Specific Risk VaR |  |  |  |  |  |  |  |  |
| Total Stressed VaR | $9 | $7 | $12 | $5 | $6 | $7 | $14 | $2 |
| Market Risk Regulatory Capital | $28 |  |  |  | $29 |  |  |  |
| Specific Risk Not Modeled Add-on | 31 |  |  |  | 23 |  |  |  |
| de Minimis Exposure Add-on | 2 |  |  |  | 1 |  |  |  |
| Total Market Risk Regulatory Capital | $61 |  |  |  | $53 |  |  |  |
| Market Risk-Weighted Assets | $760 |  |  |  | $662 |  |  |  |

---

**Liquidity Risk** 

We consider the effective and prudent management of liquidity fundamental to our safety and soundness. We define liquidity as our ability to meet our obligations when they come due. As a financial institution, we must maintain operating liquidity to meet expected daily and forecasted cash flow requirements, as well as contingent liquidity to meet unexpected (stress scenario) funding requirements. Reflecting the importance of meeting all unexpected and stress-scenario funding requirements, we identify and manage contingent liquidity, consisting of cash balances at the FRB, unencumbered high-quality liquid securities, and unused FHLB borrowing capacity. Separately, we also identify and manage asset liquidity as a subset of contingent liquidity, consisting of cash balances at the FRB and unencumbered high-quality liquid securities. We maintain additional secured borrowing capacity at the FRB discount window, but do not view this as a primary means of funding, but rather a potential source in a stressed environment or during a market disruption. We manage liquidity at the consolidated enterprise level and at each material legal entity.

Liquidity risk is the risk arising from the inability to meet our obligations when they come due. We must maintain adequate funding to meet current and future obligations, including customer loan requests, deposit maturities and withdrawals, debt service, leases, and other cash commitments, under both normal operating conditions and periods of company-specific and/or market stress.

Citizens Financial Group, Inc. \| 25

------

Liquidity risk is measured and managed by the Funding and Liquidity unit within our Treasury group in accordance with policy guidelines promulgated by our Board and the Asset Liability Committee. The Funding and Liquidity unit is responsible for maintaining a liquidity management framework that effectively manages liquidity risk. Processes within this framework include, but are not limited to, regular and comprehensive reporting, including current levels versus threshold limits for a broad set of liquidity metrics and early warning indicators, explanatory commentary relating to emerging risk trends and, as appropriate, recommended remedial strategies, liquidity stress testing, contingency funding plans, and collateral management.

Our Funding and Liquidity unit's primary goals are to deliver and maintain prudent levels of operating liquidity to support expected and projected funding requirements; contingent liquidity to support unexpected funding requirements resulting from idiosyncratic, systemic, and combination stress events; and regulatory liquidity requirements in a timely manner from stable and cost-efficient funding sources. We seek to accomplish these goals by funding loans with stable deposits, by prudently controlling dependence on wholesale funding, particularly short-term unsecured funding, and by maintaining ample available liquidity, including a contingent liquidity buffer of unencumbered high-quality loans and securities.

The Funding and Liquidity unit monitors a variety of liquidity and funding metrics and early warning indicators, including specific risk thresholds limits. These monitoring tools are broadly classified as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Current liquidity sources and capacities, including cash balances at the FRB, free and liquid securities, and secured borrowing capacity at the FHLB and FRB discount window;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Liquidity stress sources, including idiosyncratic, systemic, and combined stresses, in addition to evolving regulatory requirements; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Current and prospective exposures, including secured and unsecured wholesale funding, and spot and cumulative cash-flow gaps across a variety of horizons.

Further, certain of these metrics are monitored individually for CBNA and for our consolidated enterprise on a daily basis, including cash position, unencumbered securities, asset liquidity, and available FHLB borrowing capacity. In order to identify emerging trends and risks and inform funding decisions, specific metrics are also forecasted over a one-year horizon.

We rely on customer deposits to be our primary stable and low-cost source of funding. Our funding sources also include our ability to securitize loans in secondary markets, raise funds in the debt and equity capital markets, pledge loans and/or securities for borrowing from the FHLB, pledge securities as collateral for borrowing under repurchase agreements, and sell AFS securities. In addition, we maintain a contingency funding plan designed to ensure that liquidity sources are sufficient to meet ongoing obligations and commitments, particularly in a stressed environment or during a market disruption. The plan identifies members of the liquidity contingency team and provides a framework for management to follow, including notification and escalation of potential liquidity stress events.

As of September 30, 2025:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Organically generated deposits continue to be our primary source of funding, resulting in a consolidated period-end loan-to-deposit ratio, excluding LHFS, of 78.3%;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ Estimated insured/secured deposits comprise 64% of our consolidated deposit base of $180.0 billion;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our total available liquidity, comprised of contingent liquidity and available discount window capacity, was approximately $88.0 billion;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ Contingent liquidity was $73.1 billion, consisting of unencumbered high-quality liquid securities of $38.8 billion, unused FHLB capacity of $24.3 billion, and cash balances at the FRB of $10.0 billion; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ Available discount window capacity was $14.9 billion, defined as available total borrowing capacity from the FRB based on identified collateral, which is primarily secured by non-mortgage commercial and retail loans.

For a summary of our sources and uses of cash by type of activity for the nine months ended September 30, 2025 and 2024, see the Consolidated Statements of Cash Flows in Item 1.

Citizens Financial Group, Inc. \| 26

------

*Parent Company Liquidity* 

Our Parent Company's primary sources of cash are dividends and interest received from CBNA resulting from investing in bank equity and subordinated debt as well as externally issued preferred stock, senior debt, and subordinated debt. Uses of cash include the routine cash flow requirements as a bank holding company, including periodic share repurchases and payments of dividends, interest, and expenses; the needs of subsidiaries, including CBNA for additional equity and, as required, its need for debt financing; and the support for extraordinary funding requirements when necessary. To the extent the Parent Company relies on wholesale borrowings, uses also include payments of related principal and interest.

During the nine months ended September 30, 2025, the Parent Company completed the following transactions:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Issued $750 million of 5.253% fixed-to-floating rate senior notes due 2031;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Issued 400,000 shares of 6.500% fixed-rate reset non-cumulative perpetual Series I Preferred Stock at an aggregate offering price of $400 million; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Issued a notice to redeem all outstanding shares of the 5.650% fixed-rate reset non-cumulative perpetual Series F Preferred Stock, which was redeemed on October 6, 2025.

Our Parent Company's cash and cash equivalents represent a source of liquidity that can be used to meet various needs and totaled $3.2 billion and $2.7 billion as of September 30, 2025 and December 31, 2024, respectively.

During the three months ended September 30, 2025 and 2024, the Parent Company declared dividends on common stock of $184 million and $190 million, respectively, and declared dividends on preferred stock of $32 million and $38 million, respectively.

During the nine months ended September 30, 2025 and 2024, the Parent Company declared dividends on common stock of $555 million and $581 million, respectively, and declared dividends on preferred stock of $99 million and $103 million, respectively.

During the three months ended September 30, 2025 and 2024, the Parent Company repurchased $75 million and $325 million, respectively, of its outstanding common stock, and repurchased $475 million and $825 million, respectively, during the nine months ended September 30, 2025 and 2024.

*CBNA Liquidity*

As CBNA's primary business involves taking deposits and making loans, a key role of liquidity management is to ensure that customers have timely access to funds. Liquidity management also involves maintaining sufficient liquidity to repay wholesale borrowings, pay operating expenses, and support extraordinary funding requirements when necessary. In the ordinary course of business, the liquidity of CBNA is managed by matching sources and uses of cash. The primary sources of bank liquidity include deposits from our consumer and commercial customers; payments of principal and interest on loans and debt securities; and wholesale borrowings, as needed. The primary uses of bank liquidity include withdrawals and maturities of deposits; payment of interest on deposits; funding of loans and related commitments; and funding of securities purchases. To the extent that CBNA relies on wholesale borrowings, uses also include payments of related principal and interest. For further information on CBNA's outstanding debt see Note 7.

During the nine months ended September 30, 2025, CBNA redeemed $350 million of 5.284% fixed-to-floating rate senior notes due 2026.

Citizens Financial Group, Inc. \| 27

------

*Credit Ratings*

Credit ratings assigned by agencies such as Moody's, Standard and Poor's, and Fitch impact our access to unsecured wholesale market funds and to large uninsured customer deposits and are presented in the table below. We currently have a "stable" outlook at Standard & Poor's, a "stable" outlook at Moody's, and a "positive" outlook at Fitch. Changes in our public credit ratings could affect both the cost and availability of our wholesale funding.

---

| | | | | |
|:---|:---|:---|:---|:---|
| ***Table 19: Credit Ratings*** | | | |  |
| | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** |  |
| | **Moody's**  | **Standard &<br>Poor's** | **Fitch**  | |
| | **Moody's**  | **Standard &<br>Poor's** | **Fitch**  | **Citizens Financial Group, Inc.:** |
| Long-term issuer | Baa1 | BBB+ | BBB+ |  |
| Short-term issuer | NR | A-2 | F1 |  |
| Subordinated debt | Baa1 | BBB | BBB |  |
| Preferred Stock | Baa3 | BB+ | BB |  |
| **Citizens Bank, National Association:** |  |  |  |  |
| Long-term issuer | A3 | A- | BBB+ |  |
| Short-term issuer | (P) P-2 | A-2 | F1 |  |
| Long-term deposits | A1 | NR | A- |  |
| Short-term deposits | P-1 | NR | F1 |  |
| NR = Not rated |  |  |  |  |

---

Existing and evolving regulatory liquidity requirements represent another key driver of systemic liquidity conditions and liquidity management practices. The FRB and OCC regularly evaluate our liquidity as part of the overall supervisory process. In addition, we are subject to existing and evolving regulatory liquidity requirements, some of which are subject to further rulemaking, guidance, and interpretation by the applicable federal regulators. For further discussion, see the "Liquidity Requirements" section under "Regulation and Supervision" in our 2024 Form 10-K.

*Off-Balance Sheet Arrangements*

We engage in a variety of activities that are not reflected in our Consolidated Balance Sheets that are generally referred to as "off-balance sheet arrangements." For more information on these types of activities, see Note 11.

**Operational Risk**

Operational risk is the risk of loss due to human error, third-party performance failures, or inadequate or failed internal systems and controls and includes certain risks such as fraud, legal, and natural disasters. To mitigate these risks, we maintain a comprehensive system of internal controls designed to identify, assess, and monitor potential threats to our operations. Our risk management framework includes regular audits, employee training, cybersecurity measures, and business continuity planning. We continuously evaluate and enhance these controls to adapt to evolving risks and regulatory requirements, ensuring the integrity, reliability, and efficiency of our operations.

*Cybersecurity*

The Company's Cybersecurity Program ("CSP") drives an end-to-end, continuous process that protects our customers, colleagues, assets, premises, systems, and information (electronic and non-electronic), and is designed to ensure compliance with current and emerging federal and state laws and regulations. The CSP is designed to ensure the effective implementation of the Corporate Security and Resilience Operating Model across all business lines of the Company and is under the supervision of the Chief Security Officer.

The CSP is designed to assess and mitigate threats and risks to the Company. New and emerging threats are assessed through an intelligence lifecycle, which includes threat modeling. In addition, risk assessment processes drive risk identification and measurement related to security. Once risks are identified and measured, the Company's Enterprise Risk Management Governance Framework is leveraged to track and mitigate them. Control testing is utilized to demonstrate that risks are managed effectively, identify gaps in expected control operation, and develop appropriate remediation plans, in order to manage risk to the Company within tolerable limits.

Citizens Financial Group, Inc. \| 28

------

The Company regularly reviews the nature of its business activities and modifies the CSP as appropriate. Many of the elements of the CSP are related to cyber defense and are in place to reduce our risk to a wide range of potential cyber threats that may target our assets and information daily. The effectiveness of the CSP is assessed and measured periodically by various lines of defense within the Company and is conducted primarily through risk assessments, assurance testing, and an independent audit. External organizations are also routinely engaged to assess our CSP and test our perimeter defenses. The effectiveness of the CSP is reported periodically to the appropriate governance committees. For more information regarding our cybersecurity risk management practices and governance, see Item 1C in our 2024 Form 10-K.

**Compliance Risk**

Financial institutions are subject to many laws, rules, and regulations at both the federal and state levels. These broad-based laws, rules, and regulations include, but are not limited to, expectations relating to anti-money laundering, lending limits, client privacy, fair lending, prohibitions against unfair, deceptive, or abusive acts or practices, protections for military members as they enter active duty, and community reinvestment. Adherence to the increasing volume and complexity of regulatory changes can increase our overall compliance risk. As such, we utilize various resources to help ensure expectations are met, including a team of compliance experts dedicated to ensuring our conformance with all applicable laws, rules, and regulations. Our colleagues receive training for several broad-based laws and regulations including, but not limited to, anti-money laundering and customer privacy. Colleagues engaged in lending activities also receive training for laws and regulations related to flood disaster protection, equal credit opportunity, fair lending, and/or other courses related to the extension of credit. We hold ourselves to a high standard for adherence to compliance management and seek to continuously enhance our performance.

**CAPITAL**

As a bank and financial holding company, we are subject to regulation and supervision by the FRB. Our banking subsidiary, CBNA, is a national banking association primarily regulated by the OCC. Our regulation and supervision continues to evolve as the legal and regulatory frameworks governing our operations continue to change. See "Regulation and Supervision" in our 2024 Form 10-K for more information.

*Capital Adequacy Process*

Our assessment of capital adequacy begins with our Board-approved risk appetite and risk management framework. This framework provides for the identification, measurement, and management of material risks. There have been no significant changes to our capital adequacy risk appetite and risk management framework as described in "Capital and Regulatory Matters" in our 2024 Form 10-K.

The FRB regularly supervises and evaluates our capital adequacy and capital planning processes, including the submission of an annual capital plan approved by our Board of Directors or one of its committees. Under the FRB's capital requirements, we must maintain capital ratios above the sum of the regulatory minimum and SCB requirement to avoid restrictions on capital distributions and discretionary bonus payments. The FRB utilizes the supervisory stress test to determine our SCB, which is re-calibrated with each biennial supervisory stress test and updated annually to reflect our planned common stock dividends. As an institution subject to Category IV standards, we are subject to biennial supervisory stress testing in even-numbered years. Our SCB associated with the 2024 supervisory stress test is 4.5%, effective through September 30, 2025. In August 2025, the FRB provided us with our updated SCB requirement, which will remain at 4.5% and is effective from October 1, 2025 to September 30, 2026.

Regulations relating to capital planning, regulatory reporting, stress testing, and capital buffer requirements applicable to firms like us are presently subject to rulemaking and potential further guidance and interpretation by the applicable federal regulators. We will continue to evaluate the impact of these and any other regulatory changes, including their potential resultant changes in our regulatory and compliance costs.

For more information on our capital adequacy process, see "Capital and Regulatory Matters" in our 2024 Form 10-K.

Citizens Financial Group, Inc. \| 29

------

*Regulatory Capital Ratios and Capital Composition*

Under the current U.S. Basel III capital framework, we, and our banking subsidiary, CBNA, must meet the following specific minimum requirements: CET1 capital ratio of 4.5%, Tier 1 capital ratio of 6.0%, Total capital ratio of 8.0%, and Tier 1 leverage ratio of 4.0%. As a bank holding company, our SCB of 4.5% is imposed on top of the three minimum risk-based capital ratios listed above and a CCB of 2.5% is imposed on top of the three minimum risk-based capital ratios listed above for CBNA.

For additional discussion of the U.S. Basel III capital framework and its related application, see "Regulation and Supervision" in our 2024 Form 10-K. The table below presents the regulatory capital ratios for CFG and CBNA under the U.S. Basel III Standardized rules:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| ***Table 20: Regulatory Capital Ratios Under the U.S. Basel III Standardized Rules*** | ***Table 20: Regulatory Capital Ratios Under the U.S. Basel III Standardized Rules*** | ***Table 20: Regulatory Capital Ratios Under the U.S. Basel III Standardized Rules*** | ***Table 20: Regulatory Capital Ratios Under the U.S. Basel III Standardized Rules*** | ***Table 20: Regulatory Capital Ratios Under the U.S. Basel III Standardized Rules*** | |
| | **September 30, 2025** | **September 30, 2025** | **December 31, 2024** | **December 31, 2024** | |
|<br>(dollars in millions) | **Amount** | **Ratio** | **Amount** | **Ratio** | **Required Minimum Capital Ratio**<sup>(1)</sup> |
| **CET1 capital** |  |  |  |  |  |
| &nbsp;&nbsp;CFG | $18046 | 10.7% | $17900 | 10.8% | 9.0% |
| &nbsp;&nbsp;CBNA | 20823 | 12.4 | 20250 | 12.3 | 7.0 |
| **Tier 1 capital** |  |  |  |  |  |
| &nbsp;&nbsp;CFG | 20157 | 11.9 | 20013 | 12.1 | 10.5 |
| &nbsp;&nbsp;CBNA | 20823 | 12.4 | 20250 | 12.3 | 8.5 |
| **Total capital** |  |  |  |  |  |
| &nbsp;&nbsp;CFG | 23455 | 13.9 | 23232 | 14.0 | 12.5 |
| &nbsp;&nbsp;CBNA | 24009 | 14.3 | 23362 | 14.2 | 10.5 |
| **Tier 1 leverage** |  |  |  |  |  |
| &nbsp;&nbsp;CFG | 20157 | 9.4 | 20013 | 9.4 | 4.0 |
| &nbsp;&nbsp;CBNA | 20823 | 9.8 | 20250 | 9.6 | 4.0 |
| **Risk-weighted assets** |  |  |  |  |  |
| &nbsp;&nbsp;CFG | 168932 |  | 165699 |  |  |
| &nbsp;&nbsp;CBNA | 167767 |  | 164986 |  |  |
| **Quarterly adjusted average assets**<sup>(2)</sup> |  |  |  |  |  |
| &nbsp;&nbsp;CFG | 213536 |  | 212555 |  |  |
| &nbsp;&nbsp;CBNA | 212585 |  | 211849 |  |  |

---

<sup>(1)</sup> Represents minimum requirement under the current capital framework plus the SCB of 4.5% and CCB of 2.5% for CFG and CBNA, respectively. The SCB and CCB are not applicable to the Tier 1 leverage ratio.

<sup>(2)</sup> Represents total average assets less certain amounts deducted from Tier 1 capital.

At September 30, 2025, CFG's CET1, Tier 1, and Total capital ratios decreased compared to December 31, 2024. Dividends, common share repurchases, a $3.2 billion increase in RWA, and the full phase-in of the modified CECL transition amount was partially offset by net income. Higher commercial and industrial loans was the key driver for the increase in RWA.

At September 30, 2025, CBNA's CET1, Tier 1, and Total capital ratios increased compared to December 31, 2024. Net income was partially offset by dividend payments to the Parent Company, a $2.8 billion increase in RWA, and the full phase-in of the modified CECL transition amount. Higher commercial and industrial loans was the key driver for the increase in RWA.

At September 30, 2025, CFG's Tier 1 leverage ratio was stable and CBNA's Tier 1 leverage ratio increased compared to December 31, 2024, reflecting an increase in quarterly adjusted average assets and their respective changes in Tier 1 capital described above.

Citizens Financial Group, Inc. \| 30

------

The following table presents the components of our regulatory capital under the U.S. Basel III capital framework:

---

| | | |
|:---|:---|:---|
| ***Table 21: Capital Composition Under the U.S. Basel III Capital Framework*** | ***Table 21: Capital Composition Under the U.S. Basel III Capital Framework*** | |
| (dollars in millions) | **September 30, 2025** |<br>**December 31, 2024** |
| Total common stockholders' equity | $23718 | $22141 |
| **Exclusions:** |  |  |
| Modified CECL transitional amount |  | 96 |
| Net unrealized (gains)/losses recorded in AOCI, net of tax: |  |  |
| &nbsp;&nbsp;&nbsp;Debt securities | 1760 | 2369 |
| &nbsp;&nbsp;&nbsp;Derivatives | 213 | 925 |
| &nbsp;&nbsp;&nbsp;Unamortized net periodic benefit costs | 294 | 301 |
| **Deductions:** |  |  |
| Goodwill, net of deferred tax liability | (7762) | (7768) |
| Other intangible assets, net of deferred tax liability | (110) | (128) |
| Deferred tax assets that arise from tax loss and credit carryforwards | (67) | (36) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total CET1 capital | 18046 | 17900 |
| Qualifying preferred stock | 2111 | 2113 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Tier 1 capital | 20157 | 20013 |
| Qualifying subordinated debt<sup>(1)</sup> | 1237 | 1232 |
| Allowance for credit losses | 2201 | 2259 |
| **Exclusions from Tier 2 capital:** |  |  |
| &nbsp;&nbsp;&nbsp;Modified AACL transitional amount |  | (125) |
| &nbsp;&nbsp;&nbsp;Allowance on PCD assets | (140) | (147) |
| Adjusted allowance for credit losses | 2061 | 1987 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total capital | $23455 | $23232 |

---

<sup>(1)</sup> As of September 30, 2025 and December 31, 2024, the amount of non-qualifying subordinated debt excluded from regulatory capital was $336 million and $469 million, respectively. See Note 7 for more details on our outstanding subordinated debt.

*Capital Transactions*

We completed the following capital transactions during the nine months ended September 30, 2025:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Repurchased $475 million of our outstanding common stock;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Issued 400,000 shares of 6.500% fixed-rate reset non-cumulative perpetual Series I Preferred Stock at an aggregate offering price of $400 million;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Issued a notice to redeem all outstanding shares of the 5.650% fixed-rate reset non-cumulative perpetual Series F Preferred Stock, which was redeemed on October 6, 2025;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Declared quarterly common stock dividends of $0.42 per share, aggregating to $555 million; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Declared preferred stock dividends aggregating to $99 million.

For additional detail regarding our common and preferred stock dividends see Note 10.

On June 13, 2025, we announced that our Board of Directors increased the capacity of our common share repurchase program to $1.5 billion, an increase of $1.2 billion above the $300 million of capacity remaining under the prior June 2024 authorization. All future capital distributions are subject to consideration and approval by our Board of Directors prior to execution. The timing and amount of future dividends and share repurchases will depend on various factors, including our capital position, financial performance, balance sheet growth, market conditions, and regulatory considerations.

*AOCI Impact on Regulatory Capital*

Under the current applicable regulatory capital rules we have made the AOCI opt-out election, which enables us to exclude components of AOCI from regulatory capital. As noted in the "Capital and Stress Testing Requirements" section of "Regulation and Supervision" in our 2024 Form 10-K, the regulatory agencies are considering the inclusion of AOCI components in regulatory capital for Category IV firms like us, notably the AOCI relative to securities and pension.

Citizens Financial Group, Inc. \| 31

------

In light of this potential change, the Company considers capital ratios including the AOCI impact from securities and pension when evaluating capital utilization and adequacy, in addition to capital ratios defined by the regulatory agencies. These capital ratios are intended to complement our regulatory capital ratios and are viewed by management as useful measures reflective of the level of capital available to withstand unexpected market conditions. See "Non-GAAP Financial Measures" for more information.

The following table presents our regulatory capital ratios including the AOCI impact from securities and pension:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| ***Table 22: AOCI Impact on Regulatory Capital*** | ***Table 22: AOCI Impact on Regulatory Capital*** | ***Table 22: AOCI Impact on Regulatory Capital*** | ***Table 22: AOCI Impact on Regulatory Capital*** | ***Table 22: AOCI Impact on Regulatory Capital*** | | |
| | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** |
| | **CFG** | **CFG** | **CFG** | **CBNA** | **CBNA** | **CBNA** |
|<br>(dollars in millions) | **CET1** | **Tier 1** | **Total** | **CET1** | **Tier 1** | **Total** |
| **Regulatory capital, including AOCI impact:** |  |  |  |  |  |  |
| Regulatory capital | $18046 | $20157 | $23455 | $20823 | $20823 | $24009 |
| Unrealized gains (losses) on securities and pension | (2054) | (2054) | (2054) | (2036) | (2036) | (2036) |
| Deferred tax assets - securities and pension AOCI | (34) | (34) | (34) | (38) | (38) | (38) |
| Regulatory capital, including AOCI impact (non-GAAP) | $15958 | $18069 | $21367 | $18749 | $18749 | $21935 |
| **Risk-weighted assets, including AOCI impact:** |  |  |  |  |  |  |
| Regulatory risk-weighted assets | $168932 | $168932 | $168932 | $167767 | $167767 | $167767 |
| Unrealized gains (losses) on securities and pension | (582) | (582) | (582) | (564) | (564) | (564) |
| Deferred tax assets - securities and pension AOCI | 1682 | 1682 | 1682 | 1656 | 1656 | 1656 |
| Risk-weighted assets, including AOCI impact (non-GAAP) | $170032 | $170032 | $170032 | $168859 | $168859 | $168859 |
| **Ratio:** |  |  |  |  |  |  |
| Regulatory capital ratio | 10.7% | 11.9% | 13.9% | 12.4% | 12.4% | 14.3% |
| Regulatory capital ratio, including AOCI impact (non-GAAP) | 9.4% | 10.6% | 12.6% | 11.1% | 11.1% | 13.0% |

---

**CRITICAL ACCOUNTING ESTIMATES**

Our Consolidated Financial Statements included in this Report are prepared in accordance with GAAP, requiring us to establish accounting policies and make estimates and assumptions that affect reported amounts.

An accounting estimate requires assumptions and judgments about uncertain matters that could have a material effect on our Consolidated Financial Statements. Estimates are made using facts and circumstances known at a point in time. Changes in those facts and circumstances could produce results substantially different from those estimates. Our most significant accounting policies and estimates include the ACL, fair value measurements, and the evaluation and measurement of goodwill impairment. For additional information regarding fair value measurements and goodwill, see "Critical Accounting Estimates" in our 2024 Form 10-K.

*Allowance for Credit Losses*

The ACL of $2.2 billion at September 30, 2025 decreased $58 million compared to December 31, 2024 given improving loan mix, reflecting the reduction of the Non-Core portfolio, reduced CRE, and lower loss-content originations.

As of September 30, 2025, our ACL economic forecast over a two-year reasonable and supportable period reflects the economy going into a shallow two quarter contraction inclusive of uncertainties related to the implementation of tariffs and protectionist trade policies, inflationary pressures, and geopolitical tensions. This forecast is generally applied to the retail and commercial and industrial portfolios and projects peak unemployment of approximately 5.2% and a start-to-trough real GDP decline of approximately 0.5%, compared to peak unemployment of approximately 5.1% and a start-to-trough real GDP decline of approximately 0.4% at December 31, 2024. More severe economic scenarios are applied within the CRE portfolio, such as general office, with peak unemployment of approximately 9.4% and a start-to-trough real GDP decline of approximately 4.4%, compared to peak unemployment of approximately 9.3% and a start-to-trough real GDP decline of approximately 4.4% at December 31, 2024.

Citizens Financial Group, Inc. \| 32

------

Our determination of the ACL is sensitive to changes in forecasted macroeconomic conditions during the reasonable and supportable forecast period. To illustrate this sensitivity, we applied a more pessimistic scenario than that described above which reflects deeper real GDP contraction across our two-year reasonable and supportable forecast period with peak unemployment of approximately 6.7% and a start-to-trough real GDP decline of approximately 2.0%. Excluding consideration of qualitative adjustments, this scenario would result in a quantitative lifetime loss estimate of approximately 1.4x our modeled period-end ACL, or an increase of approximately $700 million. This analysis relates only to the modeled credit loss estimate and not to the overall period-end ACL, which includes qualitative adjustments.

Because several quantitative and qualitative factors are considered in determining the ACL, this sensitivity analysis does not necessarily reflect the nature and extent of future changes in the ACL or even what the ACL would be under these economic circumstances. The sensitivity analysis is intended to provide insights into the impact of adverse changes in the macroeconomic environment and the corresponding impact to modeled loss estimates. The hypothetical determination does not incorporate the impact of management judgment or other qualitative factors that could be applied in the actual estimation of the ACL and does not imply any expectation of future deterioration in our loss rates.

It remains difficult to estimate how changes in economic forecasts might affect our ACL because such forecasts consider a wide variety of variables and inputs, and changes in the variables and inputs may not occur at the same time or in the same direction, and such changes may have differing impacts by product type. The variables and inputs may be idiosyncratically affected by risks to the economy, including changing monetary and fiscal policies, impacts from the recent stress on the banking industry, and inflationary trends. Changes in one or multiple of the key macroeconomic variables may have a material impact on our estimation of expected credit losses.

For additional information regarding the ACL, see Note 4 and "Critical Accounting Estimates - Allowance for Credit Losses" and Note 6 in our 2024 Form 10-K.

Citizens Financial Group, Inc. \| 33

------

**ACCOUNTING AND REPORTING DEVELOPMENTS**

*Accounting standards issued but not adopted as of September 30, 2025*

---

| | | |
|:---|:---|:---|
| **Pronouncement** | **Summary of Guidance** | **Effects on Financial Statements** |
| Improvements to Income Tax Disclosures<br>*Issued December 2023* | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Requires a tabular income tax rate reconciliation that includes specific categories and other significant categories, disaggregated by nature, that exceed 5% of income tax expense at the statutory tax rate<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Requires disclosure of income taxes paid, net of refunds received, disaggregated by federal, state, and foreign taxes, and further disaggregated by individual jurisdictions that exceed 5% of total income taxes paid, net of refunds received<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Requires disclosure of pre-tax income disaggregated between domestic and foreign, and income tax expense disaggregated by federal, state, and foreign<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The amendments should be applied on a prospective basis but retrospective application is permitted | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Required effective date: Annual financial statements for the year ending December 31, 2025. We do not intend to early adopt.<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We expect to provide additional disaggregated income tax disclosures in accordance with this ASU. |
| Disaggregation of Income Statement Expenses <br>*Issued November 2024* | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Requires tabular disclosure of certain expense types, including employee compensation, depreciation, intangible asset amortization, and selling expenses <br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Requires a qualitative description of the amounts remaining in relevant expense captions that are not separately disaggregated quantitatively<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Allows for adoption on either a prospective or retrospective basis | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Required effective date: Annual financial statements for the year ending December 31, 2027, and interim reporting periods thereafter. Early adoption is permitted.<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We are currently evaluating the impact of this ASU on our required expense disclosures in the Consolidated Financial Statements. |
| Targeted Improvements to the Accounting for Internal-Use Software<br>*Issued September 2025* | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Eliminates all references to software project development stages and, as a result, requires entities to start capitalizing software costs when both of the following occur: 1) Management has authorized and committed to funding the software project, and 2) It is probable the project will be completed and the software will be used to perform the function intended<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Requires software costs to be expensed as incurred prior to meeting the capitalization requirements noted above<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Allows for adoption on a prospective, modified transition, or retrospective basis | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Required effective date: January 1, 2028. Early adoption is permitted.<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We are currently evaluating the impact of this ASU on our Consolidated Financial Statements. |

---

Citizens Financial Group, Inc. \| 34

------

**NON-GAAP FINANCIAL MEASURES**

This document contains non-GAAP financial measures that we believe provide useful information to investors to understand our results of operations or financial condition. We caution investors not to place undue reliance on such non-GAAP financial measures, but to consider them with the most directly comparable GAAP financial measures. Non-GAAP financial measures have limitations as analytical tools and should not be considered in isolation or as a substitute for our results reported under GAAP.

The following tables present the computation of non-GAAP financial measures used in the MD&A, as well as the reconciliation to the comparable GAAP financial measure, as applicable:

---

| | | |
|:---|:---|:---|
| ***Table 23: Reconciliation of Tangible Book Value per Common Share (non-GAAP)*** | ***Table 23: Reconciliation of Tangible Book Value per Common Share (non-GAAP)*** | |
| (dollars in millions, except per share data) | **September 30, 2025** |<br>**December 31, 2024** |
| Book value per common share<sup>(1)</sup> | $54.97 | $50.26 |
| **Tangible book value per common share:** |  |  |
| &nbsp;&nbsp;Common stockholders' equity | $23718 | $22141 |
| &nbsp;&nbsp;Less: Goodwill | 8187 | 8187 |
| &nbsp;&nbsp;Less: Other intangible assets | 123 | 146 |
| &nbsp;&nbsp;Add: Deferred tax liabilities related to goodwill and other intangible assets | 440 | 438 |
| Tangible common equity (non-GAAP)<sup>(2)</sup> | $15848 | $14246 |
| Common shares outstanding at period end | 431453142 | 440543381 |
| Tangible book value per common share (non-GAAP)<sup>(3)</sup> | $36.73 | $32.34 |

---

<sup>(1)</sup> Represents the most directly comparable GAAP financial measure to tangible book value per common share and is calculated based on common stockholders' equity divided by common shares outstanding at period end.

<sup>(2)</sup> Tangible common equity is a non-GAAP financial measure that excludes the impact of intangible assets, net of deferred taxes.

<sup>(3)</sup> Tangible book value per common share is a non-GAAP financial measure and is calculated based on tangible common equity divided by common shares outstanding at period end. We believe this non-GAAP financial measure serves as a useful tool to help evaluate the strength and discipline of a company's capital management strategies and as a conservative measure of total company value.

---

| | | | | |
|:---|:---|:---|:---|:---|
| ***Table 24: Reconciliation of Return on Average Tangible Common Equity (non-GAAP)*** | ***Table 24: Reconciliation of Return on Average Tangible Common Equity (non-GAAP)*** | ***Table 24: Reconciliation of Return on Average Tangible Common Equity (non-GAAP)*** | | |
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
|<br>(dollars in millions) | **2025** | **2024** | **2025** | **2024** |
| Return on average common equity<sup>(1)</sup> | 7.77% | 6.12% | 7.07% | 6.15% |
| Net income available to common stockholders | $457 | $344 | $1199 | $1005 |
| Net income available to common stockholders (annualized) | 1811 | 1369 | 1602 | 1342 |
| **Return on average tangible common equity:** |  |  |  |  |
| &nbsp;&nbsp;Average common equity | $23288 | $22380 | $22661 | $21838 |
| &nbsp;&nbsp;Less: Average goodwill | 8187 | 8187 | 8187 | 8187 |
| &nbsp;&nbsp;Less: Average other intangibles | 126 | 140 | 134 | 146 |
| &nbsp;&nbsp;Add: Average deferred tax liabilities related to goodwill and other intangible assets | 440 | 435 | 439 | 433 |
| Average tangible common equity (non-GAAP)<sup>(2)</sup> | $15415 | $14488 | $14779 | $13938 |
| Return on average tangible common equity (non-GAAP)<sup>(3)</sup> | 11.75% | 9.45% | 10.84% | 9.63% |

---

<sup>(1)</sup> Represents the most directly comparable GAAP financial measure to return on average tangible common equity and is calculated based on annualized net income available to common stockholders divided by average common equity.

<sup>(2)</sup> Average tangible common equity is a non-GAAP financial measure that excludes the impact of intangible assets, net of deferred taxes.

<sup>(3)</sup> Return on average tangible common equity is a non-GAAP financial measure and is calculated based on annualized net income available to common stockholders divided by average tangible common equity. We believe this non-GAAP financial measure serves as a useful tool to compare the profitability of financial institutions and assess the efficiency of their capital utilization without the impact of intangible assets, net of deferred taxes.

Citizens Financial Group, Inc. \| 35

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| ***Table 25: Reconciliation of Net Interest Income and Net Interest Margin on an FTE Basis (non-GAAP)*** | ***Table 25: Reconciliation of Net Interest Income and Net Interest Margin on an FTE Basis (non-GAAP)*** | ***Table 25: Reconciliation of Net Interest Income and Net Interest Margin on an FTE Basis (non-GAAP)*** | ***Table 25: Reconciliation of Net Interest Income and Net Interest Margin on an FTE Basis (non-GAAP)*** | ***Table 25: Reconciliation of Net Interest Income and Net Interest Margin on an FTE Basis (non-GAAP)*** |
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
|<br>(dollars in millions) | **2025** | **2024** | **2025** | **2024** |
| Net interest income (annualized) | $5902 | $5447 | $5771 | $5638 |
| Average interest-earning assets | 197598 | 197164 | 196334 | 198561 |
| Net interest margin<sup>(1)</sup> | 2.99% | 2.76% | 2.94% | 2.84% |
| Net interest income | $1488 | $1369 | $4316 | $4221 |
| FTE adjustment | 4 | 4 | 12 | 13 |
| Net interest income on an FTE basis (non-GAAP)<sup>(2)</sup> | $1492 | $1373 | $4328 | $4234 |
| Net interest income on an FTE basis (annualized) (non-GAAP)<sup>(2)</sup> | 5919 | 5465 | 5787 | 5656 |
| Net interest margin on an FTE basis (non-GAAP)<sup>(2)(3)</sup> | 3.00% | 2.77% | 2.95% | 2.85% |

---

<sup>(1)</sup> Represents the most directly comparable GAAP financial measure to net interest margin on an FTE basis and is calculated based on annualized net interest income divided by average interest-earnings assets.

<sup>(2)</sup> FTE basis financial measures and ratios are adjusted for the tax-exempt status of income from certain assets held by the Company using the federal statutory tax rate of 21% and are considered non-GAAP financial measures. We believe this allows management to better assess the comparability of revenue from both taxable and tax-exempt sources.

<sup>(3)</sup> Calculated based on annualized net interest income on an FTE basis divided by average interest-earnings assets.

Citizens Financial Group, Inc. \| 36

------

**ITEM 1. FINANCIAL STATEMENTS (UNAUDITED)**

---

| | |
|:---|:---|
| | <u>Page</u> |
| **<u>[Consolidated Balance Sheets](#i8c5674cd6d39421d826c711b06a6c8c1_106)</u>** | <u>[38](#i8c5674cd6d39421d826c711b06a6c8c1_106)</u> |
| **<u>[Consolidated Statements of Operations](#i8c5674cd6d39421d826c711b06a6c8c1_109)</u>** | <u>[39](#i8c5674cd6d39421d826c711b06a6c8c1_109)</u> |
| **<u>[Consolidated Statements of Comprehensive Income](#i8c5674cd6d39421d826c711b06a6c8c1_112)</u>** | <u>[40](#i8c5674cd6d39421d826c711b06a6c8c1_112)</u> |
| **<u>[Consolidated Statements of Changes in Stockholders' Equity](#i8c5674cd6d39421d826c711b06a6c8c1_115)</u>** | <u>[41](#i8c5674cd6d39421d826c711b06a6c8c1_115)</u> |
| **<u>[Consolidated Statements of Cash Flows](#i8c5674cd6d39421d826c711b06a6c8c1_118)</u>** | <u>[43](#i8c5674cd6d39421d826c711b06a6c8c1_118)</u> |
| **<u>[Notes to Consolidated Financial Statements](#i8c5674cd6d39421d826c711b06a6c8c1_121)</u>** | <u>[44](#i8c5674cd6d39421d826c711b06a6c8c1_121)</u> |
| **<u>[Note 1 - Significant Accounting Policies](#i8c5674cd6d39421d826c711b06a6c8c1_124)</u>** | <u>[44](#i8c5674cd6d39421d826c711b06a6c8c1_124)</u> |
| **<u>[Note 2 - Securities](#i8c5674cd6d39421d826c711b06a6c8c1_127)</u>** | <u>[44](#i8c5674cd6d39421d826c711b06a6c8c1_127)</u> |
| **<u>[Note 3 - Loans and Leases](#i8c5674cd6d39421d826c711b06a6c8c1_133)</u>** | <u>[47](#i8c5674cd6d39421d826c711b06a6c8c1_133)</u> |
| **<u>[Note 4 - Credit Quality and the Allowance for Credit Losses](#i8c5674cd6d39421d826c711b06a6c8c1_136)</u>** | <u>[47](#i8c5674cd6d39421d826c711b06a6c8c1_136)</u> |
| **<u>[Note 5 - Mortgage Banking and Other Serviced Loans](#i8c5674cd6d39421d826c711b06a6c8c1_139)</u>** | <u>[59](#i8c5674cd6d39421d826c711b06a6c8c1_139)</u> |
| **<u>[Note 6 - Variable Interest Entities](#i8c5674cd6d39421d826c711b06a6c8c1_142)</u>** | <u>[61](#i8c5674cd6d39421d826c711b06a6c8c1_142)</u> |
| **<u>[Note 7 - Borrowed Funds](#i8c5674cd6d39421d826c711b06a6c8c1_145)</u>** | <u>[63](#i8c5674cd6d39421d826c711b06a6c8c1_145)</u> |
| **<u>[Note 8 - Derivatives](#i8c5674cd6d39421d826c711b06a6c8c1_151)</u>** | <u>[64](#i8c5674cd6d39421d826c711b06a6c8c1_151)</u> |
| **<u>[Note 9 - Accumulated Other Comprehensive Income (Loss)](#i8c5674cd6d39421d826c711b06a6c8c1_154)</u>** | <u>[68](#i8c5674cd6d39421d826c711b06a6c8c1_154)</u> |
| **<u>[Note 10 - Stockholders' Equity](#i8c5674cd6d39421d826c711b06a6c8c1_157)</u>** | <u>[69](#i8c5674cd6d39421d826c711b06a6c8c1_157)</u> |
| **<u>[Note 11 - Commitments and Contingencies](#i8c5674cd6d39421d826c711b06a6c8c1_163)</u>** | <u>[71](#i8c5674cd6d39421d826c711b06a6c8c1_163)</u> |
| **<u>[Note 12 - Fair Value Measurements](#i8c5674cd6d39421d826c711b06a6c8c1_166)</u>** | <u>[72](#i8c5674cd6d39421d826c711b06a6c8c1_166)</u> |
| **<u>[Note 13 - Noninterest Income](#i8c5674cd6d39421d826c711b06a6c8c1_169)</u>** | <u>[76](#i8c5674cd6d39421d826c711b06a6c8c1_169)</u> |
| **<u>[Note 14 - Other Operating Expense](#i8c5674cd6d39421d826c711b06a6c8c1_172)</u>** | <u>[77](#i8c5674cd6d39421d826c711b06a6c8c1_172)</u> |
| **<u>[Note 15 - Earnings Per Share](#i8c5674cd6d39421d826c711b06a6c8c1_175)</u>** | <u>[78](#i8c5674cd6d39421d826c711b06a6c8c1_175)</u> |
| **<u>[Note 16 - Business Segments](#i8c5674cd6d39421d826c711b06a6c8c1_178)</u>** | <u>[78](#i8c5674cd6d39421d826c711b06a6c8c1_178)</u> |

---

Citizens Financial Group, Inc. \| 37

------

**CONSOLIDATED BALANCE SHEETS (UNAUDITED)**

---

| | | |
|:---|:---|:---|
| (dollars in millions, except par value) | **September 30, 2025** | **December 31, 2024** |
| **ASSETS:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash and due from banks | $1254 | $1409 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest-bearing cash and due from banks | 10396 | 9192 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest-bearing deposits in banks<sup>(1)</sup> | 694 | 635 |
| &nbsp;&nbsp;&nbsp;&nbsp;Debt securities available for sale, at fair value (including $115 and $152 pledged to creditors, respectively)<sup>(2)</sup> | 35419 | 32765 |
| &nbsp;&nbsp;&nbsp;&nbsp;Debt securities held to maturity (fair value of $7,295 and $7,540, respectively, and including $68 and $83 pledged to creditors, respectively)<sup>(2)</sup> | 8124 | 8599 |
| &nbsp;&nbsp;&nbsp;&nbsp;Loans held for sale (includes $768 and $825, respectively, measured at fair value) | 1334 | 858 |
| &nbsp;&nbsp;&nbsp;&nbsp;Loans and leases | 140870 | 139203 |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: Allowance for loan and lease losses | (1972) | (2061) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net loans and leases<sup>(1)</sup> | 138898 | 137142 |
| &nbsp;&nbsp;&nbsp;&nbsp;Derivative assets | 721 | 408 |
| &nbsp;&nbsp;&nbsp;&nbsp;Premises and equipment, net | 857 | 875 |
| &nbsp;&nbsp;&nbsp;&nbsp;Bank-owned life insurance | 3422 | 3364 |
| &nbsp;&nbsp;&nbsp;&nbsp;Goodwill | 8187 | 8187 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other intangible assets<sup>(3)</sup> | 123 | 146 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other assets<sup>(1)</sup> | 13318 | 13941 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**TOTAL ASSETS** | $222747 | $217521 |
| **LIABILITIES AND STOCKHOLDERS' EQUITY:** |  |  |
| **LIABILITIES:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Deposits: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Noninterest-bearing | $39472 | $36920 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest-bearing | 140539 | 137856 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total deposits | 180011 | 174776 |
| &nbsp;&nbsp;&nbsp;&nbsp;Short-term borrowed funds | 214 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Long-term borrowed funds<sup>(1)</sup> | 10441 | 12401 |
| &nbsp;&nbsp;&nbsp;&nbsp;Derivative liabilities | 738 | 1220 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other liabilities<sup>(1)</sup> | 5514 | 4870 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**TOTAL LIABILITIES** | 196918 | 193267 |
| Commitments and Contingencies (refer to Note 11) |  |  |
| **STOCKHOLDERS' EQUITY:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Preferred stock: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$25.00 par value,100,000,000 shares authorized; 2,150,000 shares issued and outstanding at September 30, 2025 and December 31, 2024 | 2111 | 2113 |
| &nbsp;&nbsp;&nbsp;&nbsp;Common stock: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$0.01 par value, 1,000,000,000 shares authorized; 652,107,285 shares issued and 431,453,142 shares outstanding at September 30, 2025 and 650,068,324 shares issued and 440,543,381 shares outstanding at December 31, 2024 | 7 | 7 |
| &nbsp;&nbsp;&nbsp;&nbsp;Additional paid-in capital | 22448 | 22364 |
| &nbsp;&nbsp;&nbsp;&nbsp;Retained earnings | 11056 | 10412 |
| &nbsp;&nbsp;&nbsp;&nbsp;Treasury stock, at cost, 220,654,143 and 209,524,943 shares at September 30, 2025 and December 31, 2024, respectively | (7526) | (7047) |
| &nbsp;&nbsp;&nbsp;&nbsp;Accumulated other comprehensive income (loss) | (2267) | (3595) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**TOTAL STOCKHOLDERS' EQUITY** | 25829 | 24254 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY** | $222747 | $217521 |

---

<sup>(1)</sup> Includes amounts in consolidated VIEs. See Note 6 for additional information.

<sup>(2)</sup> Includes only collateral pledged by the Company where counterparties have the right to sell or pledge the collateral.

<sup>(3)</sup> Excludes MSRs, which are reported in Other assets.

The accompanying Notes to Consolidated Financial Statements are an integral part of these statements.

Citizens Financial Group, Inc. \| 38

------

**CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
|<br>(dollars in millions, except per share data) | **2025** | **2024** | **2025** | **2024** |
| **INTEREST INCOME:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest and fees on loans and leases | $1897 | $1976 | $5577 | $6038 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest and fees on loans held for sale | 31 | 19 | 83 | 56 |
| &nbsp;&nbsp;&nbsp;&nbsp;Investment securities | 433 | 423 | 1279 | 1239 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest-bearing deposits in banks | 97 | 121 | 278 | 391 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total interest income | 2458 | 2539 | 7217 | 7724 |
| **INTEREST EXPENSE:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Deposits | 816 | 990 | 2413 | 2942 |
| &nbsp;&nbsp;&nbsp;&nbsp;Short-term borrowed funds | 5 | 3 | 22 | 14 |
| &nbsp;&nbsp;&nbsp;&nbsp;Long-term borrowed funds | 149 | 177 | 466 | 547 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total interest expense | 970 | 1170 | 2901 | 3503 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net interest income | 1488 | 1369 | 4316 | 4221 |
| &nbsp;&nbsp;&nbsp;&nbsp;Provision (benefit) for credit losses | 154 | 172 | 471 | 525 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net interest income after provision (benefit) for credit losses | 1334 | 1197 | 3845 | 3696 |
| **NONINTEREST INCOME:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Service charges and fees | 112 | 109 | 332 | 311 |
| &nbsp;&nbsp;&nbsp;&nbsp;Capital markets fees | 166 | 94 | 371 | 346 |
| &nbsp;&nbsp;&nbsp;&nbsp;Card fees | 87 | 93 | 260 | 271 |
| &nbsp;&nbsp;&nbsp;&nbsp;Wealth fees | 93 | 76 | 262 | 219 |
| &nbsp;&nbsp;&nbsp;&nbsp;Mortgage banking fees | 49 | 46 | 181 | 149 |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign exchange and derivative products | 42 | 36 | 122 | 111 |
| &nbsp;&nbsp;&nbsp;&nbsp;Letter of credit and loan fees | 48 | 45 | 137 | 130 |
| &nbsp;&nbsp;&nbsp;&nbsp;Securities gains, net | 2 | 9 | 14 | 14 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other income | 31 | 24 | 95 | 51 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total noninterest income | 630 | 532 | 1774 | 1602 |
| **NONINTEREST EXPENSE:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Salaries and employee benefits | 705 | 647 | 2082 | 1983 |
| &nbsp;&nbsp;&nbsp;&nbsp;Equipment and software | 197 | 194 | 584 | 576 |
| &nbsp;&nbsp;&nbsp;&nbsp;Outside services | 161 | 146 | 485 | 469 |
| &nbsp;&nbsp;&nbsp;&nbsp;Occupancy | 106 | 108 | 326 | 335 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other operating expense | 166 | 164 | 491 | 555 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total noninterest expense | 1335 | 1259 | 3968 | 3918 |
| &nbsp;&nbsp;&nbsp;&nbsp;Income before income tax expense | 629 | 470 | 1651 | 1380 |
| &nbsp;&nbsp;&nbsp;&nbsp;Income tax expense | 135 | 88 | 348 | 272 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**NET INCOME** | $494 | $382 | $1303 | $1108 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Net income available to common stockholders** | $457 | $344 | $1199 | $1005 |
| Weighted-average common shares outstanding: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | 431365552 | 446561996 | 434416696 | 453993833 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | 435472350 | 449913467 | 437915596 | 456461330 |
| Per common share information: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic earnings | $1.06 | $0.77 | $2.76 | $2.21 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted earnings | 1.05 | 0.77 | 2.74 | 2.20 |

---

The accompanying Notes to Consolidated Financial Statements are an integral part of these statements.

Citizens Financial Group, Inc. \| 39

------

**CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
|<br>(dollars in millions) | **2025** | **2024** | **2025** | **2024** |
| Net income | $494 | $382 | $1303 | $1108 |
| Other comprehensive income (loss), net of tax: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash flow hedges: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net unrealized gains (losses) arising during the period | (16) | 450 | 275 | (84) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Reclassification of net (gains) losses to earnings | 144 | 203 | 437 | 522 |
| &nbsp;&nbsp;&nbsp;&nbsp;Investment securities: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net unrealized gains (losses) on AFS securities arising during the period | 223 | 541 | 561 | 339 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Reclassification of net (gains) losses to earnings | 18 | 13 | 48 | 42 |
| &nbsp;&nbsp;&nbsp;&nbsp;Defined benefit plans: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net actuarial gain (loss) arising during the period |  |  |  | 4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of actuarial (gain) loss to earnings | 3 | 2 | 7 | 9 |
| Total other comprehensive income (loss), net of tax | 372 | 1209 | 1328 | 832 |
| Total comprehensive income (loss) | $866 | $1591 | $2631 | $1940 |

---

The accompanying Notes to Consolidated Financial Statements are an integral part of these statements.

Citizens Financial Group, Inc. \| 40

------

**CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (UNAUDITED)**

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Preferred<br> Stock** | **Preferred<br> Stock** | **Common<br> Stock** | **Common<br> Stock** | **Additional Paid-in Capital** | **Retained Earnings** | **Treasury Stock, at Cost** | **Accumulated Other Comprehensive Income (Loss)** | **Total** |
|<br>(dollars and shares in millions) | **Shares** | **Amount** | **Shares** | **Amount** | **Additional Paid-in Capital** | **Retained Earnings** | **Treasury Stock, at Cost** | **Accumulated Other Comprehensive Income (Loss)** | **Total** |
| **Balance at July 1, 2024** | 2 | $2112 | 453 | $6 | $22299 | $10079 | ($6492) | ($4135) | $23869 |
| Dividends declared - common stock |  |  |  |  |  | (190) |  |  | (190) |
| Dividends declared - preferred stock |  |  |  |  |  | (38) |  |  | (38) |
| Treasury stock purchased |  |  | (8) |  |  |  | (325) |  | (325) |
| Share repurchase excise tax |  |  |  |  |  |  | (3) |  | (3) |
| Share-based compensation plans |  |  |  |  | 21 |  |  |  | 21 |
| Employee stock purchase plan |  |  |  |  | 7 |  |  |  | 7 |
| Total comprehensive income (loss): |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income |  |  |  |  |  | 382 |  |  | 382 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other comprehensive income (loss) |  |  |  |  |  |  |  | 1209 | 1209 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total comprehensive income (loss) |  |  |  |  |  | 382 |  | 1209 | 1591 |
| **Balance at September 30, 2024** | 2 | $2112 | 445 | $6 | $22327 | $10233 | ($6820) | ($2926) | $24932 |
| **Balance at July 1, 2025** | 2 | $2113 | 433 | $7 | $22420 | $10783 | ($7450) | ($2639) | $25234 |
| Dividends declared - common stock |  |  |  |  |  | (184) |  |  | (184) |
| Dividends declared - preferred stock |  |  |  |  |  | (32) |  |  | (32) |
| Preferred stock issued |  | 393 |  |  |  |  |  |  | 393 |
| Preferred stock redemption |  | (395) |  |  |  | (5) |  |  | (400) |
| Treasury stock purchased |  |  | (2) |  |  |  | (75) |  | (75) |
| Share repurchase excise tax |  |  |  |  |  |  | (1) |  | (1) |
| Share-based compensation plans |  |  |  |  | 21 |  |  |  | 21 |
| Employee stock purchase plan |  |  |  |  | 7 |  |  |  | 7 |
| Total comprehensive income (loss): |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income |  |  |  |  |  | 494 |  |  | 494 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other comprehensive income (loss) |  |  |  |  |  |  |  | 372 | 372 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total comprehensive income (loss) |  |  |  |  |  | 494 |  | 372 | 866 |
| **Balance at September 30, 2025** | 2 | $2111 | 431 | $7 | $22448 | $11056 | ($7526) | ($2267) | $25829 |

---

The accompanying Notes to Consolidated Financial Statements are an integral part of these statements.

Citizens Financial Group, Inc. \| 41

------

**CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (UNAUDITED)**

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Preferred<br> Stock** | **Preferred<br> Stock** | **Common<br> Stock** | **Common<br> Stock** | **Additional Paid-in Capital** | **Retained Earnings** | **Treasury Stock, at Cost** | **Accumulated Other Comprehensive Income (Loss)** | **Total** |
|<br>(dollars and shares in millions) | **Shares** | **Amount** | **Shares** | **Amount** | **Additional Paid-in Capital** | **Retained Earnings** | **Treasury Stock, at Cost** | **Accumulated Other Comprehensive Income (Loss)** | **Total** |
| **Balance at January 1, 2024** | 2 | $2014 | 466 | $6 | $22250 | $9816 | ($5986) | ($3758) | $24342 |
| Dividends declared - common stock |  |  |  |  |  | (581) |  |  | (581) |
| Dividends declared - preferred stock |  |  |  |  |  | (103) |  |  | (103) |
| Preferred stock issued |  | 391 |  |  |  |  |  |  | 391 |
| Preferred stock redemption |  | (293) |  |  |  | (7) |  |  | (300) |
| Treasury stock purchased |  |  | (23) |  |  |  | (825) |  | (825) |
| Share repurchase excise tax |  |  |  |  |  |  | (9) |  | (9) |
| Share-based compensation plans |  |  | 2 |  | 57 |  |  |  | 57 |
| Employee stock purchase plan |  |  |  |  | 20 |  |  |  | 20 |
| Total comprehensive income (loss): |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income |  |  |  |  |  | 1108 |  |  | 1108 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other comprehensive income (loss) |  |  |  |  |  |  |  | 832 | 832 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total comprehensive income (loss) |  |  |  |  |  | 1108 |  | 832 | 1940 |
| **Balance at September 30, 2024** | 2 | $2112 | 445 | $6 | $22327 | $10233 | ($6820) | ($2926) | $24932 |
| **Balance at January 1, 2025** | 2 | $2113 | 441 | $7 | $22364 | $10412 | ($7047) | ($3595) | $24254 |
| Dividends declared - common stock |  |  |  |  |  | (555) |  |  | (555) |
| Dividends declared - preferred stock |  |  |  |  |  | (99) |  |  | (99) |
| Preferred stock issued |  | 393 |  |  |  |  |  |  | 393 |
| Preferred stock redemption |  | (395) |  |  |  | (5) |  |  | (400) |
| Treasury stock purchased |  |  | (12) |  |  |  | (475) |  | (475) |
| Share repurchase excise tax |  |  |  |  |  |  | (4) |  | (4) |
| Share-based compensation plans |  |  | 2 |  | 62 |  |  |  | 62 |
| Employee stock purchase plan |  |  |  |  | 22 |  |  |  | 22 |
| Total comprehensive income (loss): |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income |  |  |  |  |  | 1303 |  |  | 1303 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other comprehensive income (loss) |  |  |  |  |  |  |  | 1328 | 1328 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total comprehensive income (loss) |  |  |  |  |  | 1303 |  | 1328 | 2631 |
| **Balance at September 30, 2025** | 2 | $2111 | 431 | $7 | $22448 | $11056 | ($7526) | ($2267) | $25829 |

---

The accompanying Notes to Consolidated Financial Statements are an integral part of these statements.

Citizens Financial Group, Inc. \| 42

------

**CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)**

---

| | | |
|:---|:---|:---|
| | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
|<br>(dollars in millions) | **2025** | **2024** |
| **OPERATING ACTIVITIES** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income | $1303 | $1108 |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjustments to reconcile net income to net change due to operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Provision (benefit) for credit losses | 471 | 525 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net change in Loans held for sale | (81) | 62 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation, amortization, and accretion | 366 | 374 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred income tax expense (benefit) | (93) | (50) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Share-based compensation | 97 | 76 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net gain on sale of assets | (16) | (14) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net (increase) decrease in Other assets | 357 | (14) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net increase (decrease) in Other liabilities | (35) | (549) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net change due to operating activities | 2369 | 1518 |
| **INVESTING ACTIVITIES** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Investment securities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Purchases of debt securities available for sale | (5545) | (6497) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Proceeds from maturities and paydowns of debt securities available for sale | 2770 | 2112 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Proceeds from sales of debt securities available for sale | 1218 | 2080 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Proceeds from maturities and paydowns of debt securities held to maturity | 537 | 501 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net (increase) decrease in Interest-bearing deposits in banks | (59) | (243) |
| &nbsp;&nbsp;&nbsp;&nbsp;Purchases of loans | (642) | (517) |
| &nbsp;&nbsp;&nbsp;&nbsp;Sales of loans | 1428 | 186 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net (increase) decrease in Loans and leases | (3475) | 3860 |
| &nbsp;&nbsp;&nbsp;&nbsp;Capital expenditures, net | (82) | (74) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other | (183) | (29) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net change due to investing activities | (4033) | 1379 |
| **FINANCING ACTIVITIES** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net increase (decrease) in Deposits | 5235 | (2154) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net increase (decrease) in Short-term borrowed funds | 214 | (490) |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from issuance of long-term borrowed funds | 6534 | 13185 |
| &nbsp;&nbsp;&nbsp;&nbsp;Repayments of long-term borrowed funds | (8520) | (12741) |
| &nbsp;&nbsp;&nbsp;&nbsp;Treasury stock purchased | (475) | (825) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net proceeds from issuance of preferred stock | 393 | 391 |
| &nbsp;&nbsp;&nbsp;&nbsp;Redemption of preferred stock |  | (300) |
| &nbsp;&nbsp;&nbsp;&nbsp;Dividends paid to common stockholders | (555) | (581) |
| &nbsp;&nbsp;&nbsp;&nbsp;Dividends paid to preferred stockholders | (100) | (96) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other | (13) | 1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net change due to financing activities | 2713 | (3610) |
| **Net change in cash and cash equivalents**<sup>(1)</sup> | 1049 | (713) |
| **Cash and cash equivalents at beginning of period**<sup>(1)</sup> | 10601 | 11628 |
| **Cash and cash equivalents at end of period**<sup>(1)</sup> | $11650 | $10915 |
| **Non-cash items:** |  |  |
| &nbsp;&nbsp;Transfer of loans from loans held for investment to LHFS | $1939 | $249 |
| &nbsp;&nbsp;Loans securitized and transferred to AFS securities | 87 | 181 |

---

<sup>(1)</sup> Cash and cash equivalents include Cash and due from banks and Interest-bearing cash and due from banks as reflected on the Consolidated Balance Sheets.

The accompanying Notes to Consolidated Financial Statements are an integral part of these statements.

Citizens Financial Group, Inc. \| 43

------

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)**

**NOTE 1 - SIGNIFICANT ACCOUNTING POLICIES** 

*Basis of Presentation*

The accompanying unaudited interim Consolidated Financial Statements and Notes have been prepared in accordance with the instructions for Form 10-Q and, therefore, certain information and footnote disclosures required for annual financial statements prepared in accordance with GAAP are omitted. In the opinion of management, the Consolidated Financial Statements include all adjustments, consisting of normal recurring adjustments, necessary to fairly present the Company's interim period results. These unaudited interim financial statements and notes should be read in conjunction with the audited Consolidated Financial Statements and Notes included in the Company's 2024 Form 10-K. The results of operations for interim periods are not necessarily indicative of the results that may be expected for the full year.

The unaudited interim Consolidated Financial Statements include the accounts of the Parent Company and its consolidated subsidiaries, including VIEs in which the Company is a primary beneficiary. Investments in VIEs in which the Company does not have the ability to exercise significant influence are not consolidated. All intercompany transactions and balances have been eliminated in consolidation.

*Use of Estimates*

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates. Material estimates that are particularly susceptible to significant change include the determination of the ACL, fair value measurements, and the evaluation and measurement of goodwill impairment.

*Significant Accounting Policies*

For further information regarding the Company's significant accounting policies, see Note 1 in the Company's 2024 Form 10-K.

**NOTE 2 - SECURITIES** 

The following table presents the major components of securities at amortized cost and fair value:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
|<br>(dollars in millions) | **Amortized Cost**<sup>(1)</sup> | **Gross Unrealized Gains** | **Gross Unrealized Losses** | **Fair Value** | **Amortized Cost**<sup>(1)</sup> | **Gross Unrealized Gains** | **Gross Unrealized Losses** | **Fair Value** |
| U.S. Treasury and other | $4563 | $23 | ($72) | $4514 | $3631 | $3 | ($109) | $3525 |
| State and political subdivisions | 1 |  |  | 1 | 1 |  |  | 1 |
| Mortgage-backed securities: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Federal agencies and U.S. government sponsored entities | 31865 | 160 | (1474) | 30551 | 30897 | 33 | (2135) | 28795 |
| &nbsp;&nbsp;&nbsp;Other/non-agency | 268 |  | (5) | 263 | 273 |  | (13) | 260 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total mortgage-backed securities | 32133 | 160 | (1479) | 30814 | 31170 | 33 | (2148) | 29055 |
| Collateralized loan obligations | 90 |  |  | 90 | 184 |  |  | 184 |
| Total debt securities available for sale, at fair value | $36787 | $183 | ($1551) | $35419 | $34986 | $36 | ($2257) | $32765 |
| Mortgage-backed securities: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Federal agencies and U.S. government sponsored entities | $7767 | $1 | ($830) | $6938 | $8187 | $— | ($1051) | $7136 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total mortgage-backed securities | 7767 | 1 | (830) | 6938 | 8187 |  | (1051) | 7136 |
| Asset-backed securities | 357 |  |  | 357 | 412 | 1 | (9) | 404 |
| Total debt securities held to maturity | $8124 | $1 | ($830) | $7295 | $8599 | $1 | ($1060) | $7540 |
| Equity securities, at cost<sup>(2)</sup> | $710 | $— | $— | $710 | $710 | $— | $— | $710 |
| Equity securities, at fair value<sup>(2)</sup> | 286 |  |  | 286 | 220 |  |  | 220 |

---

<sup>(1)</sup> Excludes portfolio level basis adjustments of $37 million and $(75) million, respectively, for securities designated in active fair value hedge relationships under the portfolio layer method at September 30, 2025 and December 31, 2024.

<sup>(2)</sup> Included in Other assets in the Consolidated Balance Sheets.

Citizens Financial Group, Inc. \| 44

------

Accrued interest receivable on debt securities totaled $135 million and $125 million as of September 30, 2025 and December 31, 2024, respectively, and is included in Other assets in the Consolidated Balance Sheets.

The following table presents the amortized cost and fair value of debt securities by contractual maturity as of September 30, 2025. Expected maturities may differ from contractual maturities because issuers may have the right to call or prepay obligations with or without incurring penalties.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Distribution of Maturities** | **Distribution of Maturities** | **Distribution of Maturities** | **Distribution of Maturities** | **Distribution of Maturities** |
|<br>(dollars in millions) | **1 Year or Less** | **After 1 Year through 5 Years** | **After 5 Years through 10 Years** | **After 10 Years** | **Total** |
| **Amortized cost:** |  |  |  |  |  |
| U.S. Treasury and other | $— | $3380 | $1183 | $— | $4563 |
| State and political subdivisions |  |  |  | 1 | 1 |
| Mortgage-backed securities: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Federal agencies and U.S. government sponsored entities | 100 | 2274 | 1120 | 28371 | 31865 |
| &nbsp;&nbsp;&nbsp;Other/non-agency |  |  |  | 268 | 268 |
| Collateralized loan obligations |  |  | 90 |  | 90 |
| Total debt securities available for sale | 100 | 5654 | 2393 | 28640 | 36787 |
| Mortgage-backed securities: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Federal agencies and U.S. government sponsored entities |  |  |  | 7767 | 7767 |
| Asset-backed securities |  | 357 |  |  | 357 |
| Total debt securities held to maturity |  | 357 |  | 7767 | 8124 |
| Total amortized cost of debt securities | $100 | $6011 | $2393 | $36407 | $44911 |
| **Fair value:** |  |  |  |  |  |
| U.S. Treasury and other | $— | $3311 | $1203 | $— | $4514 |
| State and political subdivisions |  |  |  | 1 | 1 |
| Mortgage-backed securities: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Federal agencies and U.S. government sponsored entities | 99 | 2235 | 1073 | 27144 | 30551 |
| &nbsp;&nbsp;&nbsp;Other/non-agency |  |  |  | 263 | 263 |
| Collateralized loan obligations |  |  | 90 |  | 90 |
| Total debt securities available for sale | 99 | 5546 | 2366 | 27408 | 35419 |
| Mortgage-backed securities: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Federal agencies and U.S. government sponsored entities |  |  |  | 6938 | 6938 |
| Asset-backed securities |  | 357 |  |  | 357 |
| Total debt securities held to maturity |  | 357 |  | 6938 | 7295 |
| Total fair value of debt securities | $99 | $5903 | $2366 | $34346 | $42714 |

---

Taxable interest income from investment securities as presented in the Consolidated Statements of Operations was $433 million and $423 million for the three months ended September 30, 2025 and 2024, respectively, and $1.3 billion and $1.2 billion for the nine months ended September 30, 2025 and 2024, respectively.

The following table presents realized gains and losses on the sale of securities:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
|<br>(dollars in millions) | **2025** | **2024** | **2025** | **2024** |
| Gains | $2 | $9 | $14 | $14 |
| Losses |  |  |  |  |
| Securities gains, net | $2 | $9 | $14 | $14 |

---

At September 30, 2025 and December 31, 2024, debt securities with a carrying value of $3.6 billion and $4.0 billion, respectively, were pledged to secure public deposits, trust funds, FHLB borrowing capacity, repurchase agreements, and derivative contracts, and for other purposes as required or permitted by law.

Retained interests from the sale and securitization of originated mortgage loans totaled $87 million during the three and nine months ended September 30, 2025. Retained interests from the sale and securitization of originated mortgage loans totaled $48 million and $181 million, respectively, during the three and nine months ended September 30, 2024. The debt securities received from the issuers, FNMA and FHLMC, include a substantive guarantee and are classified as Debt securities available for sale in the Consolidated Balance Sheets.

Citizens Financial Group, Inc. \| 45

------

*Impairment*

The Company evaluated its existing HTM portfolio as of September 30, 2025 and concluded that 96% of HTM securities met the zero expected credit loss criteria and, therefore, no ACL was recognized. Lifetime expected credit losses on the remainder of the HTM portfolio were determined to be insignificant based on the modeling of the Company's credit loss position in the securities. The Company monitors the credit exposure through the use of credit quality indicators. For these securities, the Company uses external credit ratings or an internally derived credit rating when an external rating is not available. All securities were determined to be investment grade at September 30, 2025.

The following tables present AFS debt securities with fair values below their respective carrying values, disclosed by the length of time the individual securities have been in a continuous unrealized loss position:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** |
| | **Less than 12 Months** | **Less than 12 Months** | **12 Months or Longer** | **12 Months or Longer** | **Total** | **Total** |
|<br>(dollars in millions) | **Fair Value** | **Gross Unrealized Losses** | **Fair Value** | **Gross Unrealized Losses** | **Fair Value** | **Gross Unrealized Losses** |
| U.S. Treasury and other | $— | $— | $2613 | ($72) | $2613 | ($72) |
| Mortgage-backed securities: |  |  |  |  |  |  |
| &nbsp;&nbsp;Federal agencies and U.S. government sponsored entities | 4760 | (171) | 13230 | (1303) | 17990 | (1474) |
| &nbsp;&nbsp;Other/non-agency |  |  | 263 | (5) | 263 | (5) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total mortgage-backed securities | 4760 | (171) | 13493 | (1308) | 18253 | (1479) |
| Total | $4760 | ($171) | $16106 | ($1380) | $20866 | ($1551) |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
| | **Less than 12 Months** | **Less than 12 Months** | **12 Months or Longer** | **12 Months or Longer** | **Total** | **Total** |
|<br>(dollars in millions) | **Fair Value** | **Gross Unrealized Losses** | **Fair Value** | **Gross Unrealized Losses** | **Fair Value** | **Gross Unrealized Losses** |
| U.S. Treasury and other | $— | $— | $2544 | ($109) | $2544 | ($109) |
| Mortgage-backed securities: |  |  |  |  |  |  |
| &nbsp;&nbsp;Federal agencies and U.S. government sponsored entities | 9560 | (265) | 14304 | (1870) | 23864 | (2135) |
| &nbsp;&nbsp;Other/non-agency |  |  | 260 | (13) | 260 | (13) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total mortgage-backed securities | 9560 | (265) | 14564 | (1883) | 24124 | (2148) |
| Total | $9560 | ($265) | $17108 | ($1992) | $26668 | ($2257) |

---

The Company does not currently have the intent to sell these AFS debt securities, and it is not more likely than not that the Company will be required to sell them prior to recovery of their amortized cost bases. The Company determined that credit losses are not expected to be incurred on the AFS debt securities identified with unrealized losses as of September 30, 2025. The unrealized losses on these AFS debt securities reflect non-credit-related factors driven by changes in interest rates. Therefore, the Company determined that these AFS debt securities are not impaired.

Citizens Financial Group, Inc. \| 46

------

**NOTE 3 - LOANS AND LEASES** 

Loans held for investment are reported at the amount of their outstanding principal, net of charge-offs, unearned income, deferred loan origination fees and costs, and unamortized premiums or discounts on purchased loans.

The following table presents loans and leases, excluding LHFS:

---

| | | |
|:---|:---|:---|
| (dollars in millions) | **September 30, 2025** | **December 31, 2024** |
| Commercial and industrial | $46953 | $42551 |
| Commercial real estate | 25540 | 27225 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total commercial | 72493 | 69776 |
| Residential mortgages | 34477 | 32726 |
| Home equity | 18415 | 16495 |
| Automobile | 2816 | 4744 |
| Education | 8556 | 10812 |
| Other retail | 4113 | 4650 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total retail | 68377 | 69427 |
| Total loans and leases | $140870 | $139203 |

---

Accrued interest receivable on loans and leases held for investment totaled $857 million and $816 million as of September 30, 2025 and December 31, 2024, respectively, and is included in Other assets in the Consolidated Balance Sheets.

Loans pledged as collateral for FHLB borrowing capacity, primarily residential mortgages and home equity products, totaled $40.6 billion and $37.5 billion at September 30, 2025 and December 31, 2024, respectively. Loans pledged as collateral to support the contingent ability to borrow at the FRB discount window, if necessary, were primarily comprised of education, commercial and industrial, and commercial real estate loans, and totaled $20.0 billion and $22.9 billion at September 30, 2025 and December 31, 2024, respectively.

Interest income on direct financing and sales-type leases for the three months ended September 30, 2025 and 2024 was $11 million and is reported within Interest and fees on loans and leases in the Consolidated Statements of Operations. For the nine months ended September 30, 2025 and 2024, this interest income was $33 million and $31 million, respectively.

The following table presents the composition of LHFS:

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
|<br>(dollars in millions) | **Residential Mortgages**<sup>(1)</sup> | **Other retail**<sup>(2)</sup> | **Commercial**<sup>(3)</sup> | **Total** | **Residential Mortgages**<sup>(1)</sup> | **Commercial**<sup>(3)</sup> | **Total** |
| Loans held for sale at fair value | $592 | $— | $176 | $768 | $633 | $192 | $825 |
| Other loans held for sale |  | 466 | 100 | 566 |  | 33 | 33 |
| Total loans held for sale | $592 | $466 | $276 | $1334 | $633 | $225 | $858 |

---

<sup>(1)</sup> Residential mortgage LHFS at fair value are originated for sale.

<sup>(2)</sup> Other retail LHFS consist of education loans.

<sup>(3)</sup> Commercial LHFS at fair value consist of loans managed by the Company's commercial secondary loan desk. Other commercial LHFS primarily consist of loans associated with the Company's syndication business.

**NOTE 4 - CREDIT QUALITY AND THE ALLOWANCE FOR CREDIT LOSSES** 

*Allowance for Credit Losses*&nbsp;&nbsp;&nbsp;&nbsp;

The Company's estimate of expected credit losses in its loan and lease portfolios is recorded in the ACL and considers extensive historical loss experience, including the impact of loss mitigation and restructuring programs that the Company offers to borrowers experiencing financial difficulty, as well as projected loss severity as a result of loan default.

For a detailed discussion of the ACL reserve methodology and estimation techniques as of December 31, 2024, see Note 6 in the Company's 2024 Form 10-K. There were no significant changes to the ACL reserve methodology during the nine months ended September 30, 2025.

Citizens Financial Group, Inc. \| 47

------

The following table presents a summary of changes in the ACL for the three and nine months ended September 30, 2025:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** |
|<br>(dollars in millions) | **Commercial** | **Retail** | **Total** | **Commercial** | **Retail** | **Total** |
| Allowance for loan and lease losses, beginning of period | $1106 | $902 | $2008 | $1140 | $921 | $2061 |
| &nbsp;&nbsp;&nbsp;&nbsp;Charge-offs | (91) | (104) | (195) | (269) | (361) | (630) |
| &nbsp;&nbsp;&nbsp;&nbsp;Recoveries | 6 | 27 | 33 | 11 | 90 | 101 |
| Net charge-offs | (85) | (77) | (162) | (258) | (271) | (529) |
| Provision expense (benefit) for loans and leases | 62 | 64 | 126 | 201 | 239 | 440 |
| Allowance for loan and lease losses, end of period | 1083 | 889 | 1972 | 1083 | 889 | 1972 |
| Allowance for unfunded lending commitments, beginning of period | 163 | 38 | 201 | 155 | 43 | 198 |
| Provision expense (benefit) for unfunded lending commitments | 19 | 9 | 28 | 27 | 4 | 31 |
| Allowance for unfunded lending commitments, end of period | 182 | 47 | 229 | 182 | 47 | 229 |
| Total allowance for credit losses, end of period | $1265 | $936 | $2201 | $1265 | $936 | $2201 |

---

During the nine months ended September 30, 2025, net charge-offs of $529 million and a provision for expected credit losses of $471 million resulted in a decrease of $58 million to the ACL.

During the first quarter of 2025, the Company entered into an agreement to sell $1.9 billion of Non-Core education loans and subsequently reclassified these loans to LHFS. Upon reclassification to LHFS, a $25 million charge-off was recognized. This transaction will settle ratably each quarter throughout 2025, of which approximately $1.4 billion has settled to date, with the remaining $500 million scheduled to settle during the fourth quarter of 2025.

As of September 30, 2025, the Company's ACL economic forecast over a two-year reasonable and supportable period reflects the economy going into a shallow two quarter contraction inclusive of uncertainties related to the implementation of tariffs and protectionist trade policies, inflationary pressures, and geopolitical tensions. This forecast is generally applied to the retail and commercial and industrial portfolios and projects peak unemployment of approximately 5.2% and a start-to-trough real GDP decline of approximately 0.5%, compared to peak unemployment of approximately 5.1% and a start-to-trough real GDP decline of approximately 0.4% at December 31, 2024. More severe economic scenarios are applied within the CRE portfolio, such as general office, with peak unemployment of approximately 9.4% and a start-to-trough real GDP decline of approximately 4.4%, compared to peak unemployment of approximately 9.3% and a start-to-trough real GDP decline of approximately 4.4% at December 31, 2024.

Citizens Financial Group, Inc. \| 48

------

The following table presents a summary of changes in the ACL for the three and nine months ended September 30, 2024:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** |
|<br>(dollars in millions) | **Commercial** | **Retail** | **Total** | **Commercial** | **Retail** | **Total** |
| Allowance for loan and lease losses, beginning of period | $1282 | $843 | $2125 | $1250 | $848 | $2098 |
| &nbsp;&nbsp;&nbsp;&nbsp;Charge-offs | (106) | (125) | (231) | (308) | (377) | (685) |
| &nbsp;&nbsp;&nbsp;&nbsp;Recoveries | 8 | 31 | 39 | 29 | 99 | 128 |
| Net charge-offs | (98) | (94) | (192) | (279) | (278) | (557) |
| Provision expense (benefit) for loans and leases | 3 | 143 | 146 | 216 | 322 | 538 |
| Allowance for loan and lease losses, end of period | 1187 | 892 | 2079 | 1187 | 892 | 2079 |
| Allowance for unfunded lending commitments, beginning of period | 147 | 34 | 181 | 175 | 45 | 220 |
| Provision expense (benefit) for unfunded lending commitments | 17 | 9 | 26 | (11) | (2) | (13) |
| Allowance for unfunded lending commitments, end of period | 164 | 43 | 207 | 164 | 43 | 207 |
| Total allowance for credit losses, end of period | $1351 | $935 | $2286 | $1351 | $935 | $2286 |

---

*Credit Quality Indicators*

The Company presents loan and lease portfolio segments and classes by credit quality indicator and vintage year and defines the vintage date for the purpose of this disclosure as the date of the most recent credit decision. Renewals are categorized as new credit decisions and reflect the renewal date as the vintage date, except for renewals of loans modified for borrowers experiencing financial difficulty, or FDMs, which are presented in the original vintage.

The Company utilizes internal risk ratings to monitor credit quality for commercial loans and leases. For more information on these ratings see Note 6 in the Company's 2024 Form 10-K.

The following table presents the amortized cost basis of commercial loans and leases by vintage date and internal risk rating as of September 30, 2025:

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Term Loans and Leases by Origination Year** | **Term Loans and Leases by Origination Year** | **Term Loans and Leases by Origination Year** | **Term Loans and Leases by Origination Year** | **Term Loans and Leases by Origination Year** | **Term Loans and Leases by Origination Year** | **Revolving Loans** | **Revolving Loans** | |
|<br>(dollars in millions) | **2025** | **2024** | **2023** | **2022** | **2021** | **Prior to 2021** | **Within the Revolving Period** | **Converted to Term** |<br>**Total** |
| **Commercial and industrial** |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Pass | $5670 | $4526 | $1631 | $2948 | $1433 | $2220 | $25906 | $57 | $44391 |
| &nbsp;&nbsp;&nbsp;Special Mention |  | 9 | 38 | 122 | 179 | 117 | 232 |  | 697 |
| &nbsp;&nbsp;Substandard Accrual | 13 | 12 | 105 | 143 | 162 | 271 | 911 | 18 | 1635 |
| &nbsp;&nbsp;Nonaccrual |  | 6 | 15 | 60 | 23 | 76 | 45 | 5 | 230 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total commercial and industrial | 5683 | 4553 | 1789 | 3273 | 1797 | 2684 | 27094 | 80 | 46953 |
| **Commercial real estate** |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Pass | 3215 | 2079 | 918 | 4484 | 4193 | 5180 | 1454 | 4 | 21527 |
| &nbsp;&nbsp;&nbsp;Special Mention |  | 2 | 4 | 716 | 384 | 154 | 73 |  | 1333 |
| &nbsp;&nbsp;Substandard Accrual |  |  | 94 | 576 | 165 | 1006 | 23 | 113 | 1977 |
| &nbsp;&nbsp;Nonaccrual |  |  | 3 | 94 | 58 | 535 | 9 | 4 | 703 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total commercial real estate | 3215 | 2081 | 1019 | 5870 | 4800 | 6875 | 1559 | 121 | 25540 |
| **Total commercial** |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Pass | 8885 | 6605 | 2549 | 7432 | 5626 | 7400 | 27360 | 61 | 65918 |
| &nbsp;&nbsp;&nbsp;Special Mention |  | 11 | 42 | 838 | 563 | 271 | 305 |  | 2030 |
| &nbsp;&nbsp;Substandard Accrual | 13 | 12 | 199 | 719 | 327 | 1277 | 934 | 131 | 3612 |
| &nbsp;&nbsp;Nonaccrual |  | 6 | 18 | 154 | 81 | 611 | 54 | 9 | 933 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total commercial | $8898 | $6634 | $2808 | $9143 | $6597 | $9559 | $28653 | $201 | $72493 |

---

Citizens Financial Group, Inc. \| 49

------

The following table presents the amortized cost basis of commercial loans and leases by vintage date and internal risk rating as of December 31, 2024:

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Term Loans and Leases by Origination Year** | **Term Loans and Leases by Origination Year** | **Term Loans and Leases by Origination Year** | **Term Loans and Leases by Origination Year** | **Term Loans and Leases by Origination Year** | **Term Loans and Leases by Origination Year** | **Revolving Loans** | **Revolving Loans** | |
|<br>(dollars in millions) | **2024** | **2023** | **2022** | **2021** | **2020** | **Prior to 2020** | **Within the Revolving Period** | **Converted to Term** |<br>**Total** |
| **Commercial and industrial** |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Pass | $5945 | $2525 | $4194 | $2923 | $895 | $2066 | $21323 | $66 | $39937 |
| &nbsp;&nbsp;&nbsp;Special Mention | 2 | 79 | 98 | 236 | 48 | 48 | 211 |  | 722 |
| &nbsp;&nbsp;Substandard Accrual | 9 | 64 | 207 | 269 | 139 | 253 | 697 | 13 | 1651 |
| &nbsp;&nbsp;Nonaccrual |  | 11 | 68 | 62 | 5 | 55 | 34 | 6 | 241 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total commercial and industrial | 5956 | 2679 | 4567 | 3490 | 1087 | 2422 | 22265 | 85 | 42551 |
| **Commercial real estate** |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Pass | 2720 | 1305 | 5748 | 5412 | 1919 | 4199 | 1434 | 4 | 22741 |
| &nbsp;&nbsp;&nbsp;Special Mention | 1 |  | 911 | 362 | 175 | 257 | 80 | 6 | 1792 |
| &nbsp;&nbsp;Substandard Accrual | 3 | 22 | 359 | 253 | 275 | 875 | 9 | 120 | 1916 |
| &nbsp;&nbsp;Nonaccrual |  | 67 | 89 | 58 | 90 | 470 | 2 |  | 776 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total commercial real estate | 2724 | 1394 | 7107 | 6085 | 2459 | 5801 | 1525 | 130 | 27225 |
| **Total commercial** |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Pass | 8665 | 3830 | 9942 | 8335 | 2814 | 6265 | 22757 | 70 | 62678 |
| &nbsp;&nbsp;&nbsp;Special Mention | 3 | 79 | 1009 | 598 | 223 | 305 | 291 | 6 | 2514 |
| &nbsp;&nbsp;Substandard Accrual | 12 | 86 | 566 | 522 | 414 | 1128 | 706 | 133 | 3567 |
| &nbsp;&nbsp;Nonaccrual |  | 78 | 157 | 120 | 95 | 525 | 36 | 6 | 1017 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total commercial | $8680 | $4073 | $11674 | $9575 | $3546 | $8223 | $23790 | $215 | $69776 |

---

For retail loans, the Company utilizes FICO credit scores and the loan's payment and delinquency status to monitor credit quality. Management believes FICO scores are the strongest indicator of credit losses over the contractual life of the loan and assist management in predicting the borrower's future payment performance. Scores are based on current and historical national industry-wide consumer level credit performance data.

Citizens Financial Group, Inc. \| 50

------

The following table presents the amortized cost basis of retail loans by vintage date and current FICO score as of September 30, 2025:

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Term Loans by Origination Year** | **Term Loans by Origination Year** | **Term Loans by Origination Year** | **Term Loans by Origination Year** | **Term Loans by Origination Year** | **Term Loans by Origination Year** | **Revolving Loans** | **Revolving Loans** | |
|<br>(dollars in millions) | **2025** | **2024** | **2023** | **2022** | **2021** | **Prior to 2021** | **Within the Revolving Period** | **Converted to Term** |<br>**Total** |
| **Residential mortgages** |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;800+ | $1450 | $1775 | $1314 | $3238 | $4996 | $6253 | $— | $— | $19026 |
| &nbsp;&nbsp;&nbsp;740-799 | 1762 | 1056 | 761 | 1486 | 2041 | 2888 |  |  | 9994 |
| &nbsp;&nbsp;&nbsp;680-739 | 423 | 346 | 256 | 501 | 673 | 1141 |  |  | 3340 |
| &nbsp;&nbsp;&nbsp;620-679 | 41 | 62 | 76 | 161 | 178 | 504 |  |  | 1022 |
| &nbsp;&nbsp;&nbsp;<620 | 6 | 20 | 136 | 123 | 176 | 619 |  |  | 1080 |
| &nbsp;&nbsp;No FICO available<sup>(1)</sup> |  |  |  | 3 | 1 | 11 |  |  | 15 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total residential mortgages | 3682 | 3259 | 2543 | 5512 | 8065 | 11416 |  |  | 34477 |
| **Home equity** |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;800+ |  | 2 | 2 | 5 | 5 | 68 | 6401 | 186 | 6669 |
| &nbsp;&nbsp;&nbsp;740-799 |  | 1 | 3 | 4 | 3 | 49 | 5904 | 209 | 6173 |
| &nbsp;&nbsp;&nbsp;680-739 |  | 2 | 3 | 3 | 1 | 38 | 3363 | 184 | 3594 |
| &nbsp;&nbsp;&nbsp;620-679 |  |  | 1 | 2 | 2 | 15 | 867 | 169 | 1056 |
| &nbsp;&nbsp;&nbsp;<620 |  |  | 3 | 1 | 2 | 13 | 559 | 338 | 916 |
| &nbsp;&nbsp;No FICO available<sup>(1)</sup> |  |  | 1 | 1 |  | 2 | 3 |  | 7 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total home equity |  | 5 | 13 | 16 | 13 | 185 | 17097 | 1086 | 18415 |
| **Automobile** |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;800+ |  |  | 52 | 260 | 392 | 92 |  |  | 796 |
| &nbsp;&nbsp;&nbsp;740-799 |  |  | 66 | 274 | 329 | 88 |  |  | 757 |
| &nbsp;&nbsp;&nbsp;680-739 |  |  | 61 | 211 | 215 | 59 |  |  | 546 |
| &nbsp;&nbsp;&nbsp;620-679 |  |  | 35 | 123 | 120 | 36 |  |  | 314 |
| &nbsp;&nbsp;&nbsp;<620 |  |  | 43 | 155 | 157 | 48 |  |  | 403 |
| &nbsp;&nbsp;No FICO available<sup>(1)</sup> |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total automobile |  |  | 257 | 1023 | 1213 | 323 |  |  | 2816 |
| **Education** |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;800+ | 225 | 276 | 324 | 529 | 1034 | 1904 |  |  | 4292 |
| &nbsp;&nbsp;&nbsp;740-799 | 292 | 286 | 283 | 406 | 490 | 930 |  |  | 2687 |
| &nbsp;&nbsp;&nbsp;680-739 | 122 | 132 | 127 | 169 | 170 | 352 |  |  | 1072 |
| &nbsp;&nbsp;&nbsp;620-679 | 17 | 41 | 43 | 48 | 46 | 122 |  |  | 317 |
| &nbsp;&nbsp;&nbsp;<620 | 4 | 12 | 18 | 27 | 26 | 70 |  |  | 157 |
| &nbsp;&nbsp;No FICO available<sup>(1)</sup> | 4 |  |  |  |  | 27 |  |  | 31 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total education | 664 | 747 | 795 | 1179 | 1766 | 3405 |  |  | 8556 |
| **Other retail** |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;800+ | 104 | 105 | 35 | 33 | 9 | 11 | 462 |  | 759 |
| &nbsp;&nbsp;&nbsp;740-799 | 110 | 127 | 50 | 34 | 11 | 21 | 782 |  | 1135 |
| &nbsp;&nbsp;&nbsp;680-739 | 75 | 91 | 44 | 32 | 9 | 21 | 739 | 1 | 1012 |
| &nbsp;&nbsp;&nbsp;620-679 | 37 | 45 | 24 | 24 | 6 | 12 | 282 | 1 | 431 |
| &nbsp;&nbsp;&nbsp;<620 | 10 | 28 | 20 | 30 | 8 | 11 | 207 |  | 314 |
| &nbsp;&nbsp;No FICO available<sup>(1)</sup> | 13 | 1 |  |  |  | 1 | 447 |  | 462 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total other retail | 349 | 397 | 173 | 153 | 43 | 77 | 2919 | 2 | 4113 |
| **Total retail** |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;800+ | 1779 | 2158 | 1727 | 4065 | 6436 | 8328 | 6863 | 186 | 31542 |
| &nbsp;&nbsp;&nbsp;740-799 | 2164 | 1470 | 1163 | 2204 | 2874 | 3976 | 6686 | 209 | 20746 |
| &nbsp;&nbsp;&nbsp;680-739 | 620 | 571 | 491 | 916 | 1068 | 1611 | 4102 | 185 | 9564 |
| &nbsp;&nbsp;&nbsp;620-679 | 95 | 148 | 179 | 358 | 352 | 689 | 1149 | 170 | 3140 |
| &nbsp;&nbsp;&nbsp;<620 | 20 | 60 | 220 | 336 | 369 | 761 | 766 | 338 | 2870 |
| &nbsp;&nbsp;No FICO available<sup>(1)</sup> | 17 | 1 | 1 | 4 | 1 | 41 | 450 |  | 515 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total retail | $4695 | $4408 | $3781 | $7883 | $11100 | $15406 | $20016 | $1088 | $68377 |

---

<sup>(1)</sup> Represents loans for which an updated FICO score was unavailable (e.g., due to recent profile changes).

Citizens Financial Group, Inc. \| 51

------

The following table presents the amortized cost basis of retail loans by vintage date and current FICO score as of December 31, 2024:

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Term Loans by Origination Year** | **Term Loans by Origination Year** | **Term Loans by Origination Year** | **Term Loans by Origination Year** | **Term Loans by Origination Year** | **Term Loans by Origination Year** | **Revolving Loans** | **Revolving Loans** | |
|<br>(dollars in millions) | **2024** | **2023** | **2022** | **2021** | **2020** | **Prior to 2020** | **Within the Revolving Period** | **Converted to Term** |<br>**Total** |
| **Residential mortgages** |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;800+ | $1230 | $1302 | $3299 | $5109 | $2919 | $3869 | $— | $— | $17728 |
| &nbsp;&nbsp;&nbsp;740-799 | 1757 | 873 | 1568 | 2213 | 1338 | 1923 |  |  | 9672 |
| &nbsp;&nbsp;&nbsp;680-739 | 425 | 281 | 552 | 697 | 385 | 938 |  |  | 3278 |
| &nbsp;&nbsp;&nbsp;620-679 | 31 | 61 | 126 | 151 | 101 | 494 |  |  | 964 |
| &nbsp;&nbsp;&nbsp;<620 | 15 | 37 | 76 | 147 | 89 | 703 |  |  | 1067 |
| &nbsp;&nbsp;No FICO available<sup>(1)</sup> | 1 |  |  | 1 | 1 | 14 |  |  | 17 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total residential mortgages | 3459 | 2554 | 5621 | 8318 | 4833 | 7941 |  |  | 32726 |
| **Home equity** |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;800+ | 1 |  | 3 | 4 | 1 | 76 | 5634 | 200 | 5919 |
| &nbsp;&nbsp;&nbsp;740-799 |  |  | 1 | 2 | 1 | 65 | 5275 | 224 | 5568 |
| &nbsp;&nbsp;&nbsp;680-739 |  |  | 1 |  | 1 | 76 | 2995 | 183 | 3256 |
| &nbsp;&nbsp;&nbsp;620-679 |  | 1 | 4 | 3 | 2 | 60 | 752 | 141 | 963 |
| &nbsp;&nbsp;&nbsp;<620 |  | 2 | 6 | 3 | 1 | 59 | 459 | 259 | 789 |
| &nbsp;&nbsp;No FICO available<sup>(1)</sup> |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total home equity | 1 | 3 | 15 | 12 | 6 | 336 | 15115 | 1007 | 16495 |
| **Automobile** |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;800+ |  | 65 | 380 | 665 | 183 | 58 |  |  | 1351 |
| &nbsp;&nbsp;&nbsp;740-799 |  | 92 | 430 | 581 | 176 | 61 |  |  | 1340 |
| &nbsp;&nbsp;&nbsp;680-739 |  | 91 | 338 | 385 | 115 | 45 |  |  | 974 |
| &nbsp;&nbsp;&nbsp;620-679 |  | 51 | 189 | 194 | 56 | 29 |  |  | 519 |
| &nbsp;&nbsp;&nbsp;<620 |  | 47 | 197 | 216 | 62 | 38 |  |  | 560 |
| &nbsp;&nbsp;No FICO available<sup>(1)</sup> |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total automobile |  | 346 | 1534 | 2041 | 592 | 231 |  |  | 4744 |
| **Education** |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;800+ | 227 | 373 | 657 | 1517 | 1256 | 1475 |  |  | 5505 |
| &nbsp;&nbsp;&nbsp;740-799 | 290 | 359 | 571 | 804 | 637 | 811 |  |  | 3472 |
| &nbsp;&nbsp;&nbsp;680-739 | 110 | 150 | 229 | 261 | 211 | 337 |  |  | 1298 |
| &nbsp;&nbsp;&nbsp;620-679 | 27 | 48 | 55 | 58 | 51 | 111 |  |  | 350 |
| &nbsp;&nbsp;&nbsp;<620 | 5 | 12 | 21 | 28 | 25 | 60 |  |  | 151 |
| &nbsp;&nbsp;No FICO available<sup>(1)</sup> | 5 |  |  |  |  | 31 |  |  | 36 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total education | 664 | 942 | 1533 | 2668 | 2180 | 2825 |  |  | 10812 |
| **Other retail** |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;800+ | 186 | 65 | 36 | 15 | 11 | 10 | 512 |  | 835 |
| &nbsp;&nbsp;&nbsp;740-799 | 259 | 96 | 46 | 18 | 13 | 11 | 895 | 1 | 1339 |
| &nbsp;&nbsp;&nbsp;680-739 | 201 | 87 | 39 | 15 | 11 | 7 | 845 | 1 | 1206 |
| &nbsp;&nbsp;&nbsp;620-679 | 97 | 47 | 27 | 10 | 6 | 3 | 335 | 1 | 526 |
| &nbsp;&nbsp;&nbsp;<620 | 32 | 31 | 34 | 15 | 7 | 3 | 234 | 1 | 357 |
| &nbsp;&nbsp;No FICO available<sup>(1)</sup> | 5 |  |  |  |  |  | 382 |  | 387 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total other retail | 780 | 326 | 182 | 73 | 48 | 34 | 3203 | 4 | 4650 |
| **Total retail** |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;800+ | 1644 | 1805 | 4375 | 7310 | 4370 | 5488 | 6146 | 200 | 31338 |
| &nbsp;&nbsp;&nbsp;740-799 | 2306 | 1420 | 2616 | 3618 | 2165 | 2871 | 6170 | 225 | 21391 |
| &nbsp;&nbsp;&nbsp;680-739 | 736 | 609 | 1159 | 1358 | 723 | 1403 | 3840 | 184 | 10012 |
| &nbsp;&nbsp;&nbsp;620-679 | 155 | 208 | 401 | 416 | 216 | 697 | 1087 | 142 | 3322 |
| &nbsp;&nbsp;&nbsp;<620 | 52 | 129 | 334 | 409 | 184 | 863 | 693 | 260 | 2924 |
| &nbsp;&nbsp;No FICO available<sup>(1)</sup> | 11 |  |  | 1 | 1 | 45 | 382 |  | 440 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total retail | $4904 | $4171 | $8885 | $13112 | $7659 | $11367 | $18318 | $1011 | $69427 |

---

<sup>(1)</sup> Represents loans for which an updated FICO score was unavailable (e.g., due to recent profile changes).

Citizens Financial Group, Inc. \| 52

------

The following tables present gross charge-offs by vintage date for the Company's loan and lease portfolios:

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** |
| | **Term Loans and Leases by Origination Year** | **Term Loans and Leases by Origination Year** | **Term Loans and Leases by Origination Year** | **Term Loans and Leases by Origination Year** | **Term Loans and Leases by Origination Year** | **Term Loans and Leases by Origination Year** | **Revolving Loans** | **Revolving Loans** | |
|<br>(dollars in millions) | **2025** | **2024** | **2023** | **2022** | **2021** | **Prior to 2021** | **Within the Revolving Period** | **Converted to Term** |<br>**Total** |
| Commercial and industrial | $— | $— | $2 | $51 | $22 | $5 | $26 | $— | $106 |
| Commercial real estate |  | 1 | 3 | 21 | 12 | 126 |  |  | 163 |
| &nbsp;&nbsp;Total commercial |  | 1 | 5 | 72 | 34 | 131 | 26 |  | 269 |
| Residential mortgages |  |  |  |  |  | 2 |  |  | 2 |
| Home equity |  |  |  | 1 |  | 2 | 9 |  | 12 |
| Automobile |  |  | 4 | 20 | 16 | 7 |  |  | 47 |
| Education |  | 3 | 6 | 14 | 22 | 62 |  |  | 107 |
| Other retail | 29 | 27 | 16 | 9 | 4 | 7 | 101 |  | 193 |
| &nbsp;&nbsp;Total retail | 29 | 30 | 26 | 44 | 42 | 80 | 110 |  | 361 |
| Total loans and leases | $29 | $31 | $31 | $116 | $76 | $211 | $136 | $— | $630 |

---

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** |
| | **Term Loans and Leases by Origination Year** | **Term Loans and Leases by Origination Year** | **Term Loans and Leases by Origination Year** | **Term Loans and Leases by Origination Year** | **Term Loans and Leases by Origination Year** | **Term Loans and Leases by Origination Year** | **Revolving Loans** | **Revolving Loans** | |
|<br>(dollars in millions) | **2024** | **2023** | **2022** | **2021** | **2020** | **Prior to 2020** | **Within the Revolving Period** | **Converted to Term** |<br>**Total** |
| Commercial and industrial | $— | $— | $15 | $22 | $1 | $15 | $32 | $— | $85 |
| Commercial real estate |  |  | 1 | 22 | 98 | 102 |  |  | 223 |
| &nbsp;&nbsp;Total commercial |  |  | 16 | 44 | 99 | 117 | 32 |  | 308 |
| Residential mortgages |  |  |  |  |  | 4 |  |  | 4 |
| Home equity |  |  |  |  |  | 3 | 8 | 1 | 12 |
| Automobile |  | 5 | 23 | 23 | 7 | 4 | 9 | 1 | 72 |
| Education |  | 2 | 6 | 18 | 21 | 46 |  |  | 93 |
| Other retail | 25 | 10 | 7 | 12 | 2 | 8 | 132 |  | 196 |
| &nbsp;&nbsp;Total retail | 25 | 17 | 36 | 53 | 30 | 65 | 149 | 2 | 377 |
| Total loans and leases | $25 | $17 | $52 | $97 | $129 | $182 | $181 | $2 | $685 |

---

Citizens Financial Group, Inc. \| 53

------

*Nonaccrual and Past Due Assets*

The following tables present an aging analysis of accruing and nonaccrual loans and leases:

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** |
| | | **Days Past Due and Accruing** | **Days Past Due and Accruing** | **Days Past Due and Accruing** | | | |
|<br>(dollars in millions) |<br>**Current** | **30-59** | **60-89** | **90+** |<br>**Nonaccrual** |<br> **Total** |<br>**Nonaccrual with no related ACL** |
| Commercial and industrial | $46624 | $52 | $8 | $39 | $230 | $46953 | $24 |
| Commercial real estate | 24668 | 90 | 72 | 7 | 703 | 25540 | 25 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total commercial | 71292 | 142 | 80 | 46 | 933 | 72493 | 49 |
| Residential mortgages | 34052 | 80 | 43 | 114 | 188 | 34477 | 150 |
| Home equity | 18007 | 83 | 28 |  | 297 | 18415 | 206 |
| Automobile | 2702 | 62 | 21 |  | 31 | 2816 | 4 |
| Education | 8482 | 34 | 18 | 2 | 20 | 8556 | 2 |
| Other retail | 4010 | 32 | 22 |  | 49 | 4113 | 1 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total retail | 67253 | 291 | 132 | 116 | 585 | 68377 | 363 |
| Total | $138545 | $433 | $212 | $162 | $1518 | $140870 | $412 |
| Guaranteed residential mortgages<sup>(1)</sup> | $795 | $44 | $23 | $114 | $— | $976 | $— |

---

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
| | | **Days Past Due and Accruing** | **Days Past Due and Accruing** | **Days Past Due and Accruing** | | | |
|<br>(dollars in millions) |<br>**Current** | **30-59** | **60-89** | **90+** |<br>**Nonaccrual** |<br> **Total** |<br>**Nonaccrual with no related ACL** |
| Commercial and industrial | $42247 | $35 | $20 | $8 | $241 | $42551 | $31 |
| Commercial real estate | 26212 | 204 | 27 | 6 | 776 | 27225 | 32 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total commercial | 68459 | 239 | 47 | 14 | 1017 | 69776 | 63 |
| Residential mortgages | 32011 | 251 | 93 | 179 | 192 | 32726 | 142 |
| Home equity | 16097 | 88 | 27 |  | 283 | 16495 | 182 |
| Automobile | 4563 | 100 | 33 |  | 48 | 4744 | 6 |
| Education | 10686 | 45 | 23 | 2 | 56 | 10812 | 4 |
| Other retail | 4504 | 46 | 31 | 1 | 68 | 4650 | 1 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total retail | 67861 | 530 | 207 | 182 | 647 | 69427 | 335 |
| Total | $136320 | $769 | $254 | $196 | $1664 | $139203 | $398 |
| Guaranteed residential mortgages<sup>(1)</sup> | $696 | $119 | $55 | $172 | $— | $1042 | $— |

---

<sup>(1)</sup> Guaranteed residential mortgages represent loans fully or partially guaranteed by the FHA, VA, and USDA, and are included in the amounts presented for Residential mortgages.

At September 30, 2025 and December 31, 2024, the Company had collateral-dependent residential mortgage and home equity loans totaling $427 million and $372 million, respectively, and collateral-dependent commercial loans totaling $250 million and $607 million, respectively.

The amortized cost basis of mortgage loans collateralized by residential real estate for which formal foreclosure proceedings were in-process was $299 million and $295 million as of September 30, 2025 and December 31, 2024, respectively.

*Loan Modifications to Borrowers Experiencing Financial Difficulty*

The Company offers loan modifications, characterized as FDMs, to retail and commercial borrowers experiencing financial difficulty as a result of its loss mitigation activities that may result in a payment delay, interest rate reduction, term extension, principal forgiveness, or combination thereof. Payment delays consist of modifications that result in a delay of contractual amounts due greater than three months over a rolling 12-month period. Term extensions consist of modifications that result in an extension of the contractual maturity date greater than three months or a significant deferral of principal payments relative to the total outstanding principal balance of the loan.

Citizens Financial Group, Inc. \| 54

------

Commercial loan modifications are offered on a case-by-case basis and generally include a payment delay, term extension, and/or interest rate reduction. The Company does not typically offer principal forgiveness for commercial loans. Retail loan modifications are offered through structured loan modification programs, which are summarized below:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Forbearance programs provide borrowers experiencing some form of hardship a period of time during which their contractual payment obligations are suspended, resulting in a payment delay and/or term extension;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Other repayment plans are offered due to hardship and include an interest rate reduction and/or term extension designed to enable the borrower to return the loan to current status in an expeditious manner;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Settlement agreements may be executed with borrowers experiencing a long-term hardship or who are delinquent, resulting in principal forgiveness. Upon fulfillment of the terms of the settlement agreement, the unpaid principal amount is forgiven resulting in a charge-off of the outstanding principal balance; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Certain reorganization bankruptcy judgments may result in any one of the four modification types or some combination thereof.

The following tables present the period-end amortized cost of loans to borrowers experiencing financial difficulty that were modified during the three and nine months ended September 30, 2025 and 2024, disaggregated by class of financing receivable and modification type. The modification type reflects the cumulative effect of all FDMs received during the indicated period.

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** |
|<br>(dollars in millions) | **Interest Rate Reduction** | **Term Extension** | **Payment Delay** | **Interest Rate Reduction and Term Extension** | **Term Extension and Payment Delay** | **Interest Rate Reduction, Term Extension and Payment Delay** | **Total** | **Total as a % of Loan Class**<sup>(1)</sup> |
| Commercial and industrial | $1 | $151 | $— | $2 | $— | $1 | $155 | 0.33% |
| Commercial real estate |  | 388 | 22 |  | 102 |  | 512 | 2.00 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total commercial | 1 | 539 | 22 | 2 | 102 | 1 | 667 | 0.92 |
| Residential mortgages | 1 | 18 | 6 | 5 |  | 1 | 31 | 0.09 |
| Home equity | 2 | 1 | 6 | 3 |  |  | 12 | 0.07 |
| Education | 3 |  |  |  |  |  | 3 | 0.04 |
| Other retail | 5 |  |  |  |  |  | 5 | 0.12 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total retail | 11 | 19 | 12 | 8 |  | 1 | 51 | 0.07 |
| Total | $12 | $558 | $34 | $10 | $102 | $2 | $718 | 0.51% |

---

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** |
|<br>(dollars in millions) | **Interest Rate Reduction** | **Term Extension** | **Payment Delay** | **Interest Rate Reduction and Term Extension** | **Term Extension and Payment Delay** | **Total** | **Total as a % of Loan Class**<sup>(1)</sup> |
| Commercial and industrial | $— | $75 | $25 | $1 | $3 | $104 | 0.24% |
| Commercial real estate |  | 156 | 23 | 67 | 94 | 340 | 1.22 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total commercial |  | 231 | 48 | 68 | 97 | 444 | 0.62 |
| Residential mortgages | 1 | 15 | 1 | 4 | 1 | 22 | 0.07 |
| Home equity | 2 | 1 |  | 4 |  | 7 | 0.04 |
| Education | 3 | 1 | 16 |  |  | 20 | 0.18 |
| Other retail | 5 |  |  |  |  | 5 | 0.10 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total retail | 11 | 17 | 17 | 8 | 1 | 54 | 0.08 |
| Total | $11 | $248 | $65 | $76 | $98 | $498 | 0.35% |

---

Citizens Financial Group, Inc. \| 55

------

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** |
|<br>(dollars in millions) | **Interest Rate Reduction** | **Term Extension** | **Payment Delay** | **Interest Rate Reduction and Term Extension** | **Term Extension and Payment Delay** | **Interest Rate Reduction, Term Extension, and Payment Delay** | **Total** | **Total as a % of Loan Class**<sup>(1)</sup> |
| Commercial and industrial | $16 | $322 | $2 | $5 | $1 | $4 | $350 | 0.75% |
| Commercial real estate | 28 | 707 | 66 | 29 | 103 |  | 933 | 3.65 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total commercial | 44 | 1029 | 68 | 34 | 104 | 4 | 1283 | 1.77 |
| Residential mortgages | 3 | 42 | 13 | 9 | 1 | 2 | 70 | 0.20 |
| Home equity | 5 | 1 | 11 | 5 |  |  | 22 | 0.12 |
| Education | 8 |  |  |  |  |  | 8 | 0.09 |
| Other retail | 13 |  |  |  |  |  | 13 | 0.32 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total retail | 29 | 43 | 24 | 14 | 1 | 2 | 113 | 0.17 |
| Total | $73 | $1072 | $92 | $48 | $105 | $6 | $1396 | 0.99% |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** |
|<br>(dollars in millions) | **Interest Rate Reduction** | **Term Extension** | **Payment Delay** | **Interest Rate Reduction and Term Extension** | **Term Extension and Payment Delay** | **Interest Rate Reduction, Term Extension, and Payment Delay** | **Total** | **Total as a % of Loan Class**<sup>(1)</sup> |
| Commercial and industrial | $— | $179 | $86 | $1 | $23 | $— | $289 | 0.66% |
| Commercial real estate |  | 505 | 100 | 130 | 144 |  | 879 | 3.14 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total commercial |  | 684 | 186 | 131 | 167 |  | 1168 | 1.63 |
| Residential mortgages | 4 | 63 | 9 | 8 | 1 | 1 | 86 | 0.27 |
| Home equity | 3 | 2 |  | 9 |  |  | 14 | 0.09 |
| Education | 9 | 2 | 39 |  |  |  | 50 | 0.45 |
| Other retail | 13 |  |  |  |  |  | 13 | 0.27 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total retail | 29 | 67 | 48 | 17 | 1 | 1 | 163 | 0.23 |
| Total | $29 | $751 | $234 | $148 | $168 | $1 | $1331 | 0.94% |

---

<sup>(1)</sup> Represents the total amortized cost as of period-end divided by the period-end amortized cost of the corresponding loan class. Accrued interest receivable is excluded from amortized cost and is immaterial.

The following tables present the financial effect of loans to borrowers experiencing financial difficulty that were modified during the three and nine months ended September 30, 2025 and 2024, disaggregated by class of financing receivable:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** |
|<br>(dollars in millions) | **Weighted-Average Interest Rate Reduction**<sup>(1)</sup> | **Weighted-Average Term Extension (in Months)**<sup>(1)</sup> | **Weighted-Average Payment Deferral**<sup>(1)</sup> | **Amount of Principal Forgiven**<sup>(2)</sup> |
| Commercial and industrial | 2.18% | 20 | $— | $— |
| Commercial real estate |  | 12 | 5 |  |
| Residential mortgages | 1.40 | 107 |  |  |
| Home equity | 3.01 | 143 |  |  |
| Education | 5.22 |  |  |  |
| Other retail | 19.89 |  |  | 6 |

---

Citizens Financial Group, Inc. \| 56

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** |
|<br>(dollars in millions) | **Weighted-Average Interest Rate Reduction**<sup>(1)</sup> | **Weighted-Average Term Extension (in Months)**<sup>(1)</sup> | **Weighted-Average Payment Deferral**<sup>(1)</sup> | **Amount of Principal Forgiven**<sup>(2)</sup> |
| Commercial and industrial | 3.62% | 14 | $11 | $— |
| Commercial real estate | 4.31 | 9 | 1 |  |
| Residential mortgages | 1.52 | 94 |  |  |
| Home equity | 4.32 | 51 |  |  |
| Education | 4.44 | 24 |  |  |
| Other retail | 20.79 |  |  | 1 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** |
|<br>(dollars in millions) | **Weighted-Average Interest Rate Reduction**<sup>(1)</sup> | **Weighted-Average Term Extension (in Months)**<sup>(1)</sup> | **Weighted-Average Payment Deferral**<sup>(1)</sup> | **Amount of Principal Forgiven**<sup>(2)</sup> |
| Commercial and industrial | 1.52% | 18 | $— | $— |
| Commercial real estate | 0.83 | 12 | 5 |  |
| Residential mortgages | 1.27 | 110 |  |  |
| Home equity | 3.41 | 121 |  |  |
| Education | 4.71 |  |  |  |
| Other retail | 19.86 |  |  | 12 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** |
|<br>(dollars in millions) | **Weighted-Average Interest Rate Reduction**<sup>(1)</sup> | **Weighted-Average Term Extension (in Months)**<sup>(1)</sup> | **Weighted-Average Payment Deferral**<sup>(1)</sup> | **Amount of Principal Forgiven**<sup>(2)</sup> |
| Commercial and industrial | 3.72% | 15 | $3 | $— |
| Commercial real estate | 2.83 | 17 | 1 |  |
| Residential mortgages | 1.59 | 92 |  |  |
| Home equity | 4.03 | 75 |  |  |
| Education | 4.42 | 24 |  |  |
| Other retail | 20.23 |  |  | 5 |

---

<sup>(1)</sup> Weighted based on period-end amortized cost.

<sup>(2)</sup> Amounts are recorded as charge-offs.

The following tables present an aging analysis of the period-end amortized cost of loans to borrowers experiencing financial difficulty that were modified during the twelve month period ending September 30, 2025 and 2024, disaggregated by class of financing receivable. A loan in a forbearance or repayment plan is reported as past due according to its contractual terms until contractually modified. Subsequent to modification, it is reported as past due based on its restructured terms.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** |
| | | **Days Past Due and Accruing** | **Days Past Due and Accruing** | **Days Past Due and Accruing** | | |
|<br>(dollars in millions) |<br>**Current** | **30-59** | **60-89** | **90+** |<br>**Nonaccrual** |<br> **Total** |
| Commercial and industrial | $348 | $1 | $— | $35 | $61 | $445 |
| Commercial real estate | 733 | 83 | 2 | 4 | 293 | 1115 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total commercial | 1081 | 84 | 2 | 39 | 354 | 1560 |
| Residential mortgages | 49 | 7 | 6 | 16 | 19 | 97 |
| Home equity | 8 |  |  |  | 22 | 30 |
| Education | 8 |  |  |  | 2 | 10 |
| Other retail | 13 | 2 | 1 |  | 1 | 17 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total retail | 78 | 9 | 7 | 16 | 44 | 154 |
| Total | $1159 | $93 | $9 | $55 | $398 | $1714 |

---

Citizens Financial Group, Inc. \| 57

------

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **September 30, 2024** | **September 30, 2024** | **September 30, 2024** | **September 30, 2024** | **September 30, 2024** | **September 30, 2024** |
| | | **Days Past Due and Accruing** | **Days Past Due and Accruing** | **Days Past Due and Accruing** | | |
|<br>(dollars in millions) |<br>**Current** | **30-59** | **60-89** | **90+** |<br>**Nonaccrual** |<br> **Total** |
| Commercial and industrial | $211 | $35 | $1 | $— | $54 | $301 |
| Commercial real estate | 590 | 30 | 63 |  | 287 | 970 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total commercial | 801 | 65 | 64 |  | 341 | 1271 |
| Residential mortgages | 73 | 6 | 4 | 16 | 12 | 111 |
| Home equity | 11 |  |  |  | 8 | 19 |
| Education | 34 | 1 |  |  | 35 | 70 |
| Other retail | 12 | 1 | 1 |  | 1 | 15 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total retail | 130 | 8 | 5 | 16 | 56 | 215 |
| Total | $931 | $73 | $69 | $16 | $397 | $1486 |

---

The following tables present the period-end amortized cost of loans to borrowers experiencing financial difficulty that defaulted during the period presented and were modified within the previous 12 months preceding the default, disaggregated by class of financing receivable and modification type. The modification type reflects the cumulative effect of all FDMs at the time of default. A loan is considered to be in default if, subsequent to modification, it becomes 90 or more days past due or is placed on nonaccrual status.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** |
|<br>(dollars in millions) | **Interest Rate Reduction** | **Term Extension** | **Payment Delay** | **Interest Rate Reduction and Term Extension** | **Term Extension and Payment Delay** | **Total** |
| Commercial and industrial | $— | $36 | $— | $— | $— | $36 |
| Commercial real estate |  | 4 |  |  |  | 4 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total commercial |  | 40 |  |  |  | 40 |
| Residential mortgages | 1 | 8 | 4 | 3 |  | 16 |
| Home equity |  |  |  |  |  |  |
| Education | 1 |  |  |  |  | 1 |
| Other retail | 1 |  |  |  |  | 1 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total retail | 3 | 8 | 4 | 3 |  | 18 |
| Total | $3 | $48 | $4 | $3 | $— | $58 |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** |
|<br>(dollars in millions) | **Interest Rate Reduction** | **Term Extension** | **Payment Delay** | **Term Extension and Payment Delay** | **Total** |
| Commercial and industrial | $1 | $3 | $— | $15 | $19 |
| Commercial real estate |  | 75 | 21 |  | 96 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total commercial | 1 | 78 | 21 | 15 | 115 |
| Residential mortgages |  | 11 |  |  | 11 |
| Home equity |  |  |  |  |  |
| Education | 1 |  |  |  | 1 |
| Other retail | 1 |  |  |  | 1 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total retail | 2 | 11 |  |  | 13 |
| Total | $3 | $89 | $21 | $15 | $128 |

---

Citizens Financial Group, Inc. \| 58

------

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** |
|<br>(dollars in millions) | **Interest Rate Reduction** | **Term Extension** | **Payment Delay** | **Interest Rate Reduction and Term Extension** | **Term Extension and Payment Delay** | **Total** |
| Commercial and industrial | $— | $48 | $— | $— | $— | $48 |
| Commercial real estate |  | 72 | 2 |  |  | 74 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total commercial |  | 120 | 2 |  |  | 122 |
| Residential mortgages | 1 | 20 | 5 | 6 | 1 | 33 |
| Home equity | 1 |  | 1 | 1 |  | 3 |
| Education | 1 |  |  |  |  | 1 |
| Other retail | 1 |  |  |  |  | 1 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total retail | 4 | 20 | 6 | 7 | 1 | 38 |
| Total | $4 | $140 | $8 | $7 | $1 | $160 |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** |
|<br>(dollars in millions) | **Interest Rate Reduction** | **Term Extension** | **Payment Delay** | **Interest Rate Reduction and Term Extension** | **Term Extension and Payment Delay** | **Total** |
| Commercial and industrial | $1 | $3 | $— | $— | $15 | $19 |
| Commercial real estate |  | 141 | 21 |  |  | 162 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total commercial | 1 | 144 | 21 |  | 15 | 181 |
| Residential mortgages |  | 22 | 1 | 1 | 1 | 25 |
| Home equity |  |  |  | 1 |  | 1 |
| Education | 4 |  | 12 |  |  | 16 |
| Other retail | 1 |  |  |  |  | 1 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total retail | 5 | 22 | 13 | 2 | 1 | 43 |
| Total | $6 | $166 | $34 | $2 | $16 | $224 |

---

Unfunded commitments related to loans modified during the nine months ended September 30, 2025 were $342 million at September 30, 2025. Unfunded commitments related to loans modified during the year ended December 31, 2024 were $206 million at December 31, 2024.

**NOTE 5 - MORTGAGE BANKING AND OTHER SERVICED LOANS** 

*Mortgage Banking*

The Company sells residential mortgages in the secondary market and does not retain a beneficial interest in these sales but may retain the servicing rights for the loans sold. The Company may exercise its option to repurchase eligible government guaranteed residential mortgages or may be obligated to subsequently repurchase a loan if the purchaser discovers a representation or warranty violation, such as noncompliance with eligibility or servicing requirements or customer fraud that should have been identified in a loan file review.

The following table summarizes activity related to residential mortgage loans sold with servicing rights retained:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
|<br>(dollars in millions) | **2025** | **2024** | **2025** | **2024** |
| Cash proceeds from residential mortgage loans sold with servicing retained | $2528 | $2137 | $6920 | $5432 |
| Gain on sales<sup>(1)</sup> | 19 | 17 | 56 | 47 |
| Contractually specified servicing, late, and other ancillary fees<sup>(1)</sup> | 70 | 79 | 209 | 235 |

---

<sup>(1)</sup> Reported in Mortgage banking fees in the Consolidated Statements of Operations.

The unpaid principal balance of residential mortgage loans related to our MSRs was $95.2 billion and $95.6 billion at September 30, 2025 and December 31, 2024, respectively. The Company manages the risk associated with changes in the fair value of the MSRs with an active economic hedging strategy, which includes the purchase of freestanding derivatives.

Citizens Financial Group, Inc. \| 59

------

The following table summarizes changes in MSRs recorded using the fair value method:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **As of and for the Three Months Ended September 30,** | **As of and for the Three Months Ended September 30,** | **As of and for the Nine Months Ended September 30,** | **As of and for the Nine Months Ended September 30,** |
|<br>(dollars in millions) | **2025** | **2024** | **2025** | **2024** |
| Fair value as of beginning of the period | $1426 | $1568 | $1491 | $1552 |
| &nbsp;&nbsp;&nbsp;Amounts capitalized | 42 | 28 | 117 | 71 |
| &nbsp;&nbsp;Sales<sup>(1)</sup> |  |  | (72) |  |
| &nbsp;&nbsp;Changes in unpaid principal balance<sup>(2)</sup> | (41) | (46) | (120) | (135) |
| &nbsp;&nbsp;Changes in fair value<sup>(3)</sup> | 3 | (49) | 14 | 13 |
| Fair value at end of the period | $1430 | $1501 | $1430 | $1501 |

---

<sup>(1)</sup> For the nine months ended September 30, 2025, represents the sale of the excess servicing yield on MSRs related to certain FNMA mortgages with a total unpaid principal balance of $10.5 billion at the time of sale.

<sup>(2)</sup> Represents changes in value of the MSRs due to i) the passage of time including the impact from both regularly scheduled loan principal payments and partial

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;paydowns, and ii) loans that paid off during the period.

<sup>(3)</sup> Represents changes in fair value primarily driven by market conditions. These changes are recorded in Mortgage banking fees in the Consolidated Statements of Operations.

The fair value of MSRs is estimated by using the present value of estimated future net servicing cash flows, taking into consideration actual and expected mortgage loan prepayment rates, discount rates, contractual servicing fee income, servicing costs, default rates, ancillary income, and other economic factors determined based on current market interest rates. The valuation does not attempt to forecast or predict the future direction of interest rates.

The sensitivity analysis below presents the impact of an immediate 10% and 20% adverse change in key economic assumptions to the current fair value of MSRs. These sensitivities are hypothetical, with the effect of a variation in a particular assumption on the fair value of the MSRs calculated independently without changing any other assumption. Changes in one factor may result in changes in another (e.g., changes in interest rates that drive changes in prepayment rates could result in changes in discount rates) and may amplify or counteract the sensitivities. The primary risk inherent in the Company's MSRs is an increase in prepayments of the underlying mortgage loans serviced, which is largely dependent upon movements in market interest rates.

---

| | | |
|:---|:---|:---|
| (dollars in millions) | **September 30, 2025** | **December 31, 2024** |
| Fair value | $1430 | $1491 |
| Weighted average life (years) | 8.0 | 8.7 |
| Weighted average constant prepayment rate | 7.1% | 6.7% |
| &nbsp;&nbsp;Decline in fair value from 10% adverse change | $39 | $35 |
| &nbsp;&nbsp;Decline in fair value from 20% adverse change | $72 | $67 |
| Weighted average option adjusted spread | 608 bps | 632 bps |
| &nbsp;&nbsp;Decline in fair value from 10% adverse change | $40 | $42 |
| &nbsp;&nbsp;Decline in fair value from 20% adverse change | $80 | $84 |

---

The Company has mortgage banking derivatives that include commitments to originate mortgages held for sale, certain loan sale agreements, and other financial instruments that meet the definition of a derivative. Refer to Note 8 for additional information.

*Other Serviced Loans*

The Company engages in other servicing relationships from time to time. The following table presents the unpaid principal balance of other serviced loans:

---

| | | |
|:---|:---|:---|
| (dollars in millions) | **September 30, 2025** | **December 31, 2024** |
| Education | $358 | $420 |
| Commercial and industrial<sup>(1)</sup> | 88 | 92 |

---

<sup>(1)</sup> Represents the government guaranteed portion of SBA loans sold to outside investors.

Citizens Financial Group, Inc. \| 60

------

**NOTE 6 - VARIABLE INTEREST ENTITIES** 

The Company, in the normal course of business, engages in a variety of activities with entities that are considered VIEs, as defined by GAAP, with its variable interest arising from contractual, ownership, or other monetary interests in the entity. A VIE typically does not have sufficient equity at risk to finance its activities without additional subordinated financial support from other parties.

For more details regarding the Company's involvement with VIEs see Note 11 in the Company's 2024 Form 10-K.

*Consolidated VIEs*

The Company has consolidated VIEs related to secured borrowings collateralized by auto loans. The following table summarizes the carrying amount of assets and liabilities for the Company's consolidated VIEs:

---

| | | |
|:---|:---|:---|
| (dollars in millions) | **September 30, 2025** | **December 31, 2024** |
| Assets: |  |  |
| &nbsp;&nbsp;Interest-bearing deposits in banks | $169 | $209 |
| &nbsp;&nbsp;Net loans and leases | 2353 | 3843 |
| &nbsp;&nbsp;Other assets | 15 | 21 |
| Total assets | $2537 | $4073 |
| Liabilities: |  |  |
| &nbsp;&nbsp;Long-term borrowed funds | $1982 | $3375 |
| &nbsp;&nbsp;Other liabilities | 5 | 8 |
| Total liabilities | $1987 | $3383 |

---

*Secured Borrowings*

The Company utilizes a portion of its auto loan portfolio to support certain secured borrowing arrangements, which provide a source of funding for the Company and involves the transfer of auto loans to bankruptcy remote SPEs. These SPEs then issue asset-backed notes to third parties collateralized by the transferred loans.

The assets of a particular VIE are the primary source of funds to settle its obligations. Creditors of these VIEs do not have recourse to the general credit of the Company. The performance of the loans transferred is the most significant driver impacting the economic performance of the VIEs.

*Unconsolidated VIEs*

The Company is involved with various VIEs that are not consolidated including lending to SPEs, investments in asset-backed securities, and investments in entities that sponsor affordable housing, renewable energy, and economic development projects. The Company's maximum exposure to loss resulting from its involvement with these entities is limited to the balance sheet carrying amount of its investments, unfunded commitments, and the outstanding principal balance of loans to SPEs.

The following table provides a summary of the assets and liabilities included in the Consolidated Balance Sheets related to unconsolidated VIEs that the Company holds an interest in, but is not the primary beneficiary of:

---

| | | |
|:---|:---|:---|
| (dollars in millions) | **September 30, 2025** | **December 31, 2024** |
| Lending to SPEs included in Loans and leases | $4893 | $4215 |
| LIHTC investments included in Other assets | 2698 | 2631 |
| LIHTC unfunded commitments included in Other liabilities | 1065 | 1109 |
| Asset-backed investments included in HTM securities | 357 | 412 |
| Renewable energy investments included in Other assets | 217 | 269 |
| NMTC investments included in Other assets | 1 | 2 |

---

Citizens Financial Group, Inc. \| 61

------

*Lending to Special Purpose Entities*

The Company provides lending facilities to third-party sponsored SPEs within its Capital Markets business. The SPEs are primarily funded through these lending facilities or a syndication in which the Company participates. The principal risk of these lending facilities is the credit risk related to the underlying assets in the SPE, in which the Company generally holds a priority position. As of September 30, 2025 and December 31, 2024, the lending facilities had undrawn commitments to extend credit of $3.2 billion and $2.8 billion, respectively. For more information on commitments to extend credit see Note 11.

*Low Income Housing Tax Credit Partnerships* 

The Company makes certain equity investments in various limited partnerships that sponsor affordable housing projects utilizing federal tax incentives pursuant to Section 42 of the Internal Revenue Code. The objective of these investments is to generate a satisfactory return on capital, encourage the development and investment in projects that serve affordable housing product offerings, and further the goals of the Community Reinvestment Act. The principal activities of the limited partnerships include the identification, development, and operation of multifamily housing properties leased to qualifying residential tenants. Funding for these investments is generally provided through a combination of debt and equity.

*Asset-backed securities*

The Company's investments in asset-backed securities are collateralized by education loans sold to a third-party sponsored VIE. The Company acts as the primary servicer for the sold loans and receives a servicing fee. A third-party servicer is responsible for all loans that become significantly delinquent.

*Renewable Energy Entities*

The Company's investments in certain renewable energy entities provide benefits from government incentives and other tax attributes (e.g., tax depreciation).

Contingent commitments related to the Company's renewable energy investments were $43 million at September 30, 2025, and are expected to be paid in varying amounts through 2027. These payments are contingent upon the level of electricity production attained by the renewable energy entity relative to its targeted threshold, changes in the production tax credit rates set by the Internal Revenue Service, and the achievement of commercial operation for a certain renewable energy project under its power purchase agreement.

*New Markets Tax Credit Program*

The Company participates in the NMTC program which provides a tax incentive for private sector investment into economic development projects and businesses located in low-income communities.

The following table summarizes the impact to the Consolidated Statements of Operations relative to the Company's tax credit programs for which it has elected to apply the proportional amortization method of accounting:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
|<br>(dollars in millions) | **2025** | **2024** | **2025** | **2024** |
| Tax credits recognized | $99 | $99 | $309 | $290 |
| Other tax benefits recognized | 24 | 21 | 73 | 68 |
| Amortization | (98) | (88) | (304) | (276) |
| &nbsp;&nbsp;Net benefit (expense) included in Income tax expense | 25 | 32 | 78 | 82 |
| Other income | 1 | 1 | 5 | 4 |
| Allocated income (loss) on investments | (3) | (3) | (10) | (9) |
| &nbsp;&nbsp;Net benefit (expense) included in Noninterest income | (2) | (2) | (5) | (5) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net benefit (expense) included in the Consolidated Statements of Operations<sup>(1)</sup> | $23 | $30 | $73 | $77 |

---

<sup>(1)</sup> Includes the impact of tax credit investments when the election to apply the proportional amortization method was in effect during the periods presented. For 2025 and 2024, this includes LIHTC, renewable energy, and NMTC investments.

The Company did not recognize impairment losses resulting from the forfeiture or ineligibility of income tax credits or other circumstances during the three and nine months ended September 30, 2025 and 2024.

Citizens Financial Group, Inc. \| 62

------

**NOTE 7 - BORROWED FUNDS** 

*Short-term borrowed funds*

Borrowings with original maturities of one year or less are classified as short-term and were comprised of the following:

---

| | | |
|:---|:---|:---|
| (dollars in millions) | **September 30, 2025** | **December 31, 2024** |
| Other short-term borrowed funds<sup>(1)</sup> | $214 | $— |
| Total short-term borrowed funds | $214 | $— |

---

<sup>(1)</sup> Consists primarily of short positions held by the Company's commercial broker dealer. See Note 8 for additional information regarding forward purchase contracts entered into to economically hedge these short positions.

*Long-term borrowed funds*

The following table presents a summary of the Company's long-term borrowed funds:

---

| | | |
|:---|:---|:---|
| (dollars in millions) | **September 30, 2025** | **December 31, 2024** |
| **Parent Company:** |  |  |
| 4.350% fixed-rate subordinated debt, due August 2025 | $— | $133 |
| 4.300% fixed-rate subordinated debt, due December 2025 | 336 | 336 |
| 2.850% fixed-rate senior unsecured notes, due July 2026 | 500 | 499 |
| 5.841% fixed/floating-rate senior unsecured notes, due January 2030 | 1246 | 1245 |
| 2.500% fixed-rate senior unsecured notes, due February 2030 | 299 | 299 |
| 3.250% fixed-rate senior unsecured notes, due April 2030 | 747 | 747 |
| 3.750% fixed-rate reset subordinated debt, due February 2031 | 69 | 69 |
| 4.300% fixed-rate reset subordinated debt, due February 2031 | 135 | 135 |
| 4.350% fixed-rate reset subordinated debt, due February 2031 | 60 | 60 |
| 5.253% fixed/floating-rate senior unsecured notes, due March 2031 | 746 |  |
| 5.718% fixed/floating-rate senior unsecured notes, due July 2032 | 1244 | 1243 |
| 2.638% fixed-rate subordinated debt, due September 2032 | 575 | 570 |
| 6.645% fixed/floating-rate senior unsecured notes, due April 2035 | 746 | 745 |
| 5.641% fixed-rate reset subordinated debt, due May 2037 | 398 | 398 |
| **CBNA's Global Note Program:** |  |  |
| 2.250% senior unsecured notes, due April 2025 |  | 750 |
| 5.284% fixed/floating-rate senior unsecured notes, due January 2026<sup>(1)</sup> |  | 350 |
| 3.750% senior unsecured notes, due February 2026 | 499 | 492 |
| 4.575% fixed/floating-rate senior unsecured notes, due August 2028 | 799 | 798 |
| **Additional Borrowings by CBNA and Other Subsidiaries:** |  |  |
| Federal Home Loan Bank advances, 2.196% weighted average rate, due through 2045<sup>(2)</sup> | 13 | 53 |
| Secured borrowings, 5.536% weighted average rate, due through 2031<sup>(2)(3)</sup> | 2009 | 3461 |
| Other | 20 | 18 |
| Total long-term borrowed funds | $10441 | $12401 |

---

<sup>(1)</sup> Notes were redeemed on January 27, 2025.

<sup>(2)</sup> Rate disclosed reflects the weighted average rate as of September 30, 2025.

<sup>(3)</sup> Collateralized by loans. See Note 6 for additional information.

At September 30, 2025, the Company's long-term borrowed funds include principal balances of $10.5 billion, unamortized debt issuance costs and discounts of $75 million, and hedging basis adjustments of ($1) million. At December 31, 2024, the Company's long-term borrowed funds include principal balances of $12.5 billion, unamortized debt issuance costs and discounts of $85 million, and hedging basis adjustments of ($8) million. See Note 8 for further information about the Company's hedging of certain long-term borrowed funds.

Advances, lines of credit, and letters of credit from the FHLB are collateralized primarily by residential mortgages and home equity products sufficient to satisfy the collateral maintenance level established by the FHLB. The utilized FHLB borrowing capacity, primarily for advances and letters of credit, was $4.9 billion and $4.6 billion at September 30, 2025 and December 31, 2024, respectively. The Company's available FHLB borrowing capacity was $24.3 billion and $21.1 billion at September 30, 2025 and December 31, 2024, respectively. The Company can also borrow from the FRB discount window to meet short-term liquidity requirements. Collateral, including certain loans, is pledged to support this borrowing capacity. At September 30, 2025, the Company's unused secured borrowing capacity was approximately $78.0 billion, which includes unencumbered securities, FHLB borrowing capacity, and FRB discount window capacity.

Citizens Financial Group, Inc. \| 63

------

**NOTE 8 - DERIVATIVES** 

In the normal course of business, the Company enters into derivative transactions to meet the financing and hedging needs of its customers and reduce its own exposure to fluctuations in interest rates and foreign currency exchange rates. These transactions include interest rate swap contracts, interest rate options, foreign exchange contracts, residential loan commitment rate locks, interest rate future contracts, swaptions, certain commodities, forward commitments to sell TBAs, forward purchase and sale contracts, and purchase options. The Company does not use derivatives for speculative purposes. Information regarding the valuation methodology and inputs used to estimate the fair value of the Company's derivative instruments is described in Note 20 in the Company's 2024 Form 10-K.

The following table presents derivative instruments included in the Consolidated Balance Sheets:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
|<br>(dollars in millions) | **Notional Amount** | **Derivative Assets** | **Derivative Liabilities** | **Notional Amount** | **Derivative Assets** | **Derivative Liabilities** |
| **Derivatives designated as hedging instruments:** |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest rate contracts | $72437 | $303 | $2 | $69077 | $402 | $5 |
| **Derivatives not designated as hedging instruments:** |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest rate contracts | 183555 | 189 | 487 | 171193 | 160 | 905 |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign exchange contracts | 42050 | 563 | 399 | 34749 | 472 | 411 |
| &nbsp;&nbsp;&nbsp;&nbsp;Commodities contracts | 1213 | 438 | 381 | 1136 | 429 | 379 |
| &nbsp;&nbsp;&nbsp;&nbsp;TBA contracts | 5034 | 7 | 13 | 2714 | 10 | 8 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other contracts | 1221 | 23 | 4 | 615 | 3 | 2 |
| Total derivatives not designated as hedging instruments | 233073 | 1220 | 1284 | 210407 | 1074 | 1705 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total gross derivatives | 305510 | 1523 | 1286 | 279484 | 1476 | 1710 |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: Gross amounts offset in the Consolidated Balance Sheets<sup>(1)</sup> |  | (379) | (379) |  | (391) | (391) |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: Cash collateral applied<sup>(1)</sup> |  | (423) | (169) |  | (677) | (99) |
| Total net derivatives presented in the Consolidated Balance Sheets |  | $721 | $738 |  | $408 | $1220 |

---

<sup>(1)</sup> Amounts represent the impact of enforceable master netting agreements that allow the Company to net settle positive and negative positions, as well as collateral paid and received.

The Company's derivative transactions are internally divided into three sub-groups: institutional, customer facilitation, and residential loan. Certain derivative transactions within these sub-groups are designated as fair value or cash flow hedges, as described below:

*Derivatives Designated As Hedging Instruments*

The Company's institutional derivatives qualify for hedge accounting treatment. The net interest accruals on interest rate swaps designated in a fair value or cash flow hedge relationship are treated as an adjustment to interest income or interest expense of the hedged item. All hedging relationships are formally documented at inception, as well as risk management objectives and strategies for undertaking various accounting hedges. In addition, the effectiveness of hedge relationships is monitored during the duration of the hedge period. The methods utilized to assess hedge effectiveness vary based on the hedge relationship, with each relationship monitored to ensure that management's initial intent continues to be satisfied. Hedge accounting treatment is discontinued when the derivative is terminated or when it is determined that a derivative is not expected to be, or has ceased to be, an effective hedge. Changes in the fair value of a derivative are reflected in earnings after termination of the hedge relationship.

Citizens Financial Group, Inc. \| 64

------

*Fair Value Hedges*

In a fair value hedge, changes in the fair value of both the derivative instrument and the hedged asset or liability attributable to the risk being hedged are recognized in the same income statement line item in the Consolidated Statements of Operations when the changes in fair value occur. At September 30, 2025 and December 31, 2024, the Company has designated $4.7 billion of interest rate swaps as fair value hedges of its fixed-rate prepayable AFS securities using the portfolio layer method. This approach allows the Company to designate as the hedged item a stated amount of the assets that are not expected to be affected by prepayments, defaults, and other factors affecting the timing and amount of cash flows. At September 30, 2025 and December 31, 2024, the Company has also designated $3.6 billion and $3.1 billion, respectively, of interest rate swaps as fair value hedges to manage interest rate risk within its nonprepayable fixed-rate AFS securities portfolio.

The following table presents the effect of fair value hedges on the Consolidated Statements of Operations and the respective line items affected for each hedged item:

---

| | | |
|:---|:---|:---|
| | **Location and Amount of Gains (Losses) Recognized** | **Location and Amount of Gains (Losses) Recognized** |
| | **Interest Income** | **Interest Expense** |
|<br>(dollars in millions) | **Investment Securities** | **Long-Term Borrowed Funds** |
| **Three Months Ended September 30, 2025** |  |  |
| &nbsp;&nbsp;Gains (losses) on fair value hedges recognized on: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Hedged items | $12 | ($3) |
| &nbsp;&nbsp;&nbsp;&nbsp;Derivatives | (12) | 3 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amounts related to interest settlements on derivatives | 14 | (3) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total net interest income recognized on fair value hedges | $14 | ($3) |
| **Three Months Ended September 30, 2024** |  |  |
| &nbsp;&nbsp;Gains (losses) on fair value hedges recognized on: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Hedged items | $302 | ($8) |
| &nbsp;&nbsp;&nbsp;&nbsp;Derivatives | (306) | 8 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amounts related to interest settlements on derivatives | 34 | (4) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total net interest income recognized on fair value hedges | $30 | ($4) |
| **Nine Months Ended September 30, 2025** |  |  |
| &nbsp;&nbsp;Gains (losses) on fair value hedges recognized on: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Hedged items | $178 | ($7) |
| &nbsp;&nbsp;&nbsp;&nbsp;Derivatives | (180) | 7 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amounts related to interest settlements on derivatives | 38 | (8) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total net interest income recognized on fair value hedges | $36 | ($8) |
| **Nine Months Ended September 30, 2024** |  |  |
| &nbsp;&nbsp;Gains (losses) on fair value hedges recognized on: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Hedged items | $128 | ($8) |
| &nbsp;&nbsp;&nbsp;&nbsp;Derivatives | (127) | 8 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amounts related to interest settlements on derivatives | 87 | (11) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total net interest income recognized on fair value hedges | $88 | ($11) |

---

The following table reflects amounts recorded in the Consolidated Balance Sheets related to cumulative basis adjustments for fair value hedges:*&nbsp;&nbsp;&nbsp;&nbsp;*

---

| | | | | |
|:---|:---|:---|:---|:---|
| (dollars in millions) | **September 30, 2025** | **September 30, 2025** | **December 31, 2024** | **December 31, 2024** |
|  | **Debt securities available for sale**<sup>(1)</sup> | **Long-term borrowed funds** | **Debt securities available for sale**<sup>(1)</sup> | **Long-term borrowed funds** |
| Carrying amount of hedged assets<sup>(2)</sup> | $9728 | $— | $9557 | $— |
| Carrying amount of hedged liabilities |  | 499 |  | 491 |
| Cumulative amount of fair value hedging adjustments included in the carrying amount of the hedged items | 83 | (1) | (97) | (8) |

---

<sup>(1)</sup> Includes the amortized cost basis of closed portfolios used to designate hedging relationships under the portfolio layer method. The hedged item is a layer of the closed portfolio which is expected to be remaining at the end of the hedging relationship. As of September 30, 2025 and December 31, 2024, the amortized cost basis of the closed portfolios used in these hedging relationships was $6.0 billion and $6.4 billion, respectively, including associated cumulative basis adjustments of $37 million and $(75) million, respectively. The amount of the designated hedging instruments was $4.7 billion at September 30, 2025 and December 31, 2024.

<sup>(2)</sup> Carrying amount represents amortized cost.

Citizens Financial Group, Inc. \| 65

------

*Cash Flow Hedges*

In a cash flow hedge the entire change in the fair value of the interest rate swap included in the assessment of hedge effectiveness is initially recorded in OCI and is subsequently reclassified from AOCI into earnings in the period during which the hedged item affects earnings.

The Company enters into interest rate swap agreements designed primarily to hedge a portion of its floating-rate assets and liabilities. All of these swaps are deemed highly effective cash flow hedges. From time to time, the Company may also enter into certain interest rate option agreements that utilize interest rate floors and/or caps. Option premiums paid and received are excluded from the assessment of hedge effectiveness and are amortized over the life of the instruments.

During the first quarter of 2025, the Company entered into a cash flow hedge with a notional amount of $1.5 billion to manage the variability in cash flows related to the sale of Non-Core education loans, which will settle ratably each quarter throughout 2025. During the third quarter of 2025, the Company terminated $466 million of this cash flow hedge in conjunction with the quarterly settlement of the education loan sale.

The following table presents the pre-tax net gains (losses) recorded in the Consolidated Statements of Operations and in the Consolidated Statements of Comprehensive Income related to derivative instruments designated as cash flow hedges:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
|<br>(dollars in millions) | **2025** | **2024** | **2025** | **2024** |
| Pre-tax net gains (losses) recognized in OCI | ($21) | $613 | $376 | ($114) |
| Pre-tax net gains (losses) reclassified from AOCI into interest income | (193) | (276) | (591) | (711) |
| Pre-tax net gains (losses) reclassified from AOCI into noninterest income | (4) |  | (5) |  |
| Pre-tax net gains (losses) reclassified from AOCI into interest expense |  |  | (1) |  |

---

Using the September 30, 2025 interest rate curve, the Company estimates that $396 million in pre-tax net losses related to cash flow hedge strategies will be reclassified from AOCI to earnings over the next 12 months. These losses could differ from amounts recognized due to changes in interest rates, hedge de-designations, or the addition of other hedges after September 30, 2025.

*Derivatives Not Designated As Hedging Instruments*

The Company offers derivatives to customers in connection with their risk management needs consisting primarily of interest rate, foreign exchange, and commodity contracts. Market risk exposure from customer transactions is primarily managed by entering into a variety of hedging transactions with third-party dealers. Gains and losses on customer-related derivatives are reported in Foreign exchange and derivatives products in the Consolidated Statements of Operations.

During the second quarter of 2025, the Company entered into at-the-market equity offering programs to facilitate capital market activities for customers. These programs involve the concurrent short sale of an equity security and the execution of a forward purchase contract for the same equity security. The forward purchase contract economically hedges the Company's short sale position and will be closed against such position when a program concludes. Changes in fair value related to the forward purchase contracts are reported in Capital markets fees in the Consolidated Statements of Operations.

Residential mortgage loans that will be sold in the secondary market and the related loan commitments, which are considered derivatives, are accounted for at fair value. Forward contracts to sell mortgage-backed securities are utilized to hedge the fair value of the loans and related commitments. Gains and losses on the loans and related commitments, and the derivatives used to economically hedge them, are reported in Mortgage banking fees in the Consolidated Statements of Operations.

Residential MSRs are accounted for at fair value. Derivatives utilized to hedge the fair value of residential MSRs include interest rate futures, swaps, options, and forward contracts to purchase mortgage-backed securities. Gains and losses on residential MSRs and the related derivatives are reported in Mortgage banking fees in the Consolidated Statements of Operations.

Citizens Financial Group, Inc. \| 66

------

The following table presents the effect of economic hedges on noninterest income:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Amounts Recognized in <br>Noninterest Income for the** | **Amounts Recognized in <br>Noninterest Income for the** | **Amounts Recognized in <br>Noninterest Income for the** | **Amounts Recognized in <br>Noninterest Income for the** | |
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** | **Affected Line Item in the Consolidated Statements of Operations** |
|<br>(dollars in millions) | **2025** | **2024** | **2025** | **2024** | **Affected Line Item in the Consolidated Statements of Operations** |
| **Economic hedge type:** |  |  |  |  |  |
| Customer interest rate contracts | ($17) | $474 | $218 | ($209) | Foreign exchange and derivative products |
| Derivatives hedging interest rate risk | 29 | (467) | (190) | 233 | Foreign exchange and derivative products |
| Customer foreign exchange contracts | (72) | 151 | 345 | 18 | Foreign exchange and derivative products |
| Derivatives hedging foreign exchange risk | 107 | (195) | (423) | (13) | Foreign exchange and derivative products |
| Customer commodity contracts | (122) | (193) | (81) | (126) | Foreign exchange and derivative products |
| Derivatives hedging commodity price risk | 125 | 198 | 96 | 141 | Foreign exchange and derivative products |
| Residential loan commitments | 4 | 9 | 13 | 2 | Mortgage banking fees |
| Derivatives hedging residential loan commitments and mortgage loans held for sale, at fair value | (14) | (24) | (28) | (15) | Mortgage banking fees |
| Derivative contracts used to hedge residential MSRs | (1) | 47 | 26 | (9) | Mortgage banking fees |
| Derivative contracts used to hedge equity price risk | 4 |  | 15 |  | Capital markets fees |
| Total | $43 | $— | ($9) | $22 |  |

---

Citizens Financial Group, Inc. \| 67

------

**NOTE 9 - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)** 

The following table summarizes the components of the Company's OCI:

---

| | | | |
|:---|:---|:---|:---|
| (dollars in millions) | **Pre-tax** | **Tax Effect** | **After-tax** |
| **Three Months Ended September 30, 2025** |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net unrealized gains (losses) on cash flow hedges arising during the period | ($21) | $5 | ($16) |
| &nbsp;&nbsp;&nbsp;&nbsp;Reclassification of net (gains) losses on cash flow hedges to earnings | 197 | (53) | 144 |
| Net unrealized gains (losses) on cash flow hedges | 176 | (48) | 128 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net unrealized gains (losses) on AFS securities arising during the period | 300 | (77) | 223 |
| &nbsp;&nbsp;&nbsp;&nbsp;Reclassification of net (gains) losses on investment securities to earnings | 24 | (6) | 18 |
| Net unrealized gains (losses) on investment securities | 324 | (83) | 241 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net actuarial gain (loss) arising during the period |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization of actuarial (gain) loss to earnings | 4 | (1) | 3 |
| Defined benefit plans | 4 | (1) | 3 |
| Total other comprehensive income (loss) | $504 | ($132) | $372 |
| **Three Months Ended September 30, 2024** |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net unrealized gains (losses) on cash flow hedges arising during the period | $613 | ($163) | $450 |
| &nbsp;&nbsp;&nbsp;&nbsp;Reclassification of net (gains) losses on cash flow hedges to earnings | 276 | (73) | 203 |
| Net unrealized gains (losses) on cash flow hedges | 889 | (236) | 653 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net unrealized gains (losses) on AFS securities arising during the period | 720 | (179) | 541 |
| &nbsp;&nbsp;&nbsp;&nbsp;Reclassification of net (gains) losses on investment securities to earnings | 18 | (5) | 13 |
| Net unrealized gains (losses) on investment securities | 738 | (184) | 554 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net actuarial gain (loss) arising during the period |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization of actuarial (gain) loss to earnings | 3 | (1) | 2 |
| Defined benefit plans | 3 | (1) | 2 |
| Total other comprehensive income (loss) | $1630 | ($421) | $1209 |
| **Nine Months Ended September 30, 2025** |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net unrealized gains (losses) on cash flow hedges arising during the period | $376 | ($101) | $275 |
| &nbsp;&nbsp;&nbsp;&nbsp;Reclassification of net (gains) losses on cash flow hedges to earnings | 597 | (160) | 437 |
| Net unrealized gains (losses) on cash flow hedges | 973 | (261) | 712 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net unrealized gains (losses) on AFS securities arising during the period | 753 | (192) | 561 |
| &nbsp;&nbsp;&nbsp;&nbsp;Reclassification of net (gains) losses on investment securities to earnings | 64 | (16) | 48 |
| Net unrealized gains (losses) on investment securities | 817 | (208) | 609 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net actuarial gain (loss) arising during the period |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization of actuarial (gain) loss to earnings | 10 | (3) | 7 |
| Defined benefit plans | 10 | (3) | 7 |
| Total other comprehensive income (loss) | $1800 | ($472) | $1328 |
| **Nine Months Ended September 30, 2024** |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net unrealized gains (losses) on cash flow hedges arising during the period | ($114) | $30 | ($84) |
| &nbsp;&nbsp;&nbsp;&nbsp;Reclassification of net (gains) losses on cash flow hedges to earnings | 711 | (189) | 522 |
| Net unrealized gains (losses) on cash flow hedges | 597 | (159) | 438 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net unrealized gains (losses) on AFS securities arising during the period | 453 | (114) | 339 |
| &nbsp;&nbsp;&nbsp;&nbsp;Reclassification of net (gains) losses on investment securities to earnings | 56 | (14) | 42 |
| Net unrealized gains (losses) on investment securities | 509 | (128) | 381 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net actuarial gain (loss) arising during the period | 5 | (1) | 4 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization of actuarial (gain) loss to earnings | 12 | (3) | 9 |
| Defined benefit plans | 17 | (4) | 13 |
| Total other comprehensive income (loss) | $1123 | ($291) | $832 |

---

Citizens Financial Group, Inc. \| 68

------

The following table summarizes the activity in each component of AOCI, net of income taxes:

---

| | | | | |
|:---|:---|:---|:---|:---|
| (dollars in millions) | **Net Unrealized Gains (Losses) on Cash Flow Hedges** | **Net Unrealized Gains (Losses) on Investment Securities** | **Defined Benefit Plans** | **Total AOCI** |
| **Three Months Ended September 30, 2025** |  |  |  |  |
| Balance at July 1, 2025 | ($341) | ($2001) | ($297) | ($2639) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other comprehensive income (loss) before reclassifications | (16) | 223 |  | 207 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amounts reclassified from AOCI to earnings | 144 | 18 | 3 | 165 |
| Total other comprehensive income (loss) | 128 | 241 | 3 | 372 |
| Balance at September 30, 2025 | ($213) | ($1760) | ($294) | ($2267) |
| **Three Months Ended September 30, 2024** |  |  |  |  |
| Balance at July 1, 2024 | ($1302) | ($2511) | ($322) | ($4135) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other comprehensive income (loss) before reclassifications | 450 | 541 |  | 991 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amounts reclassified from AOCI to earnings | 203 | 13 | 2 | 218 |
| Total other comprehensive income (loss) | 653 | 554 | 2 | 1209 |
| Balance at September 30, 2024 | ($649) | ($1957) | ($320) | ($2926) |
| **Nine Months Ended September 30, 2025** |  |  |  |  |
| Balance at January 1, 2025 | ($925) | ($2369) | ($301) | ($3595) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other comprehensive income (loss) before reclassifications | 275 | 561 |  | 836 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amounts reclassified from AOCI to earnings | 437 | 48 | 7 | 492 |
| Total other comprehensive income (loss) | 712 | 609 | 7 | 1328 |
| Balance at September 30, 2025 | ($213) | ($1760) | ($294) | ($2267) |
| **Nine Months Ended September 30, 2024** |  |  |  |  |
| Balance at January 1, 2024 | ($1087) | ($2338) | ($333) | ($3758) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other comprehensive income (loss) before reclassifications | (84) | 339 | 4 | 259 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amounts reclassified from AOCI to earnings | 522 | 42 | 9 | 573 |
| Total other comprehensive income (loss) | 438 | 381 | 13 | 832 |
| Balance at September 30, 2024 | ($649) | ($1957) | ($320) | ($2926) |
| Primary location in the Consolidated Statements of Operations of amounts reclassified from AOCI | Net interest income | Securities gains, net and Net interest income | Other operating expense |  |

---

**NOTE 10 - STOCKHOLDERS' EQUITY** 

*Preferred Stock*

The following table summarizes the Company's preferred stock:

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | | | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **December 31, 2024** | **December 31, 2024** |
| (dollars in millions, except per share data) | **Liquidation value per share** |  | **Preferred Shares** |  | **Carrying Amount** | **Preferred Shares** | **Carrying Amount** |
| Authorized ($25 par value per share) |  |  | 100000000 |  |  | 100000000 |  |
| **Issued and outstanding:** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Series B | $1000 |  | 300000 |  | $296 | 300000 | $296 |
| &nbsp;&nbsp;&nbsp;Series C | 1000 |  | 300000 |  | 297 | 300000 | 297 |
| &nbsp;&nbsp;&nbsp;Series E | 1000 | <sup>(1)</sup> | 450000 | <sup>(2)</sup> | 437 | 450000 | 437 |
| &nbsp;&nbsp;&nbsp;Series F | 1000 |  |  |  |  | 400000 | 395 |
| &nbsp;&nbsp;&nbsp;Series G | 1000 |  | 300000 |  | 296 | 300000 | 296 |
| &nbsp;&nbsp;Series H | 1000 | <sup>(1)</sup> | 400000 | <sup>(3)</sup> | 392 | 400000 | 392 |
| &nbsp;&nbsp;Series I | 1000 | <sup>(1)</sup> | 400000 | <sup>(4)</sup> | 393 |  |  |
| Total |  |  | 2150000 |  | $2111 | 2150000 | $2113 |

---

<sup>(1)</sup> Equivalent to $25 per depositary share.

<sup>(2)</sup> Represented by 18,000,000 depositary shares each representing a 1/40th interest in the Series E Preferred Stock.

<sup>(3)</sup> Represented by 16,000,000 depositary shares each representing a 1/40th interest in the Series H Preferred Stock.

<sup>(4)</sup> Represented by 16,000,000 depositary shares each representing a 1/40th interest in the Series I Preferred Stock.

Citizens Financial Group, Inc. \| 69

------

On July 31, 2025, the Company issued $400 million, or 400,000 shares, of 6.500% fixed-rate reset non-cumulative perpetual Series I Preferred Stock, par value of $25 per share with a liquidation preference of $1,000 per share (the "Series I Preferred Stock"). As a result of this issuance, the Company received net proceeds of $393 million after underwriting fees and other expenses. The Series I Preferred Stock has no stated maturity and will not be subject to any sinking fund or other obligation of the Company. The Series I Preferred Stock is redeemable at the Company's option, in whole or in part, on any dividend payment date on or after October 6, 2030 or, in whole but not in part, at any time within the 90 days following a regulatory capital treatment event at a redemption price equal to $1,000 per share, plus any declared and unpaid dividends. The Company may not redeem shares of the Series I Preferred Stock without the prior approval of the FRB or other appropriate federal banking agency as required under applicable capital rules. Except in limited circumstances or otherwise required by law, holders of the Series I Preferred Stock do not have any voting rights.

In September 2025, the Company provided notice of its intent to redeem all outstanding shares of the 5.650% fixed-rate reset non-cumulative perpetual Series F Preferred Stock on October 6, 2025. Upon providing notice, the Series F Preferred Stock was reclassified from Preferred stock to Other liabilities in the Consolidated Balance Sheets. On October 6, 2025, the Company redeemed all outstanding shares of the Series F Preferred Stock at a redemption price of $1,000 per share.

For further detail regarding the terms and conditions of the Company's preferred stock, see Note 17 in the Company's 2024 Form 10-K.

*Dividends*

The following tables summarize the Company's common and preferred stock dividend activity:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** |
|<br>(dollars in millions, except per share data) | **Dividends Declared per Share** | **Dividends Declared** | **Dividends Paid** | **Dividends Declared per Share** | **Dividends Declared** | **Dividends Paid** |
| Common stock | $0.42 | $184 | $184 | $0.42 | $190 | $190 |
| Preferred stock |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Series B | $19.07 | $5 | $5 | $21.68 | $6 | $7 |
| &nbsp;&nbsp;&nbsp;Series C | 19.46 | 5 | 6 | 22.07 | 6 | 6 |
| &nbsp;&nbsp;&nbsp;Series D |  |  |  |  |  | 7 |
| &nbsp;&nbsp;&nbsp;Series E | 12.50 | 6 | 6 | 12.50 | 6 | 6 |
| &nbsp;&nbsp;&nbsp;Series F | 14.13 | 6 | 6 | 14.13 | 6 | 6 |
| &nbsp;&nbsp;&nbsp;Series G | 10.00 | 3 | 3 | 10.00 | 3 | 3 |
| &nbsp;&nbsp;&nbsp;Series H | 18.43 | 7 | 7 | 27.25 | 11 |  |
| Total preferred stock |  | $32 | $33 |  | $38 | $35 |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** |
|<br>(dollars in millions, except per share data) | **Dividends Declared per Share** | **Dividends Declared** | **Dividends Paid** | **Dividends Declared per Share** | **Dividends Declared** | **Dividends Paid** |
| Common stock | $1.26 | $555 | $555 | $1.26 | $581 | $581 |
| Preferred stock |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Series B | $57.26 | $17 | $17 | $65.06 | $19 | $20 |
| &nbsp;&nbsp;&nbsp;Series C | 58.43 | 17 | 18 | 60.54 | 18 | 16 |
| &nbsp;&nbsp;&nbsp;Series D |  |  |  | 39.66 | 12 | 17 |
| &nbsp;&nbsp;&nbsp;Series E | 37.50 | 17 | 17 | 37.50 | 17 | 17 |
| &nbsp;&nbsp;&nbsp;Series F | 42.38 | 17 | 17 | 42.38 | 17 | 17 |
| &nbsp;&nbsp;&nbsp;Series G | 30.00 | 9 | 9 | 30.00 | 9 | 9 |
| &nbsp;&nbsp;&nbsp;Series H | 55.31 | 22 | 22 | 27.25 | 11 |  |
| Total preferred stock |  | $99 | $100 |  | $103 | $96 |

---

*Treasury Stock*

During the nine months ended September 30, 2025 and 2024, the Company repurchased $475 million, or 11,129,200 shares, and $825 million, or 23,006,560 shares, respectively, of its outstanding common stock, which are held in treasury stock.

Citizens Financial Group, Inc. \| 70

------

**NOTE 11 - COMMITMENTS AND CONTINGENCIES** 

A summary of outstanding off-balance sheet arrangements is presented below. For more information on these arrangements, see Note 19 in the Company's 2024 Form 10-K.

---

| | | |
|:---|:---|:---|
| (dollars in millions) | **September 30, 2025** | **December 31, 2024** |
| Commitments to extend credit | $100650 | $93460 |
| Letters of credit | 1901 | 1845 |
| Loans sold with recourse | 89 | 93 |
| Risk participation agreements | 29 | 1 |
| Other commitments | 11 | 14 |
| Total | $102680 | $95413 |

---

*Commitments to Extend Credit*

Commitments to extend credit are agreements to lend to customers in accordance with conditions contractually agreed upon in advance. These commitments generally have fixed expiration dates or termination clauses and may require payment of a fee. Since many of these commitments are expected to expire without being drawn upon, the contract amounts are not necessarily indicative of future cash requirements.

*Letters of Credit* 

Letters of credit in the table above reflect commercial, standby financial, and standby performance letters of credit. Financial and performance standby letters of credit are issued by the Company for the benefit of its customers. They are used as conditional guarantees of payment to a third party in the event the customer either fails to make specific payments (financial) or fails to complete a specific project (performance). The Company's exposure to credit loss in the event of counterparty nonperformance in connection with the above instruments is represented by the contractual amount of those instruments. Letters of credit are generally secured, with collateral including, but not limited to, cash, accounts receivable, inventory, or investment securities. Credit risk associated with letters of credit is considered in determining the appropriate amount of the allowance for unfunded commitments. Standby and commercial letters of credit are issued for terms of up to two years and one year, respectively.

*Loans Sold with Recourse*

The Company is an originator and servicer of residential mortgages and routinely sells such mortgage loans in the secondary market and to GSEs. In the context of such sales, the Company makes certain representations and warranties regarding the characteristics of the underlying loans and, as a result, may be contractually required to repurchase such loans or indemnify certain parties against losses for certain breaches of those representations and warranties. The Company also sells the government guaranteed portion of certain SBA loans to outside investors, for which it retains the servicing rights.

*Risk Participation Agreements*

RPAs are guarantees issued by the Company to other parties for a fee, whereby the Company agrees to participate in the credit risk of a derivative customer of the other party. The current amount of credit exposure is spread out over multiple counterparties. At September 30, 2025, the remaining terms on these RPAs ranged from less than one year to ten years.

*Contingencies*

The Company operates in a legal and regulatory environment that exposes it to potentially significant risks. A certain amount of litigation ordinarily results from the nature of the Company's banking and other businesses. The Company is a party to legal proceedings, including class actions. The Company is also the subject of investigations, reviews, subpoenas, and regulatory matters arising out of its normal business operations which, in some instances, relate to concerns about fair lending, unfair and/or deceptive practices, and mortgage-related issues. In addition, the Company engages in discussions with relevant governmental and regulatory authorities on a regular and ongoing basis regarding various issues, and any issues discussed or identified may result in investigatory or other action being taken. Litigation and regulatory matters may result in settlements, damages, fines, penalties, public or private censure, increased costs, required remediation, restrictions on business activities, or other impacts on the Company.

Citizens Financial Group, Inc. \| 71

------

In these disputes and proceedings, the Company contests liability and the amount of damages as appropriate. Given their complex nature, and based on the Company's experience, it may be years before some of these matters are resolved. Moreover, before liability can be reasonably estimated for a claim, numerous legal and factual issues may need to be examined, including through potentially lengthy discovery and determination of important factual matters, and by addressing novel or unsettled legal issues relevant to the proceedings in question. The Company cannot predict with certainty if, how, or when such claims will be resolved or what the eventual settlement, fine, penalty, or other relief, if any, may be, particularly for claims that are at an early stage in their development or where claimants seek substantial or indeterminate damages. The Company recognizes a provision for a claim when, in the opinion of management after seeking legal advice, it is probable that a liability exists and the amount of loss can be reasonably estimated. In many proceedings, however, it is not possible to determine whether any loss is probable or to estimate the amount of any loss.

Based on information currently available, the advice of legal counsel and other advisers, and established reserves, management believes that the aggregate liabilities, if any, potentially arising from these proceedings will not have a materially adverse effect on the Company's unaudited interim Consolidated Financial Statements.

**NOTE 12 - FAIR VALUE MEASUREMENTS** 

The Company measures or monitors many of its assets and liabilities on a fair value basis. Fair value is used on a recurring basis for assets and liabilities for which fair value is the required or elected measurement basis of accounting. Fair value is also used on a nonrecurring basis to evaluate assets for impairment or for disclosure purposes. Nonrecurring fair value adjustments typically involve the application of lower of cost or market accounting or write-downs of individual assets. Fair value measurement guidance is also applied to disclosures in this Note related to assets and liabilities that are not required to be reported at fair value in the financial statements.

For more information on the measurement of fair value for the Company's assets and liabilities, including the election of the fair value option and valuation techniques utilized to measure fair value on a recurring and nonrecurring basis, see Note 20 in the Company's 2024 Form 10-K.

*Fair Value Option* 

The Company has elected to account for residential mortgage LHFS and certain commercial LHFS at fair value. The following table presents the difference between the aggregate fair value and the aggregate unpaid principal balance of LHFS measured at fair value:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
|<br>(dollars in millions) | **Aggregate Fair Value** | **Aggregate Unpaid Principal** | **Aggregate Fair Value Greater (Less) Than Aggregate Unpaid Principal** | **Aggregate Fair Value** | **Aggregate Unpaid Principal** | **Aggregate Fair Value Greater (Less) Than Aggregate Unpaid Principal** |
| Residential mortgage loans held for sale | $592 | $573 | $19 | $633 | $625 | $8 |
| Commercial loans held for sale | 176 | 186 | (10) | 192 | 199 | (7) |

---

Citizens Financial Group, Inc. \| 72

------

*Recurring Fair Value Measurements*

The Company utilizes a variety of valuation techniques to measure its assets and liabilities at fair value on a recurring basis. The following table presents assets and liabilities measured at fair value, including gross derivative assets and liabilities, on a recurring basis at September 30, 2025:

---

| | | | | |
|:---|:---|:---|:---|:---|
| (dollars in millions) | **Total** | **Level 1** | **Level 2** | **Level 3** |
| **Debt securities available for sale:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Mortgage-backed securities | $30814 | $— | $30814 | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;Collateralized loan obligations | 90 |  | 90 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;State and political subdivisions | 1 |  | 1 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;U.S. Treasury and other | 4514 | 4514 |  |  |
| &nbsp;&nbsp;&nbsp;Total debt securities available for sale | 35419 | 4514 | 30905 |  |
| **Loans held for sale:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Residential loans held for sale | 592 |  | 592 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Commercial loans held for sale | 176 |  | 176 |  |
| &nbsp;&nbsp;Total loans held for sale, at fair value | 768 |  | 768 |  |
| Mortgage servicing rights | 1430 |  |  | 1430 |
| **Derivative assets:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest rate contracts | 492 |  | 492 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign exchange contracts | 563 |  | 563 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Commodities contracts | 438 |  | 438 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;TBA contracts | 7 |  | 7 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Other contracts | 23 |  | 15 | 8 |
| &nbsp;&nbsp;&nbsp;Total derivative assets | 1523 |  | 1515 | 8 |
| Equity securities, at fair value<sup>(1)</sup> | 224 | 224 |  |  |
| Short-term investments | 73 | 30 | 43 |  |
| Total assets | $39437 | $4768 | $33231 | $1438 |
| **Derivative liabilities:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest rate contracts | $489 | $— | $489 | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign exchange contracts | 399 |  | 399 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Commodities contracts | 381 |  | 381 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;TBA contracts | 13 |  | 13 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Other contracts | 4 |  |  | 4 |
| &nbsp;&nbsp;&nbsp;Total derivative liabilities | 1286 |  | 1282 | 4 |
| Short-term borrowed funds | 213 | 203 | 10 |  |
| Other liabilities | 162 |  | 162 |  |
| Total liabilities | $1661 | $203 | $1454 | $4 |

---

<sup>(1)</sup> Excludes investments of $62 million included in Other assets in the Consolidated Balance Sheets that are measured at fair value using the net asset value per share (or its equivalent) practical expedient. These investments include capital contributions to private investment funds and have unfunded capital commitments of $17 million at September 30, 2025, which may be called at any time during prescribed time periods. The credit exposure is generally limited to the carrying amount of investments made and unfunded capital commitments.

Citizens Financial Group, Inc. \| 73

------

The following table presents assets and liabilities measured at fair value, including gross derivative assets and liabilities, on a recurring basis at December 31, 2024:

---

| | | | | |
|:---|:---|:---|:---|:---|
| (dollars in millions) | **Total** | **Level 1** | **Level 2** | **Level 3** |
| **Debt securities available for sale:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Mortgage-backed securities | $29055 | $— | $29055 | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;Collateralized loan obligations | 184 |  | 184 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;State and political subdivisions | 1 |  | 1 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;U.S. Treasury and other | 3525 | 3525 |  |  |
| &nbsp;&nbsp;&nbsp;Total debt securities available for sale | 32765 | 3525 | 29240 |  |
| **Loans held for sale:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Residential loans held for sale | 633 |  | 633 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Commercial loans held for sale | 192 |  | 192 |  |
| &nbsp;&nbsp;Total loans held for sale, at fair value | 825 |  | 825 |  |
| Mortgage servicing rights | 1491 |  |  | 1491 |
| **Derivative assets:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest rate contracts | 562 |  | 562 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign exchange contracts | 472 |  | 472 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Commodities contracts | 429 |  | 429 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;TBA contracts | 10 |  | 10 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Other contracts | 3 |  |  | 3 |
| &nbsp;&nbsp;&nbsp;Total derivative assets | 1476 |  | 1473 | 3 |
| Equity securities, at fair value<sup>(1)</sup> | 162 | 162 |  |  |
| Short-term investments | 53 | 40 | 13 |  |
| Total assets | $36772 | $3727 | $31551 | $1494 |
| **Derivative liabilities:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest rate contracts | $910 | $— | $910 | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign exchange contracts | 411 |  | 411 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Commodities contracts | 379 |  | 379 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;TBA contracts | 8 |  | 8 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Other contracts | 2 |  |  | 2 |
| &nbsp;&nbsp;&nbsp;Total derivative liabilities | 1710 |  | 1708 | 2 |
| Short-term borrowed funds |  |  |  |  |
| Other liabilities | 101 |  | 101 |  |
| Total liabilities | $1811 | $— | $1809 | $2 |

---

<sup>(1)</sup> Excludes investments of $58 million included in Other assets in the Consolidated Balance Sheets that are measured at fair value using the net asset value per share (or its equivalent) practical expedient. These investments include capital contributions to private investment funds and have unfunded capital commitments of $24 million at December 31, 2024, which may be called at any time during prescribed time periods. The credit exposure is generally limited to the carrying amount of investments made and unfunded capital commitments.

Citizens Financial Group, Inc. \| 74

------

The following tables present a roll forward of assets and liabilities measured at fair value on a recurring basis and classified as Level 3:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** |
|<br>(dollars in millions) | **Mortgage Servicing Rights** | **Other Derivative Contracts** | **Mortgage Servicing Rights** | **Other Derivative Contracts** |
| Beginning balance | $1426 | $15 | $1491 | $1 |
| &nbsp;&nbsp;&nbsp;Issuances | 42 | 21 | 117 | 55 |
| &nbsp;&nbsp;Sales<sup>(1)</sup> |  |  | (72) |  |
| &nbsp;&nbsp;Settlements<sup>(2)</sup> | (41) | (33) | (120) | (60) |
| &nbsp;&nbsp;Changes in fair value recognized in earnings<sup>(3)</sup> | 3 | 1 | 14 | 8 |
| Ending balance | $1430 | $4 | $1430 | $4 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** |
|<br>(dollars in millions) | **Mortgage Servicing Rights** | **Other Derivative Contracts** | **Mortgage Servicing Rights** | **Other Derivative Contracts** |
| Beginning balance | $1568 | $6 | $1552 | $7 |
| &nbsp;&nbsp;&nbsp;Issuances | 28 | 18 | 71 | 47 |
| &nbsp;&nbsp;Settlements<sup>(2)</sup> | (46) | (27) | (135) | (50) |
| &nbsp;&nbsp;Changes in fair value recognized in earnings<sup>(3)</sup> | (49) |  | 13 | (7) |
| Ending balance | $1501 | ($3) | $1501 | ($3) |

---

<sup>(1)</sup> For MSRs, represents the sale of the excess servicing yield on MSRs.

<sup>(2)</sup> For MSRs, represents changes in value of the MSRs due to i) the passage of time including the impact from both regularly scheduled loan principal payments and partial paydowns, and ii) loans that paid off during the period. For other derivative contracts, represents the closeout of interest rate lock commitments and other cash payments.

<sup>(3)</sup> Represents changes in fair value primarily driven by market conditions. These changes are recorded in Mortgage banking fees and Other income in the Consolidated Statements of Operations.

The following table presents quantitative information about significant unobservable inputs utilized to measure the fair value of Level 3 assets and liabilities:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | | | **September 30, 2025** | **December 31, 2024** |
|<br>**Financial Instrument**<sup>(1)</sup> |<br>**Valuation Technique** |<br>**Unobservable Input** | **Range (Weighted Average)** | **Range (Weighted Average)** |
| Mortgage servicing rights | Discounted Cash Flow | Constant prepayment rate | 5.86-14.80% CPR (7.10% CPR) | 5.08-16.32% CPR (6.70% CPR) |
| Mortgage servicing rights | Discounted Cash Flow | Option adjusted spread | 398-1,058 bps (608 bps) | 398-1,058 bps (632 bps) |
| Other derivative contracts | Internal Model | Pull through rate | 8.15-99.89% (83.07%) | 5.09-99.90% (83.06%) |
| Other derivative contracts | Internal Model | MSR value | 42.30-171.00 bps (124.76 bps) | 23.91-171.64 bps (121.23 bps) |

---

<sup>(1)</sup> Disclosures related to the fair value measurement of financial instruments deemed immaterial are not included.

*Nonrecurring Fair Value Measurements*

Fair value is also used on a nonrecurring basis to evaluate certain assets for impairment or for disclosure purposes. The following table presents losses on assets measured at fair value on a nonrecurring basis and recorded in earnings:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
|<br>(dollars in millions) | **2025** | **2024** | **2025** | **2024** |
| Collateral-dependent loans | ($39) | ($36) | ($124) | ($156) |

---

The following table presents assets measured at fair value on a nonrecurring basis:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
|<br>(dollars in millions) | **Total** | **Level 1** | **Level 2** | **Level 3** | **Total** | **Level 1** | **Level 2** | **Level 3** |
| Collateral-dependent loans | $677 | $— | $677 | $— | $979 | $— | $979 | $— |

---

Citizens Financial Group, Inc. \| 75

------

*Fair Value of Financial Instruments*

The following tables present the estimated fair value for financial instruments not recorded at fair value in the Consolidated Financial Statements. The carrying amounts are recorded in the Consolidated Balance Sheets under the indicated captions.

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** |
| | **Total** | **Total** | **Level 1** | **Level 1** | **Level 2** | **Level 2** | **Level 3** | **Level 3** |
|<br>(dollars in millions) | **Carrying Value** | **Estimated Fair Value** | **Carrying Value** | **Estimated Fair Value** | **Carrying Value** | **Estimated Fair Value** | **Carrying Value** | **Estimated Fair Value** |
| **Financial assets**<sup>(1)</sup>**:** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Debt securities held to maturity | $8124 | $7295 | $— | $— | $7767 | $6938 | $357 | $357 |
| &nbsp;&nbsp;Loans held for sale | 566 | 566 |  |  |  |  | 566 | 566 |
| &nbsp;&nbsp;Net loans and leases | 138898 | 138627 |  |  | 677 | 677 | 138221 | 137950 |
| &nbsp;&nbsp;Other assets | 710 | 710 |  |  | 689 | 689 | 21 | 21 |
| **Financial liabilities:** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Deposits | 180011 | 179967 |  |  | 180011 | 179967 |  |  |
| &nbsp;&nbsp;Short-term borrowed funds | 1 | 1 |  |  | 1 | 1 |  |  |
| &nbsp;&nbsp;Long-term borrowed funds | 10441 | 10649 |  |  | 10441 | 10649 |  |  |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
| | **Total** | **Total** | **Level 1** | **Level 1** | **Level 2** | **Level 2** | **Level 3** | **Level 3** |
|<br>(dollars in millions) | **Carrying Value** | **Estimated Fair Value** | **Carrying Value** | **Estimated Fair Value** | **Carrying Value** | **Estimated Fair Value** | **Carrying Value** | **Estimated Fair Value** |
| **Financial assets**<sup>(1)</sup>**:** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Debt securities held to maturity | $8599 | $7540 | $— | $— | $8187 | $7136 | $412 | $404 |
| &nbsp;&nbsp;Loans held for sale | 33 | 33 |  |  |  |  | 33 | 33 |
| &nbsp;&nbsp;Net loans and leases | 137142 | 136293 |  |  | 979 | 979 | 136163 | 135314 |
| &nbsp;&nbsp;Other assets | 710 | 710 |  |  | 689 | 689 | 21 | 21 |
| **Financial liabilities:** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Deposits | 174776 | 174651 |  |  | 174776 | 174651 |  |  |
| &nbsp;&nbsp;Long-term borrowed funds | 12401 | 12247 |  |  | 12401 | 12247 |  |  |

---

<sup>(1)</sup> Excludes cash-related financial instruments not recorded at fair value in the Consolidated Balance Sheets with a carrying value and estimated fair value of $12.3 billion and $11.2 billion at September 30, 2025 and December 31, 2024, respectively.

**NOTE 13 - NONINTEREST INCOME** 

A portion of the Company's noninterest income relates to certain fee-based revenue earned from contracts with customers based on the amount of consideration expected to be received upon the transfer of control of a good or service. For a description of the components of revenue from contracts with customers and how each component is recognized for the principal products and services of the Company's business segments, see Note 21 in the Company's 2024 Form 10-K.

The following tables present noninterest income segregated by revenue from contracts with customers and revenue from other sources, disaggregated by business segment. Revenue from other sources primarily includes income from letter of credit and loan fees, foreign exchange and derivative products, and mortgage banking fees.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** |
|<br>(dollars in millions) | **Consumer Banking** | **Commercial Banking** | **Non-Core** | **Other** | **Consolidated** |
| Service charges and fees | $78 | $33 | $— | $— | $111 |
| Card fees | 73 | 12 |  |  | 85 |
| Capital markets fees |  | 158 |  |  | 158 |
| Wealth fees | 93 |  |  |  | 93 |
| Other banking fees | 1 | 4 |  |  | 5 |
| Total revenue from contracts with customers | $245 | $207 | $— | $— | $452 |
| Total revenue from other sources<sup>(1)</sup> | 66 | 79 | 4 | 29 | 178 |
| Total noninterest income | $311 | $286 | $4 | $29 | $630 |

---

Citizens Financial Group, Inc. \| 76

------

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** |
|<br>(dollars in millions) | **Consumer Banking** | **Commercial Banking** | **Non-Core** | **Other** | **Consolidated**  |
| Service charges and fees | $75 | $34 | $— | $— | $109 |
| Card fees | 73 | 12 |  | 6 | 91 |
| Capital markets fees |  | 88 |  |  | 88 |
| Wealth fees | 76 |  |  |  | 76 |
| Other banking fees | 1 | 2 |  |  | 3 |
| Total revenue from contracts with customers | $225 | $136 | $— | $6 | $367 |
| Total revenue from other sources<sup>(1)</sup> | 60 | 71 |  | 34 | 165 |
| Total noninterest income | $285 | $207 | $— | $40 | $532 |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** |
|<br>(dollars in millions) | **Consumer Banking** | **Commercial Banking** | **Non-Core** | **Other** | **Consolidated** |
| Service charges and fees | $229 | $101 | $— | $— | $330 |
| Card fees | 214 | 38 |  |  | 252 |
| Capital markets fees |  | 348 |  |  | 348 |
| Wealth fees | 262 |  |  |  | 262 |
| Other banking fees | 2 | 8 |  |  | 10 |
| Total revenue from contracts with customers | $707 | $495 | $— | $— | $1202 |
| Total revenue from other sources<sup>(1)</sup> | 230 | 238 | 7 | 97 | 572 |
| Total noninterest income | $937 | $733 | $7 | $97 | $1774 |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** |
|<br>(dollars in millions) | **Consumer Banking** | **Commercial Banking** | **Non-Core** | **Other** | **Consolidated** |
| Service charges and fees | $213 | $97 | $— | $— | $310 |
| Card fees | 213 | 40 |  | 13 | 266 |
| Capital markets fees |  | 330 |  |  | 330 |
| Wealth fees | 219 |  |  |  | 219 |
| Other banking fees | 2 | 8 |  | 1 | 11 |
| Total revenue from contracts with customers | $647 | $475 | $— | $14 | $1136 |
| Total revenue from other sources<sup>(1)</sup> | 173 | 201 |  | 92 | 466 |
| Total noninterest income | $820 | $676 | $— | $106 | $1602 |

---

<sup>(1)</sup> Includes bank-owned life insurance income of $30 million and $26 million for the three months ended September 30, 2025 and 2024, respectively, and $85 million and $80 million for the nine months ended September 30, 2025 and 2024, respectively.

For the three months ended September 30, 2025 and 2024, the Company recognized trailing commissions of $4 million related to previous investment sales. For the nine months ended September 30, 2025 and 2024, the Company recognized $12 million and $11 million, respectively.

**NOTE 14 - OTHER OPERATING EXPENSE** 

The following table presents the details of Other operating expense:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
|<br>(dollars in millions) | **2025** | **2024** | **2025** | **2024** |
| Marketing | $44 | $40 | $129 | $124 |
| Deposit insurance<sup>(1)</sup> | 32 | 40 | 108 | 162 |
| Other | 90 | 84 | 254 | 269 |
| Other operating expense | $166 | $164 | $491 | $555 |

---

<sup>(1)</sup> Includes an industry-wide FDIC special assessment of $40 million for the nine months ended September 30, 2024.

Citizens Financial Group, Inc. \| 77

------

**NOTE 15 - EARNINGS PER SHARE**

Basic EPS is the amount of earnings, adjusted for preferred stock dividends and the impact of issuance costs associated with preferred stock redemptions, available to each share of common stock outstanding during the reporting period. Diluted EPS is the amount of earnings available to each share of common stock outstanding during the reporting period adjusted to include the effect of potentially dilutive common shares, which include incremental shares issued for share-based payment awards. Potentially dilutive common shares are excluded from the computation of diluted EPS in periods in which the effect would be antidilutive.

The following table presents the calculation of basic and diluted EPS:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
|<br>(dollars in millions, except per share data) | **2025** | **2024** | **2025** | **2024** |
| **Numerator (basic and diluted):** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income | $494 | $382 | $1303 | $1108 |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: Preferred stock dividends | 32 | 38 | 99 | 103 |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: Impact of preferred stock redemption | 5 |  | 5 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income available to common stockholders | $457 | $344 | $1199 | $1005 |
| **Denominator:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Weighted-average common shares outstanding - basic | 431365552 | 446561996 | 434416696 | 453993833 |
| &nbsp;&nbsp;&nbsp;&nbsp;Dilutive common shares: share-based awards | 4106798 | 3351471 | 3498900 | 2467497 |
| &nbsp;&nbsp;&nbsp;&nbsp;Weighted-average common shares outstanding - diluted | 435472350 | 449913467 | 437915596 | 456461330 |
| **Earnings per common share:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | $1.06 | $0.77 | $2.76 | $2.21 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted<sup>(1)</sup> | 1.05 | 0.77 | 2.74 | 2.20 |

---

<sup>(1)</sup> Excluded from the computation of diluted EPS were weighted-average antidilutive shares totaling 3,454 and 141,698 for the three months ended September 30, 2025 and 2024, respectively, and 16,910 and 409,167 for the nine months ended September 30, 2025 and 2024, respectively.

**NOTE 16 - BUSINESS SEGMENTS** 

The Company is managed by its CODM, the Chief Executive Officer, on a segment basis. The Company's three reportable business segments are Consumer Banking, Commercial Banking, and Non-Core. The business segments are determined based on the products and services provided, or the type of customer served. Each business segment has a segment head that reports directly to the Chief Executive Officer, who has final authority over resource allocation decisions and performance assessment. The business segments reflect this management structure and the manner in which financial information is currently evaluated by the Chief Executive Officer.

The CODM utilizes segment pretax profit or loss as the primary measure to allocate resources to the Company's business segments during the annual budgeting and forecasting process. This measure is also used to assess the performance of each segment, with a focus on monitoring net interest income, noninterest income, and noninterest expense. To ensure effective oversight, the CODM participates in monthly business review meetings, where budget- and forecast-to-actual variances for pretax profit or loss and its components are analyzed. These evaluations inform the CODM's decisions regarding the allocation of capital and resources across the business segments, ensuring alignment with the Company's strategic objectives.

Developing and applying methodologies used to allocate items among the business segments is a dynamic process. Accordingly, financial results may be revised periodically as management systems are enhanced, methods of evaluating performance or product lines are updated, or organizational structure changes occur.

For more information on the Company's business segments, as well as Other non-segment operations, see Note 26 in the Company's 2024 Form 10-K.

Citizens Financial Group, Inc. \| 78

------

The following tables present certain financial data of the Company's business segments:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** |
|<br>(dollars in millions) | **Consumer Banking** | **Commercial Banking** | **Non-Core** | **Other** | **Consolidated** |
| Net interest income | $1262 | $448 | ($7) | ($215) | $1488 |
| Noninterest income | 311 | 286 | 4 | 29 | 630 |
| Total revenue | 1573 | 734 | (3) | (186) | 2118 |
| Direct expenses<sup>(1)(2)</sup> | 692 | 223 | 1 | 419 | 1335 |
| Indirect expenses<sup>(3)</sup> | 287 | 110 | 11 | (408) |  |
| Noninterest expense | 979 | 333 | 12 | 11 | 1335 |
| Profit (loss) before provision (benefit) for credit losses | 594 | 401 | (15) | (197) | 783 |
| Provision (benefit) for credit losses | 81 | 78 | 4 | (9) | 154 |
| Income (loss) before income tax expense (benefit) | 513 | 323 | (19) | (188) | 629 |
| Income tax expense (benefit) | 130 | 75 | (5) | (65) | 135 |
| Net income (loss) | $383 | $248 | ($14) | ($123) | $494 |
| Total average assets | $80729 | $66134 | $4000 | $68254 | $219117 |

---

<sup>(1)</sup> Represents operating expenses incurred by the business segments and primarily includes salaries and employee benefits, equipment and software, outside services, and occupancy.

<sup>(2)</sup> Includes depreciation and amortization of $30 million, $5 million, and $77 million, respectively, for the Consumer Banking, Commercial Banking and Other business segments.

<sup>(3)</sup> Represents allocated corporate overhead from support functions such as information technology, finance, risk, and human resources.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** |
|<br>(dollars in millions) | **Consumer Banking** | **Commercial Banking** | **Non-Core** | **Other** | **Consolidated** |
| Net interest income | $1156 | $478 | ($28) | ($237) | $1369 |
| Noninterest income | 285 | 207 |  | 40 | 532 |
| Total revenue | 1441 | 685 | (28) | (197) | 1901 |
| Direct expenses<sup>(1)(2)</sup> | 586 | 205 | 1 | 467 | 1259 |
| Indirect expenses<sup>(3)</sup> | 330 | 95 | 22 | (447) |  |
| Noninterest expense | 916 | 300 | 23 | 20 | 1259 |
| Profit (loss) before provision (benefit) for credit losses | 525 | 385 | (51) | (217) | 642 |
| Provision (benefit) for credit losses | 84 | 91 | 17 | (20) | 172 |
| Income (loss) before income tax expense (benefit) | 441 | 294 | (68) | (197) | 470 |
| Income tax expense (benefit) | 114 | 63 | (17) | (72) | 88 |
| Net income (loss) | $327 | $231 | ($51) | ($125) | $382 |
| Total average assets | $75392 | $68092 | $8389 | $66705 | $218578 |

---

<sup>(1)</sup> Represents operating expenses incurred by the business segments and primarily includes salaries and employee benefits, equipment and software, outside services, and occupancy.

<sup>(2)</sup> Includes depreciation and amortization of $29 million, $6 million, and $79 million, respectively, for the Consumer Banking, Commercial Banking and Other business segments.

<sup>(3)</sup> Represents allocated corporate overhead from support functions such as information technology, finance, risk, and human resources.

Citizens Financial Group, Inc. \| 79

------

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** |
|<br>(dollars in millions) | **Consumer Banking** | **Commercial Banking** | **Non-Core** | **Other** | **Consolidated** |
| Net interest income | $3673 | $1328 | ($27) | ($658) | $4316 |
| Noninterest income | 937 | 733 | 7 | 97 | 1774 |
| Total revenue | 4610 | 2061 | (20) | (561) | 6090 |
| Direct expenses<sup>(1)(2)</sup> | 2040 | 660 | 2 | 1266 | 3968 |
| Indirect expenses<sup>(3)</sup> | 856 | 317 | 41 | (1214) |  |
| Noninterest expense | 2896 | 977 | 43 | 52 | 3968 |
| Profit (loss) before provision (benefit) for credit losses | 1714 | 1084 | (63) | (613) | 2122 |
| Provision (benefit) for credit losses | 248 | 239 | 43 | (59) | 471 |
| Income (loss) before income tax expense (benefit) | 1466 | 845 | (106) | (554) | 1651 |
| Income tax expense (benefit) | 371 | 195 | (27) | (191) | 348 |
| Net income (loss) | $1095 | $650 | ($79) | ($363) | $1303 |
| Total average assets | $79040 | $65931 | $5241 | $67494 | $217706 |

---

<sup>(1)</sup> Represents operating expenses incurred by the business segments and primarily includes salaries and employee benefits, equipment and software, outside services, and occupancy.

<sup>(2)</sup> Includes depreciation and amortization of $92 million, $15 million, and $230 million, respectively, for the Consumer Banking, Commercial Banking and Other business segments.

<sup>(3)</sup> Represents allocated corporate overhead from support functions such as information technology, finance, risk, and human resources.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** |
|<br>(dollars in millions) | **Consumer Banking** | **Commercial Banking** | **Non-Core** | **Other** | **Consolidated** |
| Net interest income | $3369 | $1486 | ($96) | ($538) | $4221 |
| Noninterest income | 820 | 676 |  | 106 | 1602 |
| Total revenue | 4189 | 2162 | (96) | (432) | 5823 |
| Direct expenses<sup>(1)(2)</sup> | 1728 | 626 | 3 | 1561 | 3918 |
| Indirect expenses<sup>(3)</sup> | 1006 | 302 | 71 | (1379) |  |
| Noninterest expense | 2734 | 928 | 74 | 182 | 3918 |
| Profit (loss) before provision (benefit) for credit losses | 1455 | 1234 | (170) | (614) | 1905 |
| Provision (benefit) for credit losses | 249 | 262 | 46 | (32) | 525 |
| Income (loss) before income tax expense (benefit) | 1206 | 972 | (216) | (582) | 1380 |
| Income tax expense (benefit) | 311 | 223 | (55) | (207) | 272 |
| Net income (loss) | $895 | $749 | ($161) | ($375) | $1108 |
| Total average assets | $74510 | $69046 | $9450 | $66514 | $219520 |

---

<sup>(1)</sup> Represents operating expenses incurred by the business segments and primarily includes salaries and employee benefits, equipment and software, outside services, and occupancy.

<sup>(2)</sup> Includes depreciation and amortization of $84 million, $21 million, and $233 million, respectively, for the Consumer Banking, Commercial Banking and Other business segments.

<sup>(3)</sup> Represents allocated corporate overhead from support functions such as information technology, finance, risk, and human resources.

**ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK**

Quantitative and qualitative disclosures about market risk are presented in the "Market Risk" section of Part I, Item 2 and is incorporated herein by reference.

Citizens Financial Group, Inc. \| 80

------

**ITEM 4. CONTROLS AND PROCEDURES**

The Company maintains a set of disclosure controls and procedures designed to ensure that information required to be disclosed by the Company in reports that it files or submits under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in SEC rules and forms. The design of disclosure controls and procedures is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Controls and procedures, no matter how well designed and operated, can provide only reasonable, not absolute, assurance of achieving the desired control objectives. In accordance with Rule 13a-15(b) of the Exchange Act, as of the end of the period covered by this quarterly report on Form 10-Q, an evaluation was carried out under the supervision and with the participation of the Company's management, including its Chief Executive Officer and Chief Financial Officer, of the effectiveness of its disclosure controls and procedures. Based on that evaluation, the Company's Chief Executive Officer and Chief Financial Officer concluded that the Company's disclosure controls and procedures, as of the end of the period covered by this quarterly report on Form 10-Q, were effective to provide reasonable assurance that information required to be disclosed by the Company in reports that it files or submits under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in SEC rules and forms and is accumulated and communicated to the Company's management, including the Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

There were no changes in our internal control over financial reporting identified in management's evaluation pursuant to Rules 13a-15(d) or 15d-15(d) of the Exchange Act during the period covered by this quarterly report on Form 10-Q that materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.

**PART II. OTHER INFORMATION**

**ITEM 1. LEGAL PROCEEDINGS**

Information required by this item is presented in Note 11 and is incorporated herein by reference.

**ITEM 1A. RISK FACTORS**

In addition to the other information set forth in this Report, you should consider the risks described under Item 1A "Risk Factors" in the Company's 2024 Form 10-K.

**ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS**

Details of the repurchases of the Company's common stock during the three months ended September 30, 2025 are included below:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Period** | **Total Number of Shares Repurchased** | **Average Price Paid Per Share** | **Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs**<sup>(1)</sup> | **Maximum Dollar Amount of Shares That May Yet Be Purchased as Part of Publicly Announced Plans or Programs**<sup>(1)</sup> |
| July 1, 2025 - July 31, 2025 | 1424581 | $49.46 | 1424581 | $1429533677 |
| August 1, 2025 - August 31, 2025 |  | $— |  | $1429533677 |
| September 1, 2025 - September 30, 2025 | 91655 | $49.46 | 91655 | $1425000000 |

---

<sup>(1)</sup> On June 13, 2025, the Company announced that its Board of Directors increased the capacity under its common share repurchase program to $1.5 billion, an increase of $1.2 billion above the $300 million of capacity remaining under the prior June 2024 authorization.

Common stock share repurchases may be executed in the open market or in privately negotiated transactions, including under Rule 10b5-1 plans and accelerated share repurchase and other structured transactions. The timing and exact amount of future share repurchases will be subject to various factors, including the Company's capital position, financial performance, balance sheet growth, market conditions, and regulatory considerations.

**ITEM 3. DEFAULTS UPON SENIOR SECURITIES**

None.

**ITEM 4. MINE SAFETY DISCLOSURES**

Not applicable.

Citizens Financial Group, Inc. \| 81

------

**ITEM 5. OTHER INFORMATION**

None.

**ITEM 6. EXHIBITS**

<u>[3.1 Restated Certificate of Incorporation of the Registrant as in effect on the date hereof, as filed with the Secretary of State of the State of Delaware and effective October 6, 2025 (incorporated herein by reference to Exhibit 3.2 of the Current Report on Form 8-K, filed October 6, 2025)](https://www.sec.gov/Archives/edgar/data/759944/000075994425000133/cfg-cleanrestatedcertifica.htm)</u>

<u>[3.2 Amended and Restated Bylaws of the Registrant (as amended and restated on February 16, 2023) (incorporated herein by reference to Exhibit 3.2 of the Annual Report on Form 10-K, filed February 17, 2023)](https://www.sec.gov/Archives/edgar/data/759944/000075994423000029/exhibit32-2023.htm)</u>

<u>[10.1 Executive Employment Agreement, dated August 6, 2025, between the Registrant and Aunoy Banerjee†\*](abanerjeeexecemploymentagr.htm)</u>

<u>[31.1 Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002\*](a311certexceo302-q32025.htm)</u>

<u>[31.2 Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002\*](a312certexcfo302-q32025.htm)</u>

<u>[32.1 Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002\*](a321certexceo906-q32025.htm)</u>

<u>[32.2 Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002\*](a322certexcfo906-q32025.htm)</u>

101&nbsp;&nbsp;&nbsp;&nbsp;The following materials from the Registrant's Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2025, formatted in inline XBRL: (i) the Consolidated Balance Sheets, (ii) the Consolidated Statements of Operations, (iii) the Consolidated Statements of Comprehensive Income, (iv) the Consolidated Statements of Changes in Stockholders' Equity, (v) the Consolidated Statements of Cash Flows and (vi) the Notes to Consolidated Financial Statements\*

104&nbsp;&nbsp;&nbsp;&nbsp;Cover page interactive data file in inline XBRL format, included in Exhibit 101 to this report\*

† Indicates management contract or compensatory plan or arrangement.

\* Filed herewith.

Citizens Financial Group, Inc. \| 82

------

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on November 3, 2025.

---

| | |
|:---|:---|
| CITIZENS FINANCIAL GROUP, INC. | CITIZENS FINANCIAL GROUP, INC. |
| (Registrant) | (Registrant) |
| By: | /s/ Christopher J. Schnirel |
|  | Name: Christopher J. Schnirel |
|  | Title: Executive Vice President, Chief Accounting Officer and Controller |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(Principal Accounting Officer) |

---

Citizens Financial Group, Inc. \| 83

## Exhibit 10.1

Exhibit 10.1

**EXECUTIVE EMPLOYMENT AGREEMENT** 

This EXECUTIVE EMPLOYMENT AGREEMENT (this "<u>Agreement</u>") is made as of August 6, 2025, by and between Citizens Financial Group, Inc., together with its subsidiaries and any and all successor entities (the "<u>Company</u>" or "<u>Citizens</u>"), and Aunoy Banerjee ("<u>Executive</u>").

WHEREAS the Company desires to employ Executive and to enter into this Agreement embodying the terms of such employment; and

WHEREAS Executive desires to accept such employment and enter into this Agreement.

NOW, THEREFORE, in consideration of the promises and mutual covenants herein and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties agree as follows:

**Section 1. &nbsp;&nbsp;&nbsp;&nbsp;Employment At-Will** 

&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;Executive's employment with the Company shall be strictly "at-will" and not for any fixed term. Executive understands and acknowledges that no statement, whether written or verbal, by the Company or any of its officers, employees or representatives may in any way modify, alter, or change the strictly "at-will" nature of Executive's employment relationship with the Company. Executive understands and agrees that, as an at-will employee, the Company may terminate Executive's employment without advance notice at any time, for any reason or no reason. Executive may terminate Executive's employment for any reason or no reason (a "<u>Resignation</u>") effective One Hundred and Twenty (120) days following delivery of written notice of termination to the Company's (the "<u>Notice Period</u>"); provided, that the Notice Period shall be waived to the extent Executive resigns following Citizens' material breach of this Agreement, which remains uncured thirty (30) days following Executive's provision of written notice to Citizens of such material breach.

&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;Upon receipt of Executive's written notice of Resignation, the Company may, in its sole discretion, waive or shorten the Notice Period, in which case Executive will be permitted to terminate employment immediately or at a time designated by the Company. Under such circumstances, the Company will not be obliged to pay any amount in lieu of notice. Alternatively, the Company may direct Executive not to report to work unless otherwise requested by the Company (the "<u>Garden Leave</u>"). During any period of Garden Leave, as during any Notice Period:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;&nbsp;&nbsp;&nbsp;Executive will remain an employee of the Company and will continue to be paid Executive's then Base Salary (as defined in Section 3(a)) and be eligible for employee benefits. However, Executive shall not be entitled to receive incentive compensation that would otherwise accrue through the Garden Leave.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;&nbsp;&nbsp;&nbsp;Executive will be expected to continue to undertake such duties and responsibilities as are reasonably assigned to Executive by the Chief Executive Officer or their designee, including duties to assist the Company with Executive's transition from the Company and endeavoring in good faith to maintain the Company's business, business relationships, and goodwill. Notwithstanding the foregoing, the Company reserves the right to suspend any or all of Executive's duties and powers and to relocate Executive's office to Executive's personal residence for all or part of the Garden Leave.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)&nbsp;&nbsp;&nbsp;&nbsp;Executive will remain bound by all fiduciary duties and obligations owed to the Company and its affiliates or their respective successors (collectively, the "<u>Company Affiliates</u>" and each a "<u>Company Affiliate</u>") and remain required to comply with all Company policies and practices generally applicable to executives and provided or made available in writing and the provisions of this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv)&nbsp;&nbsp;&nbsp;&nbsp;Executive may not, without the prior written consent of the Company or except in the discharge of duties and responsibilities in accordance with clause (ii) above, contact or attempt to contact any client, customer, potential client or customer, agent, referral source, professional advisor, employee, supplier or broker of the Company or any Company Affiliate.

**Section 2. &nbsp;&nbsp;&nbsp;&nbsp;Position**

&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;*Commencement Date.* The Executive's employment with the Company shall commence on a date to be mutually agreed between the Executive and the Company (the "<u>Commencement Date</u>").

*Position.* Executive shall serve as Executive Vice President, Chief Financial Officer for the Company or in such other capacity of like status as the Company required. Upon hire, Executive shall also be a member of the Executive Committee (ExCo). In this position, Executive shall report to the Chief Executive Officer or to such other person as the Company may specify from time to time.

&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;*Best Efforts.* During Executive's employment, Executive shall: (i) devote Executive's full professional time, attention, skill and energy to the performance of Executive's duties for the Company and any Company Affiliate; (ii) endeavor to dutifully, faithfully and efficiently perform Executive's duties hereunder, comply with the policies, procedures, bylaws, rules, code of conduct and practices of the Company and/or Company Affiliates, as the same may be amended from time to time, and obey all reasonable and lawful directions given by or under the authority of the Chief Executive Officer or designee, as applicable; (iii) refrain from engaging in any other business, profession or occupation for compensation or otherwise which would conflict, directly or indirectly, with the rendition of services to the Company and/or Company Affiliates, without the prior written consent of the Chief Executive Officer or designee. Executive may engage in charitable and community activities and manage Executive's personal investments provided that such activities do not materially interfere with the performance of Executive's duties hereunder or conflict with the conditions of Executive's employment; (iv) refrain from engaging in any conduct prejudicial to the interests and reputation of the Company or any Company Affiliate; and (v) endeavor to promote and extend the business of the Company and the Company Affiliates and protect and further their interests and reputation.

------

&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;*Directorships*. Executive may be required, in the sole discretion of the Company, to perform services for any Company Affiliate and may be required to undertake the role and duties of an officer or director of any Company Affiliate. No additional compensation will be paid in respect of these appointments except as otherwise mutually agreed.

&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;&nbsp;&nbsp;&nbsp;*Location.* Executive's position will be based primarily in Boston, MA, but may be relocated within a fifty (50) mile radius of the same location at the Company's sole discretion. Executive will be eligible for mutually agreeable relocation benefits. Executive may also be required to travel internationally or domestically in the performance of Executive's duties.

**Section 3. &nbsp;&nbsp;&nbsp;&nbsp;Compensation**

&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp; *Base Salary*. The Company shall pay Executive a base salary at the annualized rate of $700,000 (the "<u>Base Salary</u>") in accordance with the Company's regular payroll schedule. Executive shall be entitled to increases in Base Salary as may be determined from time to time in the sole discretion of the Company.

&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;*Incentive Compensation*. Executive will be eligible to participate in the Company's discretionary award program, as amended from time to time. For performance year 2025, Executive shall receive a guaranteed award of $3,700,000 *minus* the 2025 role-based allowance Executive received from Executive's prior employer (the "<u>2025 Guaranteed Award</u>"). For purposes of clarity, this award is in lieu of any additional discretionary award for the 2025 performance year. All subsequent incentive award amounts shall be at the sole discretion of the Company and determined annually based on a mix of factors, including but not limited to individual, team and the Company's performance as well as external economic considerations. The 2025 Guaranteed Award as well as all future discretionary awards may be awarded in cash, equity-based instruments, or in any other form and may also be deferred in full or in part, as determined by the Company. The form and the timing of payment of Executive's award, as well as other terms and conditions, will be consistent with awards granted to similarly situated colleagues. Any award Executive receives will be subject to applicable tax and other required withholdings.

The cash portion of any award will be paid by March 15<sup>th</sup> following the determination of awards and any equity-based instruments granted to Executive as part of Executive's award will be granted as soon as practicable following the determination of awards, in each case, provided that Executive remains employed by Citizens on the payment date or grant date (as applicable), executes the equity award agreement, and neither Executive nor Citizens has given notice to terminate Executive's employment prior to the payment date or grant date (as applicable).

Any equity-based instruments granted to Executive as part of Executive's award will be governed by the applicable equity plan document and award agreement. In the event of any conflict between information contained in this document and the plan or award agreement provisions, the terms of the plan and award agreement will govern. Receiving an award under the discretionary award program in certain years does not guarantee payment or level of award in any subsequent year and any award may be forfeited or reduced (*i.e*., subject to clawback) as determined appropriate by the Company in accordance with the terms of the applicable equity plan document and award agreement. The Company reserves the right to change the rules of any compensation plan or program or to cancel any such plan or program at any time without prior notice in its sole and absolute discretion.

------

**Section 4.&nbsp;&nbsp;&nbsp;&nbsp;Buy-Out Cash Award**

To recognize that Executive will forfeit deferred cash awards granted by Executive's current employer as a result of joining the Company, Executive will receive a deferred cash award valued at $1,500,000**.** The payment schedule of Executive's award shall be:

---

| | |
|:---|:---|
| <u>Vesting Date</u> | <u>Amount</u> |
| Within 30 Days of Executive's Commencement Date | $375000 |
| First Payroll Date Following 11/1/2026 | $375000 |
| First Payroll Date Following 11/1/2027 | $375000 |
| First Payroll Date Following 11/1/2028 | $375000 |

---

**Section 5.&nbsp;&nbsp;&nbsp;&nbsp;Buy-Out Equity Grant**

To recognize that Executive will forfeit equity awards granted by Executive's current employer as a result of joining the Company, Executive will receive a restricted stock unit ("<u>RSU</u>") award in respect of Citizens Financial Group, Inc. common stock subject to approval by the Compensation and Human Resources Committee of the Board of Directors or its delegate.

The grant of Executive's award is subject to Executive providing the following documents to the Company within 90 days of Executive's start date: (1) Statement or other documentation reflecting the forfeiture of Executive's award; and (2) Documentation regarding the terms of Executive's forfeited award (plan document and award agreement, or other applicable document). If satisfactory documentation is not provided within 90 days of the Commencement Date, Executive will forfeit the right to receive Executive's award (or portion of award where forfeiture is not proved) for no consideration.

As of the date of issuance, Executive's buy-out award shall be valued at approximately $3,500,000. In determining the number of RSUs to be granted, $3,500,000 will be divided by the closing price of a Citizens Financial Group, Inc. (CFG) share on the date of grant, rounded down to the nearest whole number of units.

The vesting schedule of Executive's award shall be:

---

| | |
|:---|:---|
| <u>Vesting Date</u> | <u>Value</u> |
| 11/1/2026 | 25% of total RSUs awarded |
| 11/1/2027 | 25% of total RSUs awarded |
| 11/1/2028 | 25% of total RSUs awarded |
| 11/1/2029 | 25% of total RSUs awarded |

---

------

Executive's award will be granted under the Amended and Restated Citizens Financial Group, Inc. 2014 Omnibus Incentive Plan pursuant to an award agreement which will include the terms and conditions of Executive's award. Executive will be required to electronically accept the terms of the award agreement through Fidelity's online system before the award will be processed. Fidelity's online system will include the documents governing the award and will also reflect the award's vesting schedule.

Among other terms, the award agreement will provide that if, within 12 months of Executive's start date, Executive's employment terminates or notice to terminate Executive's employment is given by either party for any reason *other* than (i) death, (ii) disability, (iii) Retirement (as defined in the award agreement), (iv) termination by the Company without cause (as defined in the award agreement) or (v) Executive's resignation following the Company's material breach of this Agreement, which remains uncured thirty (30) days following Executive's written notice to the Company thereof, all outstanding unvested awards will lapse immediately and Executive will be responsible for repaying to the Company the net value (following any applicable tax and other statutory deductions) of any Citizens Financial Group, Inc. shares that Executive has received. Repayment shall be due within 14 calendar days of the date of termination of Executive's employment. If such termination occurs prior to the vesting of the final installment of the award, any unvested portion of the award will lapse immediately for no consideration.

**Section 6.&nbsp;&nbsp;&nbsp;&nbsp;Employee Benefits, Paid Time Off, Reimbursement of Expenses**

&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;*Employee Benefits.* Executive may participate in and receive benefits under any and all benefit plans offered to similarly-situated employees of the Company, subject to the terms and conditions of those plans, policies and programs that are in effect from time to time on terms and conditions no less favorable than those offered to similarly-situated employees, generally. The Company reserves the right to amend the terms and conditions of its employee benefits and the related plans, policies and programs at any time, in the Company's sole discretion.

&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;*Paid Time Off*. Executive shall be entitled to accrue 27 days of paid time off ("<u>PTO</u>") annually, which may be scheduled as time off away from work in accordance with the Company's current PTO policy. For 2025, Executive's PTO will be pro-rated based on the 1<sup>st</sup> of the month following Executive's date of hire.

&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;*Reimbursement of Business Expenses.* Reasonable, customary and necessary travel, entertainment and other business expenses incurred by Executive in the performance of Executive's duties hereunder shall be reimbursed by the Company in accordance with the Company's policies on terms and conditions no less favorable than those offered to similarly-situated employees, generally, subject to the provision of documentation regarding such expenses.

------

&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;&nbsp;&nbsp;&nbsp;*Indemnification and D&O Coverages.* The Company shall indemnify Executive and hold Executive harmless to the fullest extent permitted by law against, and in respect of, any and all actions, suits, proceedings, claims, demands, judgments, costs, expenses (including reasonable attorney fees), losses and damages resulting from the Executive's good faith performance of his duties and obligations with the Company or any Subsidiary or any other entity to which Executive serves at the Company's request. In addition, the Company agrees to continue and maintain, at the Company's sole expense, a directors' and officers' liability insurance policy (including plan fiduciary coverage) covering Executive that is no less favorable than the coverage provided to other directors and senior officers of the Company and its Subsidiaries from time to time. Such indemnification and insurance coverage shall continue in effect both during Executive's employment and, while potential liability exists, thereafter, to the same extent as provided to active directors and senior officers.

**Section 7. &nbsp;&nbsp;&nbsp;&nbsp;Compliance with the Company's Personal Securities Transactions Policy**

Executive is subject to the Company's Personal Securities Transactions Policy, which sets forth the required procedures and processes with respect to purchases and sales of Company securities.

**Section 8. &nbsp;&nbsp;&nbsp;&nbsp;Non-Solicitation** 

&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp; *Non-Solicitation of Employees.* Executive agrees that, at any time during Executive's employment and for twelve (12) months following the date Executive ceases to be employed by the Company for any reason (the "<u>Restricted Period</u>"), Executive shall not, directly or indirectly, whether for Executive's own account or for any person or entity other than the Company or any Company Affiliate hire, employ, solicit for employment or hire, or attempt to solicit for employment or hire, any person who is employed by the Company or any Company Affiliate during the Restricted Period, nor shall Executive directly or indirectly induce any such employee to terminate Executive's employment or accept employment with anyone other than the Company or any Company Affiliate, or otherwise interfere with the relationship between the Company or any Company Affiliate and any of their employees during the Restricted Period. Anything to the contrary notwithstanding, the Company agrees that Executive shall not be deemed in violation of this Section 8 (i) if an entity with which Executive is associated hires or engages any employee of any Company Affiliate, if Executive was not, directly or indirectly, involved in hiring, identifying or approving such person as a potential recruit or employee or assisting in the recruitment of such person or (ii) Executive places general advertisements seeking employees or engages in job searches, in each case, not targeted at employees of the Company or any Company Affiliate.

&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;*Non-Solicitation of, and Non-Interference with, Customers and Prospective Clients.* Executive agrees that during Executive's employment and during the Restricted Period, Executive shall not, directly or indirectly, for any person or entity other than the Company, solicit or assist in soliciting for business any referral source or customer of any Company Affiliate, nor will Executive induce or encourage any such referral source or customer to discontinue or diminish his, her or its relationship or prospective relationship with the Company or any Company Affiliate, or divert business away from the Company or any Company Affiliate;

------

provided, however, that general solicitation through advertisement shall not constitute solicitation for purposes of this provision.

&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;*Representations.* Executive agrees that all of the foregoing restrictions are reasonable and necessary to protect the Company's business and its Confidential Information and that Executive's employment by the Company, along with the benefits and attributes of that employment, is good and valuable consideration to compensate Executive for agreeing to all restrictions contained in this Agreement. Executive also acknowledges, represents and warrants that Executive's knowledge, skills and abilities are sufficient to permit Executive to earn a satisfactory livelihood without violating these provisions. Further, Executive agrees that Executive shall not, following the termination of Executive's employment with the Company, represent or hold Executive out as being in any way connected with the business of the Company.

&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;&nbsp;&nbsp;&nbsp;*Blue Pencil.* It is expressly understood and agreed that although Executive and the Company consider the restrictions contained in this Section 8 to be reasonable, if a final judicial determination is made by an arbitrator or a court of competent jurisdiction that the time or territory or any other restriction contained in this Agreement is an unenforceable restriction against Executive, the provisions of this Agreement shall not be rendered void but shall be deemed amended to apply as to such maximum time and territory and to such maximum extent as such court may judicially determine or indicate to be enforceable. Alternatively, if an arbitrator or a court of competent jurisdiction finds that any restriction contained in this Agreement is unenforceable, and such restriction cannot be amended so as to make it enforceable, such finding shall not affect the enforceability of any of the other restrictions contained herein.

**Section 9. &nbsp;&nbsp;&nbsp;&nbsp;Confidentiality; Ownership of Materials; Duty to Return Company Property**

&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;*Confidential Information.* Executive may not at any time (whether during Executive's employment or after termination) disclose to any unauthorized person, firm or corporation or use or attempt to use for Executive's own advantage or to the advantage of any other person, firm or corporation, any confidential information relating to the business affairs or trade secrets of the Company or any Company Affiliate, or any confidential information about (howsoever obtained) or provided by any third party received during the course of or as a result of Executive's employment (the "<u>Confidential Information</u>"). Confidential Information includes, but is not limited to, confidential or proprietary information relating to employees, customers, referral sources and suppliers (former, actual and potential), Company or any Company Affiliate contracts, pricing structures, financial and marketing details, business plans, personnel strategy, any technical data, designs, formulae, product lines, intellectual property, research activities and any information which may be deemed to be commercially or price sensitive in nature, whether printed, typed, handwritten, videotaped, transmitted or transcribed on data files or on any other type of media, including but not limited to electronic and digital media, whether or not labeled as "confidential". It also includes, without limitation, any information contained in documents marked "confidential" or documents of a higher security classification and other information which, because of its nature or the circumstances in which Executive receives it, Executive should reasonably consider to be confidential. The Company reserves the right to modify the categories of Confidential Information from time to time, upon written notice to Executive.

------

&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;*Exclusions.* Except for information that is protected from disclosure by any applicable law or privilege, nothing in this Agreement prohibits or limits Executive's ability to communicate with any federal, state, or local government agency or commission ("<u>Government Agencies</u>") or otherwise participate in any investigation or proceeding that may be conducted by any Government Agency regarding suspected violations of law or otherwise participate in any legal process between Executive and the Company or any Company Affiliate, including providing documents or other information, without notice to or approval from the Company.

The provisions of this Section 9 shall not apply to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;&nbsp;&nbsp;&nbsp;Information or knowledge which subsequently comes into the public domain or becomes generally known within the Company's industry other than by way of unauthorized use or disclosure by Executive;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;&nbsp;&nbsp;&nbsp;The discharge by Executive of Executive's duties hereunder or where Executive's use or disclosure of the information has otherwise been properly authorized by the Company;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)&nbsp;&nbsp;&nbsp;&nbsp;Any information which Executive discloses in accordance with applicable public interest disclosure legislation;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv)&nbsp;&nbsp;&nbsp;&nbsp;Any disclosure required by law or by any court, arbitrator, mediator or administrative or legislative body (including any committee thereof) with jurisdiction to order Executive to disclose or make accessible any information provided, to the extent legally permitted, Executive provides the Company with five (5) working days' advanced notice before disclosing or making accessible any such information or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v)&nbsp;&nbsp;&nbsp;&nbsp;Any disclosure to Executive's legal, financial or tax advisor, made on a confidential basis for the purposes of seeking legal, financial or tax advice.

&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;*Due Care.* Executive shall exercise all due care and diligence and shall take reasonable steps to prevent the publication or disclosure by Executive of any Confidential Information relating, in particular, but not limited to, actual or proposed transactions, of any employee, customer, client or supplier (whether former, actual or potential) of any Company Affiliate including partnerships, companies, bodies, and corporations having accounts with or in any way connected to or in discussion with any Company Affiliate and all other matters relating to such customers, clients or suppliers and connections.

&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;&nbsp;&nbsp;&nbsp;*Duty to Return Confidential Information and Other Company or Company Affiliate Property.*

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;&nbsp;&nbsp;&nbsp;All reports, files, notes, memoranda, e-mails, accounts, documents or other material (including all notes and memoranda of any Confidential Information and any copies made or received by Executive in the course of Executive's employment (whether during or after)) in any form, including but not limited to electronic and digital media, are and shall remain the sole property of the Company or any Company Affiliate and, following Executive's termination of employment or at any other time upon the request of the Company or any Company Affiliate, to the extent within Executive's possession or control (other than de minimis items), shall be surrendered by Executive to the duly authorized representative of the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;&nbsp;&nbsp;&nbsp;Executive agrees that upon termination of Executive's employment with the Company for any reason, or at any other time upon the Company's request, Executive will return to the Company immediately all memoranda, books, papers, plans, information, letters and other data in any form, including but not limited to electronic and digital media, all copies thereof or therefrom, in any way relating to the business of the Company, all other property of any Company Affiliate (including, but not limited to, company car, credit cards, equipment, correspondence, data, disks, tapes, records, specifications, software, models, notes, reports and other documents together with any extracts or summaries, removable drives or other computer equipment, keys and security passes) in Executive's possession or under Executive's control and Executive further agrees that Executive will not retain or use for Executive's own account at any time any trade names, trademark or other proprietary business designation used or owned in connection with the business of the Company or any Company Affiliate.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding the foregoing, following the termination of Executive's employment, Executive may retain his personal contacts, calendars and correspondence and any information or documents reasonably necessary for the preparation of his tax returns.

&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;&nbsp;&nbsp;&nbsp;*Reasonableness*. Executive agrees that the undertakings set forth in this Section 9 and in Section 8 are reasonable and necessary to protect the legitimate business interests of the Company both during, and after the termination of, Executive's employment, and that the benefits Executive receives under this Agreement are sufficient compensation for these restrictions.

**Section 10. &nbsp;&nbsp;&nbsp;&nbsp;Intellectual Property and Developments**

&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;Executive agrees that all Developments are the sole and exclusive property of the Company and hereby assigns all rights to such Developments to the Company in all countries. Executive agrees, at the Company's expense at any time during Executive's employment or thereafter, to sign all appropriate documents and carry out all such reasonable acts as will be necessary to identify and preserve the legal protection of all Developments; however, the Company will have no obligation to compensate Executive for Executive's time spent in connection with any assistance provided unless otherwise required by law.

------

Notwithstanding the foregoing, Executive understands that no provision in this Agreement is intended to require assignment of any of Executive's rights in an invention for which Executive can prove no equipment, supplies, facilities or Confidential Information or trade secret information of the Company was used, which invention was developed entirely on Executive's own time, and which invention Executive can prove: (a) does not relate to the business of the Company or any Company Affiliate or the actual or demonstrably anticipated research or development of the Company or any Company Affiliate; or (b) does not result from any work performed by Executive for the Company. To the extent compatible with applicable state law, these provisions do not apply to any invention which is required to be assigned by the Company to the United States Government. Executive waives all moral rights in all Intellectual Property which is owned by the Company or any Company Affiliate or will be owned by the Company or any Company Affiliate, pursuant to this Section 10.

For purposes of this section, "<u>Developments</u>" means all inventions, whether or not patentable, Confidential Information, computer programs, copyright works, mask works, trademarks and other intellectual property made, conceived or authored by Executive, alone or jointly with others, while employed by the Company, whether or not during normal business hours or on the Company's premises, that are within the existing or contemplated scope of the Company's business at the time such Developments are made, conceived, or authored or which result from or are suggested by any work Executive or others may do for or on behalf of the Company or any Company Affiliate.

&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;Executive agrees to promptly submit to the Company written disclosures of all inventions, whether or not patentable, which are made, conceived, or authored by Executive, alone or jointly with others, while Executive is employed by the Company.

**Section 11. &nbsp;&nbsp;&nbsp;&nbsp;Certain Agreements**

&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;*Data Protection.* Executive shall learn and abide by the Company's data protection policy, procedures and accountabilities. Executive acknowledges that any breach of these procedures may result in the immediate termination of Executive's employment.

&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;*Personal Information*. Executive acknowledges and agrees that the Company is permitted to hold personal information about Executive as part of its personnel and other business records and, in accordance with applicable law, may use such information in the course of the Company's business.

&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;*Credit Data.* The Company reserves the right, upon five (5) days prior written notice, to, and Executive agrees that the Company may, in accordance with applicable law, carry out searches about Executive through credit reference agencies or through the Company's customer records at any time during Executive's employment for purposes of identifying any serious debt or other significant financial difficulties of Executive for the purposes of detecting, eliminating or mitigating any particular risk of employee fraud or theft. The Company will only retain the information about Executive which the Company obtains from these searches in accordance with applicable law and for so long as is needed for the purposes set out above (subject to any legal (including any regulatory) obligation which requires the Company to retain that information for a longer period). The credit reference agency will record details of the search, but these will not be available for use by lenders to assess the ability of Executive to obtain credit.

------

Executive has the right of access to Executive's personal records held by credit reference agencies. The Company will supply the names and addresses of such agencies upon request, to help Executive to exercise Executive's right of access to such records.

&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;&nbsp;&nbsp;&nbsp;*Indebtedness.* For the reasons referred to above, the Company expects Executive to manage Executive's personal finances responsibly. The Company requires that Executive draw to the attention of Executive's manager any serious debt or significant financial difficulties that he may have, including those which result in court action being taken against Executive.

**Section 12.** &nbsp;&nbsp;&nbsp;&nbsp;**Remedies** 

The Company and Executive agree that it may be impossible to measure solely in money the damages which will accrue to the Company or any Company Affiliate by reason of Executive's failure to observe any of the obligations of Sections 7, 8, 9, or 10 of this Agreement. Therefore, if the Company or any Company Affiliate shall institute any action or proceeding to enforce such provisions, Executive hereby waives the claim or defense that there is an adequate remedy at law and agrees in any such action or proceeding not to interpose the claim or defense that such remedy exists at law. Without limiting any other remedies that may be available to the Company, Executive hereby specifically affirms the appropriateness of injunctive or other equitable relief in any such action and acknowledges that nothing contained within this Agreement shall preclude the Company from seeking or receiving any other relief, including without limitation, any form of injunctive or equitable relief. Executive also agrees that, should he violate the provisions of any restrictive covenant such that the Company shall be forced to undertake any efforts to defend, confirm or declare the validity of the covenants contained within this Agreement, the time restrictions set forth therein shall be extended for a period of time equal to the pendency of any court proceedings, including appeals with respect to the covenants at issue. Further, Executive agrees that, should the Company or any Company Affiliate undertake any efforts to defend, confirm or declare the validity of any of the covenants contained in Sections 7, 8, 9, or 10 of this Agreement, the Company or any Company Affiliate shall be entitled to recover from Executive all its reasonable attorneys' fees and costs incurred in successfully prosecuting or defending any such action or engaging in any such efforts.

**Section 13. &nbsp;&nbsp;&nbsp;&nbsp;No Conflicts**

Executive represents and warrants to the Company that on the Commencement Date, to the best of Executive's knowledge, Executive's acceptance of employment with, and performance of Executive's duties for, the Company or any Company Affiliate will not conflict with or result in a violation or breach of, or constitute a default under, any contract, agreement or understanding to which Executive is, or was, a party or of which Executive is aware and that there are no restrictions, covenants, agreements or limitations on Executive's right or ability to enter into and perform the terms of this Agreement.

------

**Section 14. &nbsp;&nbsp;&nbsp;&nbsp;Severance**

&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;Termination without Cause

In the event Executive is terminated without Cause, Executive shall be entitled to receive a severance payment equal to two (2) weeks of Base Salary per year of service, subject to a minimum severance payment equal to twenty-six (26) weeks of Base Salary (the "<u>No Cause Severance Payment</u>"). The No Cause Severance Payment shall be made in a lump sum, subject to execution and non-revocation of the Company's Standard Release of claims in favor of the Company then in use (the "<u>Standard Release</u>"), within seventy (70) days of the termination of Executive's employment; provided, however, if under the Company's Standard Release, Executive is permitted more than seventy (70) days to sign and not revoke the release, such amount shall still be paid within such seventy (70)-day period. If the period between the termination of Executive's employment and the latest possible effective date of the release spans two calendar years, the severance payment shall be paid by the Company in the second calendar year. "Cause" has the same definition as detailed in Section 14(c).

&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;Change of Control

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;&nbsp;&nbsp;&nbsp;In the event Executive's employment is terminated by the Company without Cause (other than by reason of Executive's death or disability) or the Executive resigns with Good Reason, in each case within twenty-four (24) months following a Change of Control, Executive shall receive a payment equivalent to: (1) two times the sum of (A) Executive's Base Salary at the time of termination and (B) the average cash bonus paid to Executive during the prior three years; plus (2) a pro-rata bonus for the year in which termination occurs, based on the average cash bonus paid to Executive during the prior three years (together, the "<u>COC Severance Payment</u>"). In addition, all outstanding equity awards held by Executive (RSUs and PSUs) would become immediately vested upon involuntary termination under the circumstances described in this Section.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;&nbsp;&nbsp;&nbsp;Any COC Severance Payment made in accordance with this subsection of this Agreement shall be in lieu of and not in addition to any payments to which Executive may otherwise have been entitled in accordance with subsection 14(a) of this Agreement and shall be in full and final settlement of all claims Executive may have arising out of or in connection with his employment or its termination, other than with respect to any outstanding equity held by Executive, which shall be treated as provided for in the applicable Company stock plan and award agreements governing such awards.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)&nbsp;&nbsp;&nbsp;&nbsp;The COC Severance Payment shall be made in a lump sum, subject to execution and non-revocation of the Company's Standard Release within seventy (70) days of the termination of Executive's employment; provided, however, if under the Company's Standard Release, Executive is permitted more than seventy (70) days to sign and not revoke the release, such amount shall still be paid within such seventy (70)-day period. If the period between the termination of Executive's employment and the latest possible effective date of the release spans two calendar years, the severance payment shall be paid by the Company in the second calendar year.

------

&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;Definitions

"<u>Cause</u>" means: (i) any conviction (including a plea of guilty or of *nolo contendere* or entry into a pre-trial diversion program) of Executive for the commission of a felony or any conviction of any criminal offense within the scope of Section 19 of the Federal Deposit Insurance Act, 12 U.S.C. § 1829; (ii) Executive commits an act of gross misconduct, fraud, embezzlement, theft or material dishonesty with the Executive's duties or in the course of Executive's employment with the Company or any Company Affiliate; (iii) failure on the part of Executive to perform his employment duties in any material respect, which is not cured to the reasonably satisfaction of the Company within thirty (30) days after Executive receives written notice of such failure; (iv) Executive materially violates Sections 8, 9, and/or 10 of this Agreement; and/or (v) Executive makes any material false or disparaging comments about the Company or any Company Affiliate, or any Company or Company Affiliate employee, officer, or director, or engages in any such activity which in the opinion of the Company is not consistent with providing an orderly handover of Executive's responsibilities.

"<u>Good Reason</u>" means any of the following changes, as compared to Executive's terms of employment prior to a Change of Control:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A.&nbsp;&nbsp;&nbsp;&nbsp;a material diminution in Executive's authority, duties, or responsibilities (including any materially adverse change in Executive's title or reporting lines);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;B.&nbsp;&nbsp;&nbsp;&nbsp;a material diminution in Executive's base salary other than a general reduction in base salary not to exceed 10% in the aggregate that affects all similarly situated employees; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;C.&nbsp;&nbsp;&nbsp;&nbsp;a relocation of Executive's principal place of employment by more than fifty (50) miles from his current principal place of employment unless the new principal place of employment is closer to Executive's home address.

Provided, however, that Executive's must give written notice to the Company within thirty (30) days of the initial existence of any of the foregoing changes and, the Company shall have thirty (30) days upon receipt of such notice to remedy the condition so as to eliminate the Good Reason, and if not remedied, Executive's employment must terminate no later than sixty (60) days following the expiration of such cure period. Notwithstanding the foregoing, the Executive's continued employment shall not constitute a waiver of the Executive's rights with respect to any circumstance constituting Good Reason.

"<u>Change of Control</u>" means the occurrence of any one or more of the following events:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;&nbsp;&nbsp;&nbsp;any Person (as defined in Section 3(a)(9) of the Exchange Act of 1934, as amended and used in Sections 13(d) and 14(d) thereof, including "group" as defined in Section 13(d) thereof), other than an employee benefit plan or trust maintained by the Company or any Company Affiliate, becomes the Beneficial Owner (as defined in Rule 13d-3 under the Exchange Act of 1934, as amended),

------

directly or indirectly, of securities of the Company representing more than 50% of the combined voting power of the Company's outstanding securities entitled to vote generally in the election of directors;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;&nbsp;&nbsp;&nbsp;at any time during a period of 12 consecutive months, individuals who at the beginning of such period constituted the Board of Directors of the Company (the "<u>Board</u>") and any new member of the Board whose election or nomination for election was approved by a vote of at least a majority of the directors then still in office who either were directors at the beginning of such period or whose election or nomination for election was so approved, cease for any reason to constitute a majority of members of the Board; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)&nbsp;&nbsp;&nbsp;&nbsp;the consummation of (A) a merger or consolidation of the Company with any other corporation or entity, other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior to such merger or consolidation continuing to represent (either by remaining outstanding or being converted into voting securities of the surviving entity or, if applicable, the ultimate parent thereof) at least 50% of the combined voting power and total fair market value of the securities of the Company or such surviving entity or parent outstanding immediately after such merger or consolidation, or (B) any sale, lease, exchange or other transfer to any Person of assets of the Company, in one transaction or a series of related transactions, having an aggregate fair market value of more than 50% of the fair market value of the Company and its subsidiaries (the "<u>Company Value</u>") immediately prior to such transaction(s), but only to the extent that, in connection with such transaction(s) or within a reasonable period thereafter, the Company's shareholders receive distributions of cash and/or assets having a fair market value that is greater than 50% of the Company Value immediately prior to such transaction(s).

**Section 15.&nbsp;&nbsp;&nbsp;&nbsp;Dispute Resolution; Mediation and Arbitration** 

Except as provided in the last sentence of this Section 15 to the fullest extent permitted by law, the Company and Executive agree to waive their rights to seek remedies in court, including but not limited to rights to a trial by jury. The Company and Executive agree that any dispute between or among them or their affiliates or related entities arising out of, relating to or in connection with this Agreement or Executive's employment with the Company, including but not limited to claims for discrimination or other alleged violations of any federal, state or local employment and labor law statutes, ordinances or regulations, will be resolved in accordance with a confidential two-step dispute resolution procedure involving: (1) Step One: non-binding mediation, and (2) Step Two: binding arbitration under the Federal Arbitration Act, 9 U.S.C. § 1, et. seq., or state law, whichever is applicable. Any such mediation or arbitration hereunder shall be under the auspices of the American Arbitration Association ("<u>AAA</u>") pursuant to its then current Employment Arbitration Rules and Mediation Procedures (the "<u>AAA Employment Rules</u>"). Disputes encompassed by this Section 15 include claims for discrimination arising under local, state or federal statutes or ordinances and claims arising under any state's labor laws. Notwithstanding anything to the contrary in the AAA Employment Rules, the mediation process (Step One) may be ended by either party to the dispute upon notice to the other party that it desires to terminate the mediation and proceed to the Step Two arbitration; provided, however, that neither party may so terminate the mediation process prior to the occurrence of at least one (1) mediation session with the mediator.

------

No arbitration shall be initiated or take place with respect to a given dispute if the parties have successfully achieved a mutually agreed to resolution of the dispute as a result of the Step One mediation. The mediation session(s) and, if necessary, the arbitration hearing shall be held in the city nearest to Executive's office location during the course of Executive's employment with the Company or an alternative location mutually agreeable to Executive and the Company.

The arbitration (if the dispute is not resolved by mediation) will be conducted by a single AAA arbitrator, mutually selected by the parties, as provided for by the AAA Employment Rules. The Company will be responsible for the AAA charges, including the costs of the mediator and arbitrator. The Company and Executive agree that the arbitrator shall apply the substantive law of the State of Massachusetts to all state law claims and federal law to any federal law claims, that discovery shall be conducted in accordance with the AAA Employment Rules or as otherwise permitted by law as determined by the arbitrator. In accordance with the AAA Employment Rules (a copy of which is available through AAA's website, www.adr.org), the arbitrator's award shall consist of a written statement as to the disposition of each claim and the relief, if any, awarded on each claim. The Company and Executive understand that the right to appeal or to seek modification of any ruling or award by the arbitrator is limited under state and federal law. Any award rendered by the arbitrator will be final and binding, and judgment may be entered on it in any court of competent jurisdiction. Nothing contained herein shall restrict either party from seeking temporary injunctive relief in a court of law to the extent set forth in this Agreement.

In the unlikely event the AAA refuses to accept jurisdiction over a dispute, Executive and the Company agree to submit to Judicial-Arbitration-Mediation Services ("<u>JAMS</u>") mediation and arbitration applying the JAMS equivalent of the AAA Employment Rules. If AAA and JAMS refuse to accept jurisdiction, the parties may litigate in a court of competent jurisdiction.

**Section 16. Miscellaneous**

&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;*Governing Law.* This Agreement shall be governed by and construed in accordance with the laws of the State of Massachusetts, without regard for the conflict of laws provisions thereof.

&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;*Entire Agreement and Amendments; Survivorship; Strict Construction*.

This Agreement contains the entire understanding and agreement of the parties with respect to the subject matter hereof. There are no restrictions, agreements, promises, warranties, covenants or undertakings between the parties with respect to the subject matter herein other than those expressly set forth or incorporated by reference herein. This Agreement may not be altered, modified, or amended except by written instrument signed by the parties hereto, which attaches a copy of this Agreement.

The respective rights and obligations of the parties hereunder shall survive any termination of this Agreement to the extent necessary to the intended preservation of such rights and obligations.

------

&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;*Section 280G*.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;&nbsp;&nbsp;&nbsp;If the aggregate of all amounts and benefits due to Executive under this Agreement or any other plan, program, agreement or arrangement of the Company or any Company Affiliate, which, if received by Executive in full, would constitute "parachute payments," as such term is defined in and under Section 280G of the Internal Revenue Code of 1986, as amended (the "<u>Code</u>"), (collectively, "<u>Change of Control Benefits</u>"), reduced by all federal, state and local taxes applicable thereto, including the excise tax imposed pursuant to Section 4999 of the Code, is less than the amount Executive would receive, after all such applicable taxes, if Executive received aggregate Change of Control Benefits equal to an amount which is $1.00 less than three (3) times Executive's "base amount," as defined in and determined under Section 280G of the Code, then such Change of Control Benefits shall be reduced or eliminated to the extent necessary so that the Change of Control Benefits received by the Executive will not constitute parachute payments. If a reduction in the Change of Control Benefits is necessary, reduction shall occur in the following order unless the Executive elects in writing a different order, subject to the Company's consent (which shall not be unreasonably withheld or delayed): (i) severance payment based on multiple of Base Salary and/or annual bonus; (ii) other cash payments; (iii) any annual incentive compensation paid as severance; (iv) acceleration of vesting of stock options with an exercise price that exceeds the then fair market value of stock subject to the option, provided such options are not permitted to be valued under Treasury Regulations Section 1.280G-1 Q/A – 24(c); (v) any equity awards accelerated or otherwise valued at full value, provided such equity awards are not permitted to be valued under Treasury Regulations Section 1.280G-1 Q/A – 24(c); (vi) acceleration of vesting of stock options with an exercise price that exceeds the then fair market value of stock subject to the option, provided such options are permitted to be valued under Treasury Regulations Section 1.280G-1 Q/A – 24(c); (vii) acceleration of vesting of all other stock options and equity awards; and (viii) within any category, reductions shall be from the last due payment to the first.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;&nbsp;&nbsp;&nbsp;It is possible that after the determinations and selections made pursuant to Section 16(c)(i), Executive will receive Change of Control Benefits that are, in the aggregate, either more or less than the amounts contemplated by Section 14 above (hereafter referred to as an "<u>Excess Payment</u>" or "<u>Underpayment</u>," respectively). If there is an Excess Payment, Executive shall promptly repay the Company an amount consistent with this Section 16(c). If there is an Underpayment, the Company shall pay Executive an amount consistent with this Section 16(c).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)&nbsp;&nbsp;&nbsp;&nbsp;The determinations with respect to this Section shall be made by an independent auditor (the "<u>Auditor</u>") compensated by the Company. The Auditor shall be the Company's regular independent auditor, unless the regular independent auditor is unable or unwilling to makes such determinations, in which event the Auditor shall be a nationally-recognized United States public accounting firm chosen by the Company.

&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;&nbsp;&nbsp;&nbsp;*Tax Compliance*. All compensation paid to Executive is intended to, and is reasonably believed to, comply with Internal Revenue Code Section 409A ("<u>Section 409A</u>") of the Internal Revenue Code of 1986, as amended, as well as other tax related laws and regulations to the extent it does not fall into any applicable exclusion, and shall be interpreted and construed consistent with that intent.

------

Notwithstanding the foregoing, the Company makes no representations that the terms of this Agreement (and any compensation payable thereunder) comply with Section 409A, and in no event shall the Company be liable for any taxes, interest, penalties or other expenses that may be incurred by Executive on account of non-compliance with Section 409A. No expenses eligible for reimbursement, or in-kind benefits to be provided, during any calendar year shall affect the amounts eligible for reimbursement in any other calendar year, to the extent subject to the requirements of Section 409A, and no such right to reimbursement or right to in-kind benefits shall be subject to liquidation or exchange for any other benefit. For purposes of Section 409A, each payment in a series of installment payments, if any, provided under this Agreement shall be treated as a separate payment. Any payments under this Agreement that may be excluded from Section 409A either as separation pay due to an involuntary separation from service or as a short-term deferral shall be excluded from Section 409A to the maximum extent possible. Any payments to be made under this Agreement upon a termination of employment shall only be made if such termination of employment constitutes a "separation from service" under Section 409A. Notwithstanding the foregoing and any provision in this Agreement to the contrary, if on the date of Executive's termination of employment, Executive is deemed to be a "specified employee" within the meaning of Section 409A and any payment or benefit provided to Executive in connection with Executive's termination of employment is determined to constitute "nonqualified deferred compensation" within the meaning of Section 409A, then such payment or benefit due upon, or within the six-month period following, a termination of Executive's employment (whether under this Agreement, any other plan, program, payroll practice or any equity grant) and which do not otherwise qualify under the exemptions under Treas. Reg. Section 1.409A-1 (including, without limitation, payments that constitute "separation pay" within the meaning of Section 409A), shall be paid or provided to Executive in a lump sum on the earlier of (a) the date which is six months and one day after Executive's "separation from service" (as such term is defined in Section 409A) for any reason other than death, and (b) the date of Executive's death, and any remaining payments and benefits shall be paid or provided in accordance with the payment dates specified in this Agreement for such payment or benefit. If any provision of this Agreement contravenes Section 409A or would cause Executive to be subject to additional taxes, interest or penalties under Section 409A, Executive and the Company shall discuss in good faith modifications to this Agreement in order to mitigate or eliminate such taxes, interest or penalties.

------

In making such modifications the Company and Executive must reasonably attempt to maintain the original intent of the applicable provision without contravening the provisions of Section 409A to the maximum extent practicable.

&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;&nbsp;&nbsp;&nbsp;*No Waiver.* The failure of a party to insist upon strict adherence to any term of this Agreement on any occasion shall not be considered a waiver of such party's rights or deprive such party of the right thereafter to insist upon strict adherence to that term or any other term of this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;&nbsp;&nbsp;&nbsp;*Severability.* In the event that any one or more of the provisions of this Agreement shall be or become invalid, illegal or unenforceable in any respect, the validity, legality and enforceability of the remaining provisions of this Agreement shall not be affected thereby.

&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;&nbsp;&nbsp;&nbsp;*Assignment.* This Agreement shall not be assignable by Executive. This Agreement shall be freely assignable by the Company without restriction.

&nbsp;&nbsp;&nbsp;&nbsp;(h)&nbsp;&nbsp;&nbsp;&nbsp;*Successors; Binding Agreement.* This Agreement shall inure to the benefit of and be binding upon personal or legal representatives, executors, administrators, successors, heirs, distributees, devisees, legatees and permitted assigns. To the extent this Agreement is assigned by the Company, it shall remain secondarily liable for its obligations hereunder. In the event of Executive's death, the Company shall provide his estate (or beneficiaries) with any payments due to Executive under this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;&nbsp;&nbsp;&nbsp;*Notice.* For the purpose of this Agreement, notices and all other communications provided for in the Agreement shall be in writing and shall be deemed to have been duly given when delivered or three (3) business days after mailing registered mail, return receipt requested, postage prepaid or by recognized courier, addressed to the respective addresses set forth on the execution page of this Agreement, provided that all notices to the Company shall be directed to Neil Rosolinsky, Deputy General Counsel, COO, Legal, 437 Madison Ave., 18th fl., New York, NY 10022 or to such other address as either party may have furnished to the other in writing in accordance herewith, except that notice of change of address shall be effective only upon receipt.

&nbsp;&nbsp;&nbsp;&nbsp;(j)&nbsp;&nbsp;&nbsp;&nbsp;*Withholding Taxes; Deductions*. The Company shall withhold from any amounts payable under this Agreement such federal, state and local taxes as are required to be withheld pursuant to any applicable law or regulation. Executive agrees that the Company may, at any time during, or in any event upon termination of Executive's employment, deduct from Executive's compensation, any monies due by Executive to the Company for any undisputed overpayment made and/or outstanding loans that have matured, advances, relocation expenses and/or salary paid in respect of PTO that was taken but not earned, unless otherwise prohibited by law.

&nbsp;&nbsp;&nbsp;&nbsp;(k)&nbsp;&nbsp;&nbsp;&nbsp;*Counterparts; Effectiveness.* This Agreement may be signed in counterparts, each of which shall be an original, with the same effect as if the signatures thereto and hereto were upon the same instrument. This Agreement shall become effective when each party hereto shall have received a counterpart hereof signed by the other party hereto, including by fax or electronic pdf.

------

[Signature Page to Follow]

------

IN WITNESS WHEREOF, the parties hereto have duly executed this Agreement as of the day and year first above written.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;EXECUTIVE

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>/s/ Aunoy Banerjee</u> 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Aunoy Banerjee

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;COMPANY

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>/s/ Susan LaMonica</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;By: &nbsp;&nbsp;&nbsp;&nbsp;Susan LaMonica

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Chief Human Resources Officer

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Citizens Financial Group, Inc.

## Exhibit 31.1

EXHIBIT 31.1

**CERTIFICATION PURSUANT TO** 

**SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002**

_________________________________________________________________________________________

I, Bruce Van Saun, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.&nbsp;&nbsp;&nbsp;&nbsp;I have reviewed this Quarterly Report on Form 10-Q of Citizens Financial Group, Inc.;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.&nbsp;&nbsp;&nbsp;&nbsp;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.&nbsp;&nbsp;&nbsp;&nbsp;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.&nbsp;&nbsp;&nbsp;&nbsp;The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.&nbsp;&nbsp;&nbsp;&nbsp;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.&nbsp;&nbsp;&nbsp;&nbsp;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c.&nbsp;&nbsp;&nbsp;&nbsp;Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d.&nbsp;&nbsp;&nbsp;&nbsp;Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.&nbsp;&nbsp;&nbsp;&nbsp;The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.&nbsp;&nbsp;&nbsp;&nbsp;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.&nbsp;&nbsp;&nbsp;&nbsp;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal controls over financial reporting.

Date: November 3, 2025&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| |
|:---|
| /s/ Bruce Van Saun |
| Bruce Van Saun |
| Chief Executive Officer |

---

## Exhibit 31.2

EXHIBIT 31.2

**CERTIFICATION PURSUANT TO** 

**SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002**

_________________________________________________________________________________________

I, Aunoy Banerjee, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.&nbsp;&nbsp;&nbsp;&nbsp;I have reviewed this Quarterly Report on Form 10-Q of Citizens Financial Group, Inc.;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.&nbsp;&nbsp;&nbsp;&nbsp;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.&nbsp;&nbsp;&nbsp;&nbsp;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.&nbsp;&nbsp;&nbsp;&nbsp;The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.&nbsp;&nbsp;&nbsp;&nbsp;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.&nbsp;&nbsp;&nbsp;&nbsp;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c.&nbsp;&nbsp;&nbsp;&nbsp;Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d.&nbsp;&nbsp;&nbsp;&nbsp;Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.&nbsp;&nbsp;&nbsp;&nbsp;The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.&nbsp;&nbsp;&nbsp;&nbsp;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.&nbsp;&nbsp;&nbsp;&nbsp;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal controls over financial reporting.

Date: November 3, 2025&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| |
|:---|
| /s/ Aunoy Banerjee |
| Aunoy Banerjee |
| Chief Financial Officer |

---

## Exhibit 32.1

EXHIBIT 32.1

**CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,** 

**AS ADOPTED PURSUANT TO SECTION 906**

**OF THE SARBANES-OXLEY ACT OF 2002**

_________________________________________________________________________________________

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned Chief Executive Officer of Citizens Financial Group, Inc. (the "Company"), does hereby certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.&nbsp;&nbsp;&nbsp;&nbsp;The Quarterly Report on Form 10-Q of the Company for the quarter ended September 30, 2025 (the "Form 10-Q") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

&nbsp;&nbsp;&nbsp;&nbsp;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.&nbsp;&nbsp;&nbsp;&nbsp;The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: November 3, 2025

---

| |
|:---|
| /s/ Bruce Van Saun |
| Bruce Van Saun |
| Chief Executive Officer |

---

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff on request.

## Exhibit 32.2

EXHIBIT 32.2

**CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,** 

**AS ADOPTED PURSUANT TO SECTION 906**

**OF THE SARBANES-OXLEY ACT OF 2002**

_________________________________________________________________________________________

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned Chief Financial Officer of Citizens Financial Group, Inc. (the "Company"), does hereby certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.&nbsp;&nbsp;&nbsp;&nbsp;The Quarterly Report on Form 10-Q of the Company for the quarter ended September 30, 2025 (the "Form 10-Q") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

&nbsp;&nbsp;&nbsp;&nbsp;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.&nbsp;&nbsp;&nbsp;&nbsp;The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: November 3, 2025

---

| |
|:---|
| /s/ Aunoy Banerjee |
| Aunoy Banerjee |
| Chief Financial Officer |

---

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff on request.

<br>